13. 多発性硬化症／視神経脊髄炎 Disease details / Clinical trials / Drug dev / DR info

(-)-trans-delta-9-Tetrahydrocannabinol   
   Bionorica research GmbH
      2007   Phase 3   EUCTR2006-004255-38-DK   Austria;Denmark;Germany;
      2007   -   EUCTR2006-004255-38-DE   Austria;Germany;
      2007   -   EUCTR2006-004255-38-AT   Austria;Germany;
(IM) AVONEX®   
   Trio Medicines Ltd.
      2001   Phase 1   NCT01863069   United Kingdom;
(R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methylethyl) benzamide   
   Canbex Therapeutics Ltd
      2015   Phase 2   EUCTR2014-004412-11-GB   United Kingdom;
/0.5ml GA   
   Teva Pharmaceutical Industries Ltd.
      2012   -   EUCTR2011-005550-57-PL   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2012   -   EUCTR2011-005550-57-LV   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2012   -   EUCTR2011-005550-57-GR   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2012   -   EUCTR2011-005550-57-EE   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2012   -   EUCTR2011-005550-57-BG   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
/0.5ml glatiramer acetate   
   Teva Pharmaceutical Industries Ltd.
      2012   -   EUCTR2011-005550-57-PL   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2012   -   EUCTR2011-005550-57-LV   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2012   -   EUCTR2011-005550-57-GR   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2012   -   EUCTR2011-005550-57-EE   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2012   -   EUCTR2011-005550-57-BG   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
0,5 mg Fingolimod   
   Novartis Pharmaceuticals
      2016   Phase 4   NCT02575365   Turkey;
032166011   
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
033283045   
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
034091165   
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
035418060   
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
1 - Andrographis paniculata p/st extract   
   Universidad Austral de Chile
      2012   Phase 1/Phase 2   NCT02280876   Chile;
1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone   
   GlaxoSmithKline Research & Development Ltd
      2013   Phase 2   EUCTR2012-003627-38-GB   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   Phase 2   EUCTR2012-003627-38-BG   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   -   EUCTR2012-003627-38-SE   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   -   EUCTR2012-003627-38-DE   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   -   EUCTR2012-003627-38-CZ   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)   
   Acorda Therapeutics
      2003   Phase 2   NCT00053417   Canada;United States;
10000IU vitamin D   
   University College Dublin
      2012   Phase 1/Phase 2   NCT01728922   Ireland;
11C-ACETATE   
   department of neurology, Osaka university school of medicine
      2015   -   JPRN-UMIN000018154   Japan;
11C-BMS-986196   
   Bristol-Myers Squibb
      2021   Phase 1   NCT05064436   United Kingdom;United States;
11C-MCI   
   National Institute of Mental Health (NIMH)
      2022   Phase 2   NCT05062083   United States;
11C-PBR28   
   Massachusetts General Hospital
      2020   Phase 4   NCT04230174   -
11C-PIB   
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2009   -   EUCTR2008-004174-40-FR   France;
11C]-PK-11195   
   AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
      2016   Phase 2   EUCTR2015-001202-34-IT   Italy;
11C]flumazenil   
   VU University medical center Amsterdam
      2017   Phase 4   EUCTR2017-002636-16-NL   Netherlands;
13-PCV Booster   
   Hoffmann-La Roche
      2015   Phase 3   NCT02545868   Canada;United States;
13-valent pneumococcal conjugate vaccine (13-PCV)   
   Novartis Pharmaceuticals
      2018   Phase 3   NCT03650114   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
1393641-34-3   
   GENEURO SA
      2016   Phase 2   EUCTR2015-004059-29-IT   Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration   
   Celgene International II Sàrl
      2016   Phase 1   EUCTR2016-003073-18-GB   United Kingdom;
18F-DPA-714 and 18F-FDG   
   Assistance Publique - Hôpitaux de Paris
      2012   -   NCT02305264   France;
18F-PM-PBB3   
   Chang Gung Memorial Hospital
      2020   Phase 1/Phase 2   NCT04242056   -
18F]DPA-714   
   VU University Medical Center
      2014   -   EUCTR2014-002547-17-NL   Netherlands;
19 nor vitamin d   
   University of Wisconsin, Madison
      1998   Phase 1   NCT01257958   United States;
2 - Excipients   
   Universidad Austral de Chile
      2012   Phase 1/Phase 2   NCT02280876   Chile;
2 mA Transcranial Direct Current Stimulation   
   University of Iowa
      2020   -   NCT04391023   United States;
2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate ester   
   Queen Mary University London
      2019   Phase 2   EUCTR2019-000169-19-GB   United Kingdom;
2-CdA, 2-chloro-2'-deoxy-beta-D-adenosine   
   MERCK SERONO SA
      2011   Phase 3   EUCTR2009-017978-21-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands;
2-CdA, 2-chloro-2'-deoxy-ß-D-adenosine   
   MERCK SERONO SA
      2011   Phase 3   EUCTR2009-017978-21-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands;
2-CdA, 2-chloro-2?-deoxy-beta-D-adenosine   
   Merck Serono S.A. - Geneva
      2011   Phase 3   EUCTR2009-017978-21-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-CdA, 2-chloro-2?-deoxy-ß-D-adenosine   
   Merck Serono S.A. - Geneva
      2011   Phase 3   EUCTR2009-017978-21-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-CdA, 2-chloro-2’-deoxy-beta-D-adenosine   
   Merck Serono S.A. - Geneva
      2012   Phase 3   EUCTR2009-017978-21-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2012   Phase 3   EUCTR2009-017978-21-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2012   Phase 3   EUCTR2009-017978-21-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-LV   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-FI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   -   EUCTR2009-017978-21-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   -   EUCTR2009-017978-21-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-017978-21-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-CdA, 2-chloro-2’-deoxy-ß-D-adenosine   
   Merck Serono S.A. - Geneva
      2012   Phase 3   EUCTR2009-017978-21-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2012   Phase 3   EUCTR2009-017978-21-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2012   Phase 3   EUCTR2009-017978-21-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-LV   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-FI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   -   EUCTR2009-017978-21-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   -   EUCTR2009-017978-21-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-017978-21-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-chloro-2'-deoxy-beta-D-adenosine (2-CdA)   
   Merck Serono S.A. - Geneva
      2009   Phase 3   EUCTR2008-003706-33-GB   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-chloro-2'-deoxy-ß-D-adenosine (2-CdA)   
   Merck Serono S.A. - Geneva
      2009   Phase 3   EUCTR2008-003706-33-GB   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-chloro-2'-deoxyadenosine (2-CdA)   
   MERCK KGAA
      2018   Phase 4   EUCTR2017-002631-42-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
   Merck KGaA
      2018   Phase 4   EUCTR2017-002632-17-SK   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-SE   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-PT   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-NL   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-LT   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-HU   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-GR   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-GB   Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-FR   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-FI   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-ES   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-DK   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-CZ   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-BE   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2018   Phase 4   EUCTR2017-002632-17-AT   Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2-chloro-2'-deoxyadenosine, 2CdA   
   Merck Serono International S.A.
      2006   -   EUCTR2004-005148-28-LT   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-FI   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-EE   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-DK   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-CZ   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-BE   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
   Merck Serono International, a branch of Laboratoires Serono S.A.
      2005   Phase 3   EUCTR2004-005148-28-GB   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
   Merck Serono International, a branch of Laboratories Serono S.A.
      2005   -   EUCTR2004-005148-28-DE   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
   Serono International S.A.
      2006   Phase 3   EUCTR2004-005148-28-SK   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
      2006   -   EUCTR2004-005148-28-LV   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-AT   Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2-chloro-2?-deoxy-beta-D-adenosine   
   Merck Serono International
      2009   -   EUCTR2008-003706-33-ES   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2?-deoxy-ß-D-adenosine   
   Merck Serono International
      2009   -   EUCTR2008-003706-33-ES   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-beta-D-adenosine   
   Merck Serono International
      2010   -   EUCTR2008-003706-33-GR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2008-003706-33-FR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
   Merck Serono S.A. - Geneva
      2009   -   EUCTR2008-003706-33-NO   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-003706-33-AT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-beta-D-adenosine (2-CdA)   
   Merck Serono S.A. - Geneva
      2009   Phase 3   EUCTR2008-003706-33-BE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2009   -   EUCTR2008-003706-33-SE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2009   -   EUCTR2008-003706-33-DE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2009   -   EUCTR2008-003706-33-CZ   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2009   -   EUCTR2008-003706-33-BG   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2008   -   EUCTR2008-003706-33-FI   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2008   -   EUCTR2008-003706-33-EE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
   Merck Serono SA - Geneva
      2009   -   EUCTR2008-003706-33-PT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-ß-D-adenosine   
   Merck Serono International
      2010   -   EUCTR2008-003706-33-GR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2008-003706-33-FR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
   Merck Serono S.A. - Geneva
      2009   -   EUCTR2008-003706-33-NO   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-003706-33-AT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-ß-D-adenosine (2-CdA)   
   Merck Serono S.A. - Geneva
      2009   Phase 3   EUCTR2008-003706-33-BE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2009   -   EUCTR2008-003706-33-SE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2009   -   EUCTR2008-003706-33-DE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2009   -   EUCTR2008-003706-33-CZ   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2009   -   EUCTR2008-003706-33-BG   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2008   -   EUCTR2008-003706-33-FI   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2008   -   EUCTR2008-003706-33-EE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
   Merck Serono SA - Geneva
      2009   -   EUCTR2008-003706-33-PT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxyadenosine (2-CdA)   
   Merck KGaA
      2018   Phase 4   EUCTR2017-002631-42-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002631-42-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002631-42-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002631-42-FR   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002631-42-FI   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002631-42-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002631-42-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
      2018   Phase 4   EUCTR2017-002631-42-AT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
   Merck Serono International S.A.
      2008   -   EUCTR2007-000381-20-NL   Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
      2008   -   EUCTR2007-000381-20-GR   Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
      2007   Phase 3   EUCTR2007-000381-20-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lithuania;Netherlands;Portugal;United Kingdom;
   Merck Serono S.A. - Geneva
      2008   Phase 3   EUCTR2007-000381-20-GB   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2008   Phase 3   EUCTR2007-000381-20-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-000381-20-PT   Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
      2008   -   EUCTR2007-000381-20-LV   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-000381-20-LT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-000381-20-EE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-000381-20-DK   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-000381-20-DE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-000381-20-CZ   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-000381-20-BG   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2007   -   EUCTR2007-000381-20-FI   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2007   -   EUCTR2007-000381-20-AT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
200106 or EMD 28162   
   Merck Serono
      2011   -   EUCTR2010-020328-23-LV   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2011   -   EUCTR2010-020328-23-LT   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2010   Phase 2   EUCTR2010-020328-23-DK   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2010   -   EUCTR2010-020328-23-FI   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
   Merck Serono SA - Geneva, an affiliate of Merck KGaA
      2012   Phase 2   EUCTR2010-020328-23-PT   Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2011   -   EUCTR2010-020328-23-AT   Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
23-PPV   
   Hoffmann-La Roche
      2015   Phase 3   NCT02545868   Canada;United States;
23-valent pneumococcal polysaccharide vaccine   
   Biogen
      2015   Phase 2   NCT02097849   United States;
23-valent pneumococcal polysaccharide vaccine (23-PPV)   
   Novartis Pharmaceuticals
      2018   Phase 3   NCT03650114   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
25OH-Vitamin D   
   Charité - Universitätsmedizin Berlin
      2011   Phase 2   EUCTR2011-002785-20-DE   Germany;
2B3-201   
   BBB-Therapeutics B.V.
      2013   Phase 1   NCT02048358   Netherlands;
3,4-diaminopyridine   
   Assistance Publique - Hôpitaux de Paris
      2005   Phase 3   NCT00190268   France;
   University of Aarhus
      2006   Phase 2   NCT00342381   Denmark;
4 mA Transcranial Direct Current Stimulation   
   University of Iowa
      2020   -   NCT04391023   United States;
5000IU vitamin D   
   University College Dublin
      2012   Phase 1/Phase 2   NCT01728922   Ireland;
52069.00.01   
   Philipps-Universität Marburg
      2010   -   EUCTR2009-011088-35-DE   Germany;
9060X   
   Allergan
      2008   -   EUCTR2006-006299-39-NL   France;Netherlands;
      2008   -   EUCTR2006-006299-39-FR   France;Netherlands;
   Allergan Ltd.
      2013   -   EUCTR2012-000957-30-PT   Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
      2013   -   EUCTR2012-000957-30-GB   Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
      2012   -   EUCTR2012-000957-30-CZ   Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
      2012   -   EUCTR2012-000957-30-BE   Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
A4I Antagonist   
   Hoffmann-La Roche
      2007   Phase 2   NCT00104143   Bulgaria;Canada;Czech Republic;Finland;Germany;Poland;Russian Federation;Slovakia;Spain;United Kingdom;United States;
AB1010   
   AB Science
      2022   Phase 3   EUCTR2021-000639-30-ES   Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-003735-32-SK   Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom;
      2015   Phase 3   EUCTR2012-003735-32-GR   Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom;
      2015   Phase 3   EUCTR2010-021219-17-BG   Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2010-021219-17-GR   Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey;
      2013   -   EUCTR2010-021219-17-PL   Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;
      2012   Phase 3   EUCTR2010-021219-17-SK   Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-021219-17-ES   Bulgaria;Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;United States;
      2011   Phase 3   EUCTR2010-021219-17-DE   Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
ABR-215062   
   TEVA
      2005   -   EUCTR2004-003943-28-IT   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
   Teva Pharmaceutical Industries Ldt
      2005   Phase 2   EUCTR2005-004334-41-IT   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
ABR-215062 sodium salt   
   Teva Pharmaceutical Industries Ltd
      2010   Phase 3   EUCTR2009-015815-42-SK   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
      2010   Phase 3   EUCTR2009-015815-42-PL   Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
      2010   Phase 3   EUCTR2009-015815-42-LT   Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
      2010   Phase 3   EUCTR2009-015815-42-EE   Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
      2010   Phase 3   EUCTR2009-015815-42-CZ   Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
      2010   Phase 3   EUCTR2009-015815-42-BG   Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
      2010   Phase 3   EUCTR2009-012989-30-SE   Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-012989-30-FR   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2009-012989-30-BG   Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-012989-30-AT   Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2009-012989-30-NL   Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2009-012989-30-LT   Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2009-012989-30-HU   Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2009-012989-30-GB   Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2009-012989-30-ES   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2009-012989-30-EE   Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2009-012989-30-CZ   Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2009-011234-99-DE   Germany;
      2008   -   EUCTR2007-003226-19-PT   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-003226-19-LT   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-003226-19-BG   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   Phase 3   EUCTR2007-003226-19-FR   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   Phase 3   EUCTR2007-003226-19-ES   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003226-19-SE   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003226-19-NL   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003226-19-LV   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003226-19-HU   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003226-19-GB   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003226-19-EE   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003226-19-DE   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003226-19-CZ   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-003226-19-AT   Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2006   Phase 2   EUCTR2005-004334-41-GB   Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom;
      2006   Phase 2   EUCTR2005-004334-41-ES   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
      2006   Phase 2   EUCTR2005-004334-41-DE   Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
      2006   Phase 2   EUCTR2005-004334-41-CZ   Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
      2005   Phase 2   EUCTR2005-004334-41-HU   Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
      2005   Phase 2   EUCTR2004-003943-28-GB   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
      2005   Phase 2   EUCTR2004-003943-28-ES   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
      2005   -   EUCTR2004-003943-28-HU   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
      2005   -   EUCTR2004-003943-28-DE   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
      2005   -   EUCTR2004-003943-28-CZ   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
ABT-555   
   AbbVie
      2016   Phase 1   NCT02601885   United States;
      2015   Phase 1   NCT02606630   United Kingdom;
ABT-874/Human monoclonal antibody against IL-12   
   AbbVie (prior sponsor, Abbott)
      2004   Phase 2   NCT00086671   Canada;Germany;Netherlands;United Kingdom;United States;
ABX-1431 HCl   
   Abide Therapeutics
      2017   Phase 1   NCT03138421   United Kingdom;
ACT-1   
   Actelion Pharmaceuticals Ltd
      2015   Phase 3   EUCTR2012-000540-10-LV   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-LT   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-GR   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-FR   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-FI   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-CZ   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
ACT-128800   
   ACTELION Pharmaceuticals Ltd
      2010   Phase 2   EUCTR2009-011470-15-PL   Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2009-011470-15-NL   Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2009-011470-15-HU   Australia;Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2009-011470-15-GB   Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2009-011470-15-FI   Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2009-011470-15-DE   Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2009-011470-15-CZ   Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2009-011470-15-BG   Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2009-011470-15-AT   Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-011470-15-ES   Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
   ACTELION Pharmaceuticals Ltd.
      2010   Phase 2   EUCTR2009-011470-15-SE   Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
   Actelion Pharmaceuticals Ltd
      2015   Phase 3   EUCTR2012-000540-10-SE   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-PT   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-PL   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-LV   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-LT   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-HU   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-HR   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-GR   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-FR   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-FI   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-ES   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-DE   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-CZ   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2008-006786-92-FR   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-011470-15-IT   Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   Phase 2   EUCTR2008-006786-92-ES   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   Phase 2   EUCTR2008-006786-92-CZ   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   Phase 2   EUCTR2008-006786-92-BE   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-006786-92-SE   Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-006786-92-PL   Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-006786-92-NL   Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-006786-92-HU   Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-006786-92-GB   Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-006786-92-FI   Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-006786-92-BG   Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-006786-92-AT   Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
   Actelion Pharmaceuticals Ltd.
      2019   Phase 3   EUCTR2012-000541-12-HR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004719-10-PT   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004719-10-LV   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004719-10-HU   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004719-10-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004719-10-GR   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004719-10-GB   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004719-10-FI   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004719-10-CZ   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004719-10-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2012-000541-12-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2017   Phase 3   EUCTR2016-004719-10-SE   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-004719-10-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-004719-10-LT   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-004719-10-ES   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2012-000541-12-PL   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2017   Phase 3   EUCTR2012-000541-12-FR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2017   Phase 3   EUCTR2012-000541-12-FI   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2017   Phase 3   EUCTR2012-000541-12-BG   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2016   Phase 3   EUCTR2012-000541-12-PT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2016   Phase 3   EUCTR2012-000541-12-HU   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2016   Phase 3   EUCTR2012-000541-12-GR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2016   Phase 3   EUCTR2012-000541-12-ES   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2016   Phase 3   EUCTR2012-000541-12-DK   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2016   Phase 3   EUCTR2012-000541-12-DE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2016   Phase 3   EUCTR2012-000541-12-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2016   Phase 3   EUCTR2012-000541-12-AT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
      2009   -   EUCTR2008-006786-92-IT   Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
ACT-128800 Dose 1   
   Actelion
      2009   Phase 2   NCT01006265   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
ACT-128800 Dose 2   
   Actelion
      2009   Phase 2   NCT01006265   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
ACT-128800 Dose 3   
   Actelion
      2009   Phase 2   NCT01006265   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
ACTH   
   Neurologique Foundation, Inc.
      2009   Phase 2/Phase 3   NCT00947895   United States;
   Providence Health & Services
      2015   Phase 3   NCT02315872   United States;
   University of Minnesota
      2013   Phase 2   NCT01950234   United States;
   University of Southern California
      2009   Phase 1   NCT01049451   United States;
ACTHAR Gel (ACTH)   
   University of Colorado, Denver
      2013   Phase 4   NCT01838174   United States;
ACTOS (Pioglitazone)   
   University of Illinois at Chicago
      2003   Phase 1   NCT00242177   United States;
ADS-5102   
   Adamas Pharmaceuticals, Inc.
      2015   Phase 2   NCT02471222   United States;
ADS-5102,   
   Adamas Pharmaceuticals, Inc.
      2018   Phase 3   NCT03567057   Canada;United States;
      2018   Phase 3   NCT03436199   Canada;United States;
AERT, (R)-Baclofen   
   Osmotica Pharmaceutical US LLC
      2018   Phase 3   EUCTR2017-004101-40-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2018   Phase 3   EUCTR2017-004101-40-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2018   Phase 3   EUCTR2017-004101-40-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2018   Phase 3   EUCTR2017-004100-22-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2018   Phase 3   EUCTR2017-004100-22-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2018   Phase 3   EUCTR2017-004100-22-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
AGEE cream   
   University of Nebraska
      2010   Phase 4   NCT00988988   United States;
AHSC   
   University Medical Centre Hamburg-Eppendorf
      2020   Phase 2   EUCTR2016-001166-29-DE   Germany;
AIMSPRO   
   Daval International Limited
      2008   Phase 2   EUCTR2006-006872-39-GB   United Kingdom;
AIN   
   NOVARTIS FARMA
      2013   -   EUCTR2012-004019-29-IT   Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
AIN457   
   NOVARTIS FARMA
      2013   -   EUCTR2012-004019-29-IT   Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
   Novartis Farmacéutica, S.A.
      2013   -   EUCTR2012-004019-29-ES   Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
   Novartis Pharma AG
      2013   Phase 2   EUCTR2012-004019-29-CZ   Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
      2013   Phase 2   EUCTR2012-004019-29-BE   Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
      2013   -   EUCTR2012-004019-29-SE   Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
      2013   -   EUCTR2012-004019-29-PT   Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
      2013   -   EUCTR2012-004019-29-PL   Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
      2013   -   EUCTR2012-004019-29-FI   Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
      2013   -   EUCTR2012-004019-29-DE   Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
   Novartis Pharma K.K.
      2013   Phase 2   JPRN-JapicCTI-132178   -
   Novartis Pharma Services AG
      2012   -   EUCTR2011-001629-25-CZ   Czech Republic;Russian Federation;Ukraine;
      2009   Phase 2   EUCTR2009-011626-34-SE   Czech Republic;Sweden;
      2009   -   EUCTR2009-011626-34-CZ   Czech Republic;Russian Federation;Serbia;Sweden;Ukraine;
   Novartis Pharmaceuticals
      2013   Phase 2   NCT01874340   Belgium;Canada;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
      2012   Phase 2   NCT01433250   Czech Republic;Russian Federation;Ukraine;
      2009   Phase 2   NCT01051817   Czech Republic;Russian Federation;Serbia;Sweden;Ukraine;
ALKS 8700   
   Biogen
      2017   Phase 3   NCT03093324   Germany;Poland;United States;
      2015   Phase 3   NCT02634307   Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
ALKS 8700 Delayed Release (DR)   
   Alkermes, Inc.
      2019   Phase 3   EUCTR2017-001294-16-DE   Germany;Poland;United States;
      2017   Phase 3   EUCTR2017-001294-16-PL   Germany;Poland;United States;
ALKS 8700 Delayed Release (DR) Capsule   
   Alkermes, Inc.
      2016   Phase 3   EUCTR2015-005160-41-PL   Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
      2016   Phase 3   EUCTR2015-005160-41-ES   Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
      2016   Phase 3   EUCTR2015-005160-41-BG   Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
      2016   Phase 3   EUCTR2015-005160-41-BE   Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
   Biogen Idec Research Limited
      2016   Phase 3   EUCTR2015-005160-41-DE   Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
ALTRI FARMACI DEL SISTEMA NERVOSO   
   GLAXO SMITHKLINE
      2004   -   EUCTR2004-000374-31-IT   Italy;
ALXN1210   
   ALEXION PHARMACEUTICALS INCORPORATED
      2020   Phase 3   EUCTR2019-003352-37-IT   Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
   Alexion Pharmaceuticals, Inc.
      2020   Phase 3   EUCTR2019-003352-37-PL   Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-003352-37-NL   Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-003352-37-ES   Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-003352-37-DK   Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-003352-37-DE   Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-003352-37-AT   Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
AMILORIDE HYDROCHLORIDE, 2 H2O   
   Universitätsklinik für Neurologie, Medizinische Universität Wien
      2013   -   EUCTR2012-005113-39-AT   Austria;
AN100226   
   Biogen Idec Limited
      2011   -   EUCTR2010-024000-10-ES   Belgium;Germany;Italy;Spain;
      2011   -   EUCTR2010-024000-10-DE   Belgium;Germany;Italy;Spain;
      2011   -   EUCTR2010-024000-10-BE   Belgium;Germany;Italy;Spain;
   Biogen Idec Ltd.
      2004   -   EUCTR2004-000047-18-SE   Sweden;
AN100226, BG00002   
   Biogen Idec Limited
      2012   Phase 3   EUCTR2010-021978-11-IE   Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
      2012   -   EUCTR2010-021978-11-BE   Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-021978-11-GB   Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-021978-11-ES   Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-021978-11-DK   Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-021978-11-CZ   Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
      2011   -   EUCTR2010-021978-11-SE   Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
      2011   -   EUCTR2010-021978-11-PL   Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
      2011   -   EUCTR2010-021978-11-FI   Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
      2011   -   EUCTR2010-021978-11-DE   Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
   Biogen Idec Research Limited
      2019   Phase 3   EUCTR2018-002145-11-NL   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-002145-11-FR   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-002145-11-ES   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-002145-11-DE   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
      2015   Phase 4   EUCTR2013-004622-29-DK   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2015   Phase 4   EUCTR2013-004622-29-DE   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2015   -   EUCTR2013-005586-39-DE   Germany;Italy;United States;
      2014   Phase 4   EUCTR2013-004622-29-SE   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-GB   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-ES   Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-CZ   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   -   EUCTR2013-004622-29-IT   Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2013   -   EUCTR2012-005082-13-IT   Italy;
ANK-700   
   Anokion SA
      2020   Phase 1   NCT04602390   United States;
ARICEPT   
   OSPEDALE S. RAFFAELE
      2008   -   EUCTR2008-001940-38-IT   Italy;
ARN-6039   
   Arrien Pharmaceuticals
      2016   Phase 1   NCT03237832   -
ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI   
   NOVARTIS PHARMA SERVICES AG
      2017   Phase 3   EUCTR2015-005419-33-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA   
   NOVARTIS PHARMA SERVICES AG
      2017   Phase 3   EUCTR2015-005418-31-IT   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
ASA   
   Biogen Idec Research Limited
      2014   -   EUCTR2013-001895-40-IE   Ireland;United Kingdom;
ASB-683699   
   GLAXO SMITHKLINE
      2004   -   EUCTR2004-000374-31-IT   Italy;
ATA188   
   Atara Biotherapeutics
      2017   Phase 1/Phase 2   NCT03283826   Australia;United States;
ATG   
   Baylor College of Medicine
      1999   Phase 2   NCT00040482   United States;
ATL1102   
   Antisense Therapeutics Ltd.
      2007   Phase 2   EUCTR2006-004736-79-SK   Czech Republic;Slovakia;
      2007   -   EUCTR2006-004736-79-CZ   Czech Republic;
ATX-MS-1467   
   Apitope Technology (Bristol) Ltd.
      2010   Phase 1   NCT01097668   Russian Federation;United Kingdom;
   Merck KGaA
      2014   Phase 2   NCT01973491   Germany;
      2013   Phase 2   EUCTR2013-002916-28-LV   Latvia;Russian Federation;
AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA   
   NOVARTIS PHARMA SERVICES AG
      2017   Phase 3   EUCTR2015-005419-33-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-005418-31-IT   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE   
   UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
      2016   Phase 4   EUCTR2016-001515-20-IT   Italy;
AUTOLOGOUS T-LYMPHOCYTES   
   ImCyse S.A
      2014   Phase 1;Phase 2   EUCTR2014-001081-99-BE   Belgium;
AV605   
   Avigen Inc
      2007   Phase 2   EUCTR2007-001031-63-CZ   Czech Republic;Germany;
      2007   -   EUCTR2007-001031-63-DE   Germany;
AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE   
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable   
   Biogen Idec Ltd
      2010   Phase 3   EUCTR2009-012500-11-ES   Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
AVONEX 30 µg/0,5 ml solution for injection   
   Università degli Studi Aldo Moro
      2019   Phase 3   EUCTR2017-005129-18-IT   Italy;
AVONEX IM 4SIR 30MCG/0,5ML 4AG   
   Universita di Firenze
      2006   -   EUCTR2006-004937-13-IT   Italy;
AVONEX*IM 4SIR 30MCG/0,5ML+4AG   
   TEVA ITALIA srl
      2008   -   EUCTR2007-005450-23-IT   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
AVONEX®   
   BIOGEN IDEC RESEARCH LIMITED
      2019   Phase 3   EUCTR2018-003008-38-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
   Biogen Idec Research Limited
      2020   Phase 3   EUCTR2018-003008-38-DE   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-SK   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-PT   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-HU   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-HR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-GR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-ES   Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
      2019   Phase 3   EUCTR2018-003008-38-CZ   Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
      2019   Phase 3   EUCTR2018-003008-38-BG   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-BE   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      -   Phase 3   EUCTR2018-003008-38-FR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
AVP-923   
   Avanir Pharmaceuticals
      2011   Phase 2   NCT01324232   Argentina;Czech Republic;Czechia;Germany;Poland;Spain;United Kingdom;United States;
      2002   Phase 3   NCT00050232   United States;
   Avanir Pharmaceuticals, Inc.
      2012   Phase 2   EUCTR2011-002178-22-GB   Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
      2012   -   EUCTR2011-002178-22-PL   Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
      2012   -   EUCTR2011-002178-22-CZ   Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
      2011   Phase 2   EUCTR2011-002178-22-ES   Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States;
AZATIOPRINA HEX. 50CPR 50MG BL   
   Universita di Firenze
      2006   -   EUCTR2006-004937-13-IT   Italy;
Abatacept   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2010   Phase 2   NCT01116427   Canada;United States;
Abobotulinumtoxin A   
   Neurology Center of New England P.C.
      2018   Phase 3   NCT03585569   United States;
Acetaminophen Tab   
   Columbia University
      2019   Phase 1/Phase 2   NCT03824938   United States;
Acetazolamide   
   The University of Texas Health Science Center, Houston
      2016   Phase 2   NCT02466074   United States;
Acetylsalicylic acid   
   Biogen
      2014   Phase 4   NCT02090413   Ireland;United Kingdom;
Acetylsalicylic acid at 1st visit,   
   Columbia University
      2017   Early Phase 1   NCT03051646   United States;
Aciclovir   
   Genzyme, a Sanofi Company
      2014   Phase 4   NCT02205489   Belgium;France;Netherlands;Spain;
Aclasta 5 mg Infusionslösung   
   Novartis Pharma GmbH
      2010   -   EUCTR2009-011888-37-DE   Germany;
Aclasta 5mg solution for infusion   
   North Bristol Trust
      2009   -   EUCTR2008-005304-93-GB   United Kingdom;
Acthar   
   OhioHealth
      2014   -   NCT02258217   United States;
Acthar Gel   
   Aaron Miller
      2013   -   NCT01900093   United States;
   Tanner Foundation for Multiple Sclerosis
      2013   -   NCT01906684   United States;
Active Comparator receiving Extavia®   
   Charite University, Berlin, Germany
      2013   Phase 2/Phase 3   NCT01647880   Germany;
Active Control   
   Biogen
      2014   Phase 1   NCT02201849   United States;
Acyclovir   
   Genzyme, a Sanofi Company
      2017   Phase 3   NCT03368664   Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      2015   Phase 1   NCT02583594   Spain;
      2014   Phase 1   NCT02282826   Germany;
   Sanofi
      2016   Phase 1   NCT02977533   Germany;
Ad26.COV2.S   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States;
Adderall XR   
   London Health Sciences Centre
      2012   Phase 2/Phase 3   NCT01667484   Canada;
   Sarah Morrow
      2016   Phase 2/Phase 3   NCT02676739   Canada;
Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)   
   Weill Medical College of Cornell University
      2016   Phase 4   NCT02446886   United States;
Albumin (Human) , United States Pharmacopeia (USP)   
   Grifols Therapeutics Inc.
      2002   Phase 2   NCT00220779   Austria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Poland;Slovakia;Sweden;United Kingdom;United States;
Albuterol   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2001   -   NCT00039988   United States;
Alcohol Wipes vs. No Alcohol Wipes   
   Teva Neuroscience, Inc.
      2004   Phase 4   NCT00220922   United States;
Alemtuzumab   
   Cambridge University Hospitals NHS Foundation Trust
      2012   Phase 1/Phase 2   NCT01712945   United Kingdom;
   Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
      2012   Phase 2   EUCTR2011-005606-30-GB   United Kingdom;
   Central Texas Neurology Consultants
      2011   Phase 3   NCT01333358   -
   GENZYME CORPORATION
      2017   Phase 3   EUCTR2016-003100-30-IT   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
   Genzyme Corporation
      2017   Phase 3   EUCTR2016-003100-30-PT   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-NO   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-NL   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-GR   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-GB   Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-ES   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-DE   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-BE   Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-AT   Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      2015   Phase 3;Phase 4   EUCTR2013-003884-71-NL   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2015   Phase 3;Phase 4   EUCTR2013-003884-71-DK   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2009-010788-18-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2015   -   EUCTR2013-003884-71-BE   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
      2014   Phase 4   EUCTR2014-000092-62-NL   Belgium;France;Netherlands;Spain;Switzerland;
      2014   Phase 4   EUCTR2014-000092-62-FR   Belgium;France;Netherlands;Spain;Switzerland;
      2014   Phase 4   EUCTR2014-000092-62-ES   Belgium;France;Netherlands;Spain;Switzerland;
      2014   Phase 4   EUCTR2014-000092-62-BE   Belgium;France;Netherlands;Spain;Switzerland;
      2014   Phase 3;Phase 4   EUCTR2013-003884-71-IT   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
      2014   Phase 3;Phase 4   EUCTR2013-003884-71-HR   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2014   Phase 3;Phase 4   EUCTR2013-003884-71-DE   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2014   Phase 3;Phase 4   EUCTR2013-003884-71-CZ   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2013-003884-71-ES   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
      2011   Phase 3   EUCTR2009-010788-18-IT   Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2009-010788-18-SE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-010788-18-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-010788-18-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-010788-18-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-010788-18-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2009-010788-18-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2009-010788-18-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2009-010788-18-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2008   Phase 3   EUCTR2007-001162-32-FR   Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2007-001162-32-ES   Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2007-001162-32-CZ   Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2007-001162-32-BE   Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2007-001161-14-FR   Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
      2008   -   EUCTR2007-001162-32-SE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-001162-32-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-001162-32-NL   Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-001162-32-IT   Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-001162-32-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-001162-32-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-001162-32-AT   Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-001161-14-SE   Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
      2008   -   EUCTR2007-001161-14-PL   Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
      2008   -   EUCTR2007-001161-14-DE   Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
      2008   -   EUCTR2007-001161-14-CZ   Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
      2007   Phase 3   EUCTR2007-001162-32-GB   Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2007-001161-14-GB   Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
      -   Phase 3   EUCTR2016-003100-30-PL   Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      -   Phase 3   EUCTR2016-003100-30-Outside-EU/EEA   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      -   Phase 3   EUCTR2016-003100-30-FR   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      -   Phase 3   EUCTR2016-003100-30-BG   Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
   Genzyme, a Sanofi Company
      2009   Phase 3   NCT00930553   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2007   Phase 3   NCT00548405   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2007   Phase 3   NCT00530348   Argentina;Australia;Brazil;Canada;Croatia;Czech Republic;Former Serbia and Montenegro;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;United States;
      2002   Phase 2   NCT00050778   Croatia;Poland;Russian Federation;United Kingdom;United States;
   Glostrup University Hospital, Copenhagen
      2017   -   NCT03193086   Denmark;
   Hadassah Medical Organization
      2015   -   NCT02529839   -
   Haukeland University Hospital
      2018   Phase 3   NCT03477500   Denmark;Netherlands;Norway;Sweden;
   Helse Bergen HF, Haukeland University Hospital
      2018   Phase 3   EUCTR2017-001362-25-DK   Denmark;Netherlands;
   Queen Mary University of London
      2017   -   NCT03250169   United Kingdom;
   R&D Addenbrookes Hospital
      2008   Phase 2   EUCTR2005-002305-23-GB   United Kingdom;
   Seah Lim M.D.
      2012   Phase 2   NCT01679041   United States;
   Sheffield Teaching Hospitals
      2020   Phase 3   EUCTR2019-001549-42-GB   United Kingdom;
   University Hospital Muenster
      2015   Phase 4   NCT02419378   Germany;
   University of Aarhus
      2017   -   NCT03806387   Denmark;
   University of Chicago
      2011   Phase 4   NCT01395316   -
   University of Texas Southwestern Medical Center
      2018   Phase 4   NCT03135249   United States;
   Universitätsklinikum Hamburg-Eppendorf
      2021   Phase 2   NCT04971005   Germany;
Alemtuzumab (GZ402673)   
   Genzyme, a Sanofi Company
      2015   -   NCT03774914   Austria;Belgium;Canada;Denmark;Germany;Italy;Spain;Sweden;United Kingdom;United States;
Alemtuzumab GZ402673   
   Genzyme, a Sanofi Company
      2017   Phase 3   NCT03368664   Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      2015   Phase 4   NCT02255656   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
      2015   Phase 1   NCT02583594   Spain;
      2014   Phase 4   NCT02205489   Belgium;France;Netherlands;Spain;
Alemtuzumab Injection   
   Maritime Neurology
      2016   -   NCT04633967   Canada;
Alemtuzumab Injection [Lemtrada]   
   University Hospital Muenster
      2017   -   NCT04082260   Germany;
Alemtuzumab immunotherapy   
   Samuel Forrester Hunter, MD, PhD
      2012   Phase 1   NCT01624714   United States;
Alfuzosin   
   Capital District Health Authority, Canada
      2007   Phase 2/Phase 3   NCT00688948   Canada;
All patients in the study will be treated with ocrelizumab   
   Providence Health & Services
      2020   -   NCT05081700   United States;
AlloRx   
   The Foundation for Orthopaedics and Regenerative Medicine
      2022   Phase 1   NCT05003388   Antigua and Barbuda;
Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells   
   Genesis Limited
      2015   Phase 1/Phase 2   NCT02418325   Trinidad and Tobago;
   Novo Cellular Medicine Institute LLP
      2015   Phase 1/Phase 2   NCT02587715   Trinidad and Tobago;
Allogeneic fecal microbiota   
   St. Petersburg State Pavlov Medical University
      2019   Phase 1   NCT04203017   Russian Federation;
Alpha Lipoic Acid   
   Rebecca Spain
      2018   Phase 1   NCT03493841   United States;
Alpha lipoic acid   
   University of Iowa
      2010   Phase 1   NCT01381354   United States;
Alpha-lipoic acid   
   National Center for Complementary and Integrative Health (NCCIH)
      1999   Phase 1/Phase 2   NCT00010842   United States;
Alpha1-antitrypsin   
   Stanford University
      2014   Phase 1   NCT02087813   United States;
Amantadine   
   FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
      2011   -   EUCTR2010-023678-38-IT   Italy;
   Johns Hopkins University
      2017   Phase 3   NCT03185065   United States;
American ginseng extract HT-1001   
   Oregon Health and Science University
      2005   Phase 2   NCT00754832   United States;
Amiloride   
   UCL
      2014   Phase 2   EUCTR2012-005394-31-GB   United Kingdom;
   University College, London
      2014   Phase 2   NCT01910259   United Kingdom;
   University of Oxford
      2013   Phase 2   NCT01802489   United Kingdom;
Amiloride Hydrochloride   
   Oxford Racliffe NHS Trust
      2008   -   EUCTR2007-004051-11-GB   United Kingdom;
Amilostad HCT tablets   
   Universitätsklinik für Neurologie, Medizinische Universität Wien
      2013   -   EUCTR2012-005113-39-AT   Austria;
Amyvid radiopharmaceutical   
   Brain Health Alliance
      2021   Early Phase 1   NCT04390009   United States;
Anakinra   
   National Institute of Neurological Disorders and Stroke (NINDS)
      2019   Phase 1/Phase 2   NCT04025554   United States;
AndroGel Topical Gel   
   University of California, Los Angeles
      2018   Phase 2   NCT03000127   United States;
Androgel 10 grams of gel containing 100 mg of testosterone   
   University of California, Los Angeles
      2002   Phase 1/Phase 2   NCT00405353   United States;
Andrographolides   
   Innobioscience SpA
      2014   Phase 1/Phase 2   NCT02273635   Chile;
Anesthetic Topical Adhesive Synera   
   Brown, Theodore R., M.D., MPH
      2013   Phase 4   NCT01834586   United States;
Anti LP40 antibody, subclass IgG4 LA294   
   Eli Lilly and Company
      2010   -   EUCTR2008-007459-28-BG   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
      2009   Phase 2   EUCTR2008-007459-28-FR   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
      2009   -   EUCTR2008-007459-28-HU   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
      2009   -   EUCTR2008-007459-28-FI   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
      2009   -   EUCTR2008-007459-28-DK   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
      2009   -   EUCTR2008-007459-28-DE   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
      2009   -   EUCTR2008-007459-28-CZ   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
      2009   -   EUCTR2008-007459-28-BE   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
Anti-CD25 Humanized Monoclonal Antibody   
   Protein Design Labs, Inc.
      2006   -   EUCTR2005-001567-55-DE   Germany;Spain;United Kingdom;
      2005   Phase 2   EUCTR2005-001567-55-GB   Austria;Germany;Spain;United Kingdom;
      2005   -   EUCTR2005-001567-55-ES   Germany;Spain;United Kingdom;
      2005   -   EUCTR2005-001567-55-AT   Austria;Germany;Spain;United Kingdom;
Anti-CD52 monoclonal antibody   
   Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
      2012   Phase 2   EUCTR2011-005606-30-GB   United Kingdom;
Anti-Thymocyte Globulin   
   Fred Hutchinson Cancer Research Center
      2008   Phase 2   NCT00716066   United States;
Anti-thymocyte globulin   
   Fred Hutchinson Cancer Research Center
      1997   Phase 1   NCT00014755   United States;
Anticholinergic medication   
   Wellspect HealthCare
      2009   -   NCT00913510   Belgium;France;Germany;Netherlands;United Kingdom;
Anticuerpo monoclonal anti-LINGO-1 humano   
   Biogen Idec Research Limited
      2013   Phase 2   EUCTR2011-006262-40-ES   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Antihistamine   
   Genentech, Inc.
      2016   Phase 3   NCT02688985   Canada;Germany;Sweden;United States;
   Hoffmann-La Roche
      2020   Phase 3   NCT04548999   Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   NCT04544436   Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
   Providence Health & Services
      2020   Phase 3   NCT04175834   United States;
Antimycotic   
   Università Popolare Homo & Natura
      2015   Phase 1   NCT02632591   Italy;
Antithymocyte   
   Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
      2006   -   EUCTR2006-002562-19-IT   Italy;
Antithymocyte immunoglobulin (rabbit)   
   AZIENDA OSPEDALIERA DI PADOVA
      -   Phase 1   EUCTR2008-005773-35-IT   Italy;
Anxiety/depression and work and activities   
   University Hospital, Strasbourg, France
      2019   Phase 2   NCT03910738   France;
Apitox - pure honeybee toxin   
   Apimeds, Inc.
      2019   Phase 3   NCT03710655   -
Arbaclofen   
   Osmotica Pharmaceutical US LLC
      2018   Phase 3   NCT03319732   United States;
      2018   Phase 3   NCT03290131   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Serbia;United States;
      2013   Phase 3   NCT01844232   Russian Federation;Ukraine;United States;
      2012   Phase 3   NCT01743651   Russian Federation;Ukraine;United States;
Arbaclofen ER Tablets   
   Osmotica Pharmaceutical US LLC
      2016   Phase 3   NCT02869425   United States;
Arbaclofen Extended Release Tablets   
   Osmotica Pharmaceutical US LLC
      2018   Phase 3   EUCTR2017-004101-40-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2018   Phase 3   EUCTR2017-004101-40-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2018   Phase 3   EUCTR2017-004101-40-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2018   Phase 3   EUCTR2017-004100-22-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2018   Phase 3   EUCTR2017-004100-22-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2018   Phase 3   EUCTR2017-004100-22-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
Arbaclofen placarbil 15 mg BID   
   XenoPort, Inc.
      2011   Phase 3   NCT01359566   United States;
Arbaclofen placarbil 30 mg BID   
   XenoPort, Inc.
      2011   Phase 3   NCT01359566   United States;
Arbaclofen placarbil 45 mg BID   
   XenoPort, Inc.
      2011   Phase 3   NCT01359566   United States;
Aricept 10 mg filmdragerade tabletter   
   Neurology Unit
      2005   -   EUCTR2005-003410-15-SE   Sweden;
Aricept 5 mg filmdragerade tabletter   
   Neurology Unit
      2005   -   EUCTR2005-003410-15-SE   Sweden;
Arm 1 - GEH120714 (18F) Injection   
   GE Healthcare
      2013   Phase 1   NCT01738347   Canada;United States;
Armodafinil   
   University of Missouri, Kansas City
      2009   Phase 2/Phase 3   NCT00981084   United States;
Arzerra   
   GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.
      2012   -   EUCTR2011-002333-19-IT   Canada;Czech Republic;Germany;Italy;Netherlands;Russian Federation;Spain;United States;
   NOVARTIS PHARMA AG
      2018   Phase 2   EUCTR2017-004702-17-IT   Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
   Novartis Farmacéutica S.A.
      2020   Phase 3   EUCTR2019-001341-40-ES   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
   Novartis Farmacéutica, S.A
      2019   Phase 3   EUCTR2017-004703-51-ES   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
   Novartis Farmacéutica, S.A.
      2018   Phase 2   EUCTR2017-004702-17-ES   Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
      2016   Phase 3   EUCTR2015-005419-33-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-ES   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
   Novartis Pharma Services AG
      2016   Phase 3   EUCTR2015-005419-33-SK   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
   Novartis Pharma AG
      2021   Phase 3   EUCTR2019-001341-40-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-001341-40-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-001341-40-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-001341-40-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-001341-40-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-LV   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-LT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-HR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-GR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-FR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-FI   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-DK   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004703-51-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2019   Phase 2   EUCTR2017-004702-17-PL   Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
      2018   Phase 3   EUCTR2017-004703-51-SK   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-004703-51-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-004703-51-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-004703-51-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-004702-17-LV   Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
      2018   Phase 2   EUCTR2017-004702-17-LT   Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
      2018   Phase 2   EUCTR2017-004702-17-EE   Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
      2018   Phase 2   EUCTR2017-004702-17-CZ   Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
      2018   Phase 2   EUCTR2017-004702-17-BG   Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
      2018   Phase 2   EUCTR2017-004702-17-AT   Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
      2017   Phase 3   EUCTR2015-005418-31-FR   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-HU   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-GR   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-BE   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
   Novartis Pharma Services AG
      2017   Phase 3   EUCTR2015-005419-33-HR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-005419-33-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-005419-33-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-005418-31-NL   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-005418-31-CZ   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-LT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-FI   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-SK   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-SE   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-PL   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-HR   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-GB   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-EE   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-DE   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-BG   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Arzerra®   
   GlaxoSmithKline Research and Development Limited
      2012   -   EUCTR2011-002333-19-CZ   Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
      2011   Phase 2   EUCTR2011-002333-19-DK   Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
      2011   -   EUCTR2011-002333-19-NL   Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
   GlaxoSmithKline SA
      2011   Phase 2   EUCTR2011-002333-19-ES   Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
Aspirin 650mg Oral Capsule   
   Columbia University
      2019   Phase 1/Phase 2   NCT03824938   United States;
Atacicept   
   EMD Serono
      2009   Phase 2   NCT00853762   Australia;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;New Caledonia;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2008   Phase 2   NCT00642902   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
   Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany
      2008   -   EUCTR2007-003936-50-SE   Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
   Merck Serono International
      2009   Phase 2   EUCTR2008-005021-11-FR   Belgium;Czech Republic;France;Sweden;
      2009   Phase 2   EUCTR2008-005021-11-CZ   Belgium;Czech Republic;France;Sweden;
      2009   -   EUCTR2008-005021-11-SE   Belgium;Czech Republic;France;Sweden;
   Merck Serono International S.A.
      2008   Phase 2   EUCTR2007-003936-50-FR   Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
      2008   Phase 2   EUCTR2007-003936-50-ES   Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-003936-50-NL   Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
   Merck Serono S.A. - Geneva
      2008   -   EUCTR2007-003936-50-GB   Australia;Austria;Canada;Czech Republic;France;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-003936-50-AT   Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
   Merck Serono SA - Geneva, An affiliate of Merck KGaA, Darmstadt, Germany
      2009   -   EUCTR2008-005021-11-BE   Belgium;Czech Republic;France;Sweden;
   Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
      2008   -   EUCTR2007-003936-50-CZ   Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-003936-50-BE   Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
   Merck Serono SA-Geneva
      2008   -   EUCTR2007-003936-50-LT   Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Atomoxetine   
   Icahn School of Medicine at Mount Sinai
      2017   Phase 2   NCT03091400   United States;
Atorvastatin   
   DR DIMENSIONE RICERCA
      2005   -   EUCTR2005-001009-25-IT   Italy;
   National Institute of Allergy and Infectious Diseases (NIAID)
      2005   Phase 2   NCT00094172   Canada;United States;
   Sun Yat-sen University
      2006   -   NCT00818103   China;
   University Hospital Inselspital, Berne
      2005   Phase 2   NCT00942591   Switzerland;
Aubagio   
   F. HOFFMANN - LA ROCHE LTD.
      2021   Phase 3   EUCTR2020-001168-28-IT   Bulgaria;Denmark;Finland;France;Italy;Netherlands;United States;
      2021   Phase 3   EUCTR2019-004857-10-IT   Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
   F. Hoffman-La Roche
      2021   Phase 3   EUCTR2020-001168-28-DK   Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Greece;India;Italy;Korea, Republic of;Mexico;Poland;Portugal;Russian Federation;Turkey;United Kingdom;United States;
   F. Hoffmann-La Roche Ltd
      2021   Phase 3   EUCTR2020-001168-28-BG   Bulgaria;Finland;France;Netherlands;United States;
      2021   Phase 3   EUCTR2019-004857-10-NL   Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
      2021   Phase 3   EUCTR2019-004857-10-HU   Finland;France;Germany;Hungary;Netherlands;Portugal;United States;
      2021   Phase 3   EUCTR2019-004857-10-DE   Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
      2020   Phase 3   EUCTR2019-004857-10-FI   Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
   GENZYME CORPORATION
      2020   Phase 3   EUCTR2020-000637-41-IT   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
   Genzyme Corporation
      2021   Phase 3   EUCTR2020-000644-55-DE   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000637-41-AT   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000644-55-SK   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-PT   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-NL   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-LV   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-HU   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-GR   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-GB   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-FR   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-CZ   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000637-41-SE   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-PL   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-LT   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-FI   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-DK   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-DE   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-CZ   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-BG   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2014   Phase 4   EUCTR2013-001439-34-IT   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-001439-34-GR   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-001439-34-GB   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-001439-34-DE   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-001439-34-BE   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-001439-34-AT   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2013   Phase 4   EUCTR2013-001439-34-SE   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2013   Phase 4   EUCTR2013-001439-34-FI   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2013   Phase 4   EUCTR2013-001439-34-ES   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
   MERCK HEALTHCARE KGaA
      2020   Phase 3   EUCTR2019-004980-36-IT   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
   MS Centrum, Department of Neurology, Sshlgrenska University Hospital
      2018   Phase 4   EUCTR2016-004414-10-SE   Sweden;
   Merck Healthcare KGaA
      2021   Phase 3   EUCTR2019-004980-36-SI   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-004980-36-SK   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-004980-36-PT   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-004980-36-NO   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-004980-36-LV   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-004980-36-LT   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-004980-36-GR   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-004980-36-DE   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-004980-36-BG   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-004972-20-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-004972-20-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-004972-20-FI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-004972-20-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-004972-20-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-004972-20-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-004972-20-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2019-004972-20-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
   Novartis Farmacéutica S.A.
      2022   Phase 3   EUCTR2020-005929-89-ES   Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
      2022   Phase 3   EUCTR2020-005899-36-ES   Slovakia;Spain;
   Novartis Farmacéutica, S.A.
      2016   Phase 3   EUCTR2015-005419-33-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-ES   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
   Novartis Pharma Services AG
      2016   Phase 3   EUCTR2015-005419-33-SK   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
   Novartis Pharma AG
      2022   Phase 3   EUCTR2020-005929-89-SE   Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
      2022   Phase 3   EUCTR2020-005899-36-SK   Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-005418-31-FR   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-HU   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-GR   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-BE   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
   Novartis Pharma Services AG
      2017   Phase 3   EUCTR2015-005419-33-HR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-005419-33-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-005419-33-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-005418-31-NL   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-005418-31-CZ   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-LT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-FI   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005419-33-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-SK   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-SE   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-PL   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-HR   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-GB   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-EE   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-DK   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-DE   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-005418-31-BG   Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Aubagio 14 mg film-coated tablets   
   F. Hoffmann-La Roche Ltd
      2021   Phase 3   EUCTR2019-004857-10-PT   Finland;France;Germany;Netherlands;Portugal;United States;
Aubagio®   
   Actelion Pharmaceuticals Ltd
      2015   Phase 3   EUCTR2012-000540-10-SE   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-PT   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-PL   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-LV   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-LT   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-HU   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-HR   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-GR   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-FR   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-FI   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-ES   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-DE   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2012-000540-10-CZ   Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Autologous Bone Marrow-Derived Mononuclear Stem Cells   
   Genesis Limited
      2015   Phase 1/Phase 2   NCT02418351   India;Trinidad and Tobago;
   Novo Cellular Medicine Institute LLP
      2015   Phase 1/Phase 2   NCT02587806   India;Trinidad and Tobago;
Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope   
   Imcyse SA
      2015   Phase 1/Phase 2   NCT02427776   Belgium;
Autologous Hematopoietic Stem Cell   
   Makati Medical Center
      2015   Phase 1   NCT03113162   Philippines;
Autologous Hematopoietic Stem Cell Transplantation   
   Fred Hutchinson Cancer Research Center
      2008   Phase 2   NCT00716066   United States;
   National Institute of Allergy and Infectious Diseases (NIAID)
      2019   Phase 3   NCT04047628   United Kingdom;United States;
   Universitätsklinikum Hamburg-Eppendorf
      2021   Phase 2   NCT04971005   Germany;
Autologous Mesenchymal Cell Product   
   Imperial College London
      2012   Phase 2   EUCTR2012-002357-35-GB   United Kingdom;
Autologous Mesenchymal Stem Cells   
   Antonio Uccelli
      2012   Phase 1/Phase 2   NCT01854957   Italy;
   University of Jordan
      2012   Phase 1/Phase 2   NCT01895439   Jordan;
Autologous Stem Cell Transplantation   
   Northwestern Memorial Hospital
      2001   Phase 1   NCT00017628   United States;
Autologous Stem Cells   
   Northwestern University
      2019   Phase 2/Phase 3   NCT03829566   United States;
      2017   Phase 3   NCT03342638   United States;
Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)   
   Fundació Institut Germans Trias i Pujol
      2017   Phase 1   NCT02903537   Spain;
Autologous adipose derived mesenchymal cells   
   American CryoStem Corporation
      2014   Phase 1   NCT02326935   Cayman Islands;
Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved   
   Banc de Sang i Teixits
      2014   -   EUCTR2012-000734-19-ES   Spain;
Autologous bone marrow transplantation   
   Hadassah Medical Organization
      2015   -   NCT02529839   -
Autologous hematopoietic stem cell transplant   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2006   Phase 2   NCT00288626   United States;
Autologous hematopoietic stem cells   
   University Medical Centre Hamburg-Eppendorf
      2020   Phase 2   EUCTR2016-001166-29-DE   Germany;
Autologous mesenchymal stem cell transplantation   
   The Cleveland Clinic
      2011   Phase 1   NCT00813969   United States;
Autologous mesenchymal stem cells   
   Albert Saiz
      2010   Phase 2   NCT01228266   Spain;
   Karolinska Institutet
      2013   Phase 1/Phase 2   NCT01730547   Sweden;
      2012   Phase 1   NCT03778333   Sweden;
   Tianjin Medical University General Hospital
      2013   Phase 2   NCT02249676   China;
Avonex   
   Biogen
      2013   Phase 2   NCT01864148   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
   Biogen Idec
      2010   Phase 3   NCT01181115   China;
   Biogen Idec Research Limited
      2013   Phase 2   EUCTR2011-006262-40-NL   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
   Celgene International II Sàrl (CIS II)
      2015   Phase 3   EUCTR2014-002320-27-PL   Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-002320-27-LV   Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-002320-27-LT   Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-002320-27-HU   Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-002320-27-HR   Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-002320-27-GB   Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-002320-27-BG   Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2014-002320-27-PT   Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2014-002320-27-EE   Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2014   Phase 2;Phase 3   EUCTR2012-002714-40-SK   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2014   Phase 2;Phase 3   EUCTR2012-002714-40-GB   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2013   Phase 2;Phase 3   EUCTR2012-002714-40-HU   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2013   Phase 2;Phase 3   EUCTR2012-002714-40-BG   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2013   Phase 2;Phase 3   EUCTR2012-002714-40-BE   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
   Centrum Neurologii Krzysztof Selmaj
      2016   Phase 2   EUCTR2016-002180-33-PL   Poland;
   F. Hoffman-La Roche Ltd
      2008   Phase 2   EUCTR2007-006338-32-DE   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
   F.Hoffmann-La Roche Ltd.
      2008   -   EUCTR2007-006338-32-IT   Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States;
   Genentech, Inc.
      2008   Phase 2   NCT00676715   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
   Hoffman La Roche Ltd
      2008   Phase 2   EUCTR2007-006338-32-SK   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2008   Phase 2   EUCTR2007-006338-32-GB   Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2008   Phase 2   EUCTR2007-006338-32-FR   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
      2008   Phase 2   EUCTR2007-006338-32-ES   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
      2008   Phase 2   EUCTR2007-006338-32-DK   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2008   Phase 2   EUCTR2007-006338-32-CZ   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2008   Phase 2   EUCTR2007-006338-32-BG   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2008   Phase 2   EUCTR2007-006338-32-BE   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-006338-32-NL   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
      2008   -   EUCTR2007-006338-32-FI   Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
   Karolinska Institutet
      2017   Phase 4   EUCTR2017-002634-24-SE   Sweden;
      2017   Phase 4   EUCTR2016-003587-39-SE   Sweden;
   MedImmune LLC
      2012   -   EUCTR2011-005475-16-GB   Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
   Medizinische Universität Innsbruck
      2014   Phase 4   EUCTR2012-005450-30-AT   Austria;Sweden;
      2014   -   EUCTR2012-005450-30-SE   Austria;Sweden;
   Merck Healthcare KGaA
      2020   Phase 3   EUCTR2018-004701-11-BG   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-004700-19-BG   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
   Merck KGaA
      2014   Phase 3   EUCTR2013-002351-15-AT   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-003126-83-HU   Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-003126-83-GR   Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-003126-83-ES   Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-003126-83-DE   Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-003126-83-BG   Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-PT   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-LV   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-HU   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-ES   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-EE   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-BG   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
   NOVARTIS PHARMA AG
      2021   Phase 3   EUCTR2020-004505-32-IT   France;Germany;Italy;Spain;
   Novartis Farma
      2013   -   EUCTR2011-005677-23-IT   Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
   Novartis Farmaceutica S.A.
      2013   -   EUCTR2011-005677-23-ES   Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
   Novartis Pharma Service AG
      2015   Phase 3   EUCTR2011-005677-23-HR   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-GB   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-EE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2011-005677-23-RO   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-DE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-BG   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
      2013   -   EUCTR2011-005677-23-LV   Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
   Novartis Pharma Services AG
      2014   Phase 3   EUCTR2011-005677-23-PL   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-NL   Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-AT   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2011-005677-23-SE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-SK   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-LT   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-001437-16-DE   Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
      2006   -   EUCTR2006-000704-17-PT   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
   PD Dr. Marcus Müller
      2015   Phase 1   NCT02364986   Germany;
   Receptos, Inc.
      2015   Phase 3   EUCTR2014-002320-27-SE   Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-002320-27-NL   Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-002320-27-ES   Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2014   Phase 2;Phase 3   EUCTR2012-002714-40-HR   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2013   Phase 2;Phase 3   EUCTR2012-002714-40-IT   Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2013   Phase 2;Phase 3   EUCTR2012-002714-40-GR   Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2013   Phase 2;Phase 3   EUCTR2012-002714-40-ES   Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States;
   Saint Francis Care
      2012   -   NCT01641120   United States;
   Teva Pharmaceutical Industries, Ltd.
      2014   -   EUCTR2013-002082-19-NL   Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2014   -   EUCTR2013-002082-19-ES   Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
      2013   Phase 3   EUCTR2013-002082-19-GB   Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
      2013   Phase 3   EUCTR2013-002082-19-BE   Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2013   -   EUCTR2013-002082-19-SE   Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
      2013   -   EUCTR2013-002082-19-FI   Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
      2013   -   EUCTR2013-002082-19-DK   Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
   Turku University Hospital
      2013   Phase 4   EUCTR2013-004626-28-FI   Finland;
Avonex (Interferon beta 1a)   
   University of California, San Francisco
      2006   Phase 2   NCT00501943   United States;
Avonex (interferon beta-1a), Biogen Idec Ltd   
   Bayer
      2016   -   NCT02749396   Finland;
Avonex 30 microgram/0.5 ml Solution for Injection   
   Teva Pharmaceutical Industries Ltd
      2008   Phase 3   EUCTR2007-005450-23-SK   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain;
      2008   -   EUCTR2007-005450-23-LT   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
      2008   -   EUCTR2007-005450-23-EE   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
      2008   -   EUCTR2007-005450-23-DE   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
      2008   -   EUCTR2007-005450-23-CZ   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
      2008   -   EUCTR2007-005450-23-BG   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Avonex 30 microgramos/0.5 ml Solución para inyección   
   Teva Pharmaceutical Industries Ltd
      2008   -   EUCTR2007-005450-23-ES   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Avonex and Topamax   
   Multiple Sclerosis Institute
      2004   Phase 2   NCT00217295   United States;
Avonex prefilled syringe via manual IM injection   
   Biogen
      2009   Phase 3   NCT00828204   United States;
Avonex/Betaseron/Copaxone/Rebif   
   Sheffield Teaching Hospitals NHS Foundation Trust
      2013   Phase 2/Phase 3   NCT03133403   United Kingdom;
Avonex/Zocor   
   University of North Carolina
      2004   Phase 4   NCT00146068   United States;
Avonex®   
   Biocad
      2017   Phase 2/Phase 3   NCT02744222   Russian Federation;
   EMD Serono
      1999   Phase 3   NCT00292266   -
   EMD Serono Research & Development Institute, Inc.
      2019   Phase 3   NCT04032171   Germany;United States;
      2019   Phase 3   NCT04032158   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
   Teva Branded Pharmaceutical Products R&D, Inc.
      2014   Phase 3   NCT01975298   Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2008   Phase 3   NCT00605215   Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Montenegro;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
   University Hospital Motol
      2011   Phase 4   EUCTR2011-001956-12-CZ   Czech Republic;
Avonex® monotherapy ( administered i.m. each week)   
   State University of New York at Buffalo
      2005   -   NCT00463710   United States;
Azathioprine   
   Isfahan University of Medical Sciences
      2015   Phase 2/Phase 3   NCT03002038   Iran, Islamic Republic of;
   The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
      2019   Phase 4   ChiCTR1900025744   China;
      2014   -   ChiCTR-ICR-15007177   China;
   Tianjin Medical University General Hospital
      2017   Phase 2/Phase 3   NCT03350633   China;
   Universita di Firenze
      2006   -   EUCTR2006-004937-13-IT   Italy;
Azathioprine (AZA)   
   Hoffmann-La Roche
      2021   Phase 3   NCT04660539   Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Azithromycin   
   National Center for Research Resources (NCRR)
      2001   Phase 2   NCT00043264   United States;
B001 injection   
   Shanghai Pharmaceuticals Holding Co., Ltd
      2022   Early Phase 1   NCT05145361   China;
BAF312   
   NOVARTIS FARMA
      2010   -   EUCTR2009-014392-51-IT   Finland;Germany;Hungary;Italy;Poland;Spain;
      2009   -   EUCTR2008-008719-25-IT   Finland;Germany;Hungary;Italy;Spain;
   NOVARTIS PHARMA SERVICES AG
      2021   Phase 3   EUCTR2020-002700-39-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Novartis Farmacéutica S.A.
      2021   Phase 3   EUCTR2020-002700-39-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Novartis Farmacéutica, S.A
      2009   -   EUCTR2008-008719-25-ES   Finland;Germany;Hungary;Italy;Spain;
   Novartis Pharma AG
      2021   Phase 3   EUCTR2020-002700-39-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-002700-39-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-002700-39-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-002700-39-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-002700-39-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-002700-39-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-002700-39-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-002700-39-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-002700-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2020-002700-39-EE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2020-002700-39-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Novartis Pharma K.K.
      2014   Phase 3   JPRN-JapicCTI-142447   -
   Novartis Pharma Services AG
      2010   Phase 2   EUCTR2009-014392-51-PL   Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
      2010   Phase 2   EUCTR2009-014392-51-HU   Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
      2010   Phase 2   EUCTR2009-014392-51-FI   Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
      2010   -   EUCTR2009-014392-51-DE   Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
      2009   -   EUCTR2008-008719-25-HU   Finland;Germany;Hungary;Italy;Spain;
      2009   -   EUCTR2008-008719-25-FI   Finland;Germany;Hungary;Italy;Spain;
      -   -   EUCTR2008-008719-25-DE   Finland;Germany;Hungary;Italy;Spain;
   Novartis Pharmaceuticals
      2021   Phase 4   NCT04792567   Germany;
      2012   Phase 3   NCT01665144   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 2   NCT01185821   Canada;Finland;Germany;Hungary;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;Turkey;United States;
      2009   Phase 2   NCT00879658   Canada;Finland;Germany;Hungary;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;Turkey;United States;
BAF312 0,25 mg tablet   
   Novartis Pharma Services AG
      2012   -   EUCTR2011-006043-30-NL   Netherlands;
BAF312 1 mg tablet   
   Novartis Pharma Services AG
      2012   -   EUCTR2011-006043-30-NL   Netherlands;
BAF312 4 mg tablet   
   Novartis Pharma Services AG
      2012   -   EUCTR2011-006043-30-NL   Netherlands;
BAF312 hemifumarate   
   NOVARTIS FARMA
      2012   -   EUCTR2012-003056-36-IT   Argentina;Australia;Austria;Bulgaria;Canada;Czech Republic;Egypt;Estonia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Farmacéutica S.A
      2012   -   EUCTR2012-003056-36-ES   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Pharma Services AG
      2015   -   EUCTR2012-003056-36-FR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-IE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-GR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-SK   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-LT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-EE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   -   EUCTR2012-003056-36-LV   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   -   EUCTR2011-006043-30-NL   Netherlands;
      -   Phase 3   EUCTR2012-003056-36-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
BAF312A   
   NOVARTIS FARMA
      2012   -   EUCTR2012-003056-36-IT   Argentina;Australia;Austria;Bulgaria;Canada;Czech Republic;Egypt;Estonia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Farmacéutica S.A
      2012   -   EUCTR2012-003056-36-ES   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Pharma GmbH
      2021   Phase 4   EUCTR2020-005752-38-DE   Germany;
   Novartis Pharma Services AG
      2015   -   EUCTR2012-003056-36-FR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-IE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-GR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003056-36-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-SK   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-LT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-EE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-003056-36-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   -   EUCTR2012-003056-36-LV   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      -   Phase 3   EUCTR2012-003056-36-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
BAT4406F   
   Bio-Thera Solutions
      2019   Phase 1   NCT04146285   China;
BAY 79-4998   
   Bayer Vital GmbH
      2006   -   EUCTR2006-002361-39-DE   Germany;
BAY86-5046   
   Bayer AG
      2017   Phase 4   EUCTR2017-001176-31-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-FI   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-DK   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
   Bayer HealthCare AG
      2013   Phase 4   EUCTR2012-005262-35-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2013   -   EUCTR2012-005262-35-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      -   -   EUCTR2014-004613-93-Outside-EU/EEA   China;
BAY86-5046_Interferon-beta-1b   
   Bayer
      2007   -   NCT01158183   United States;
BBR 2778   
   Fondation Charcot Stichting
      2009   Phase 1;Phase 2   EUCTR2007-003086-40-BE   Belgium;France;
      2008   -   EUCTR2007-003086-40-FR   France;
BCD-033 (interferon beta 1a)   
   Biocad
      2014   Phase 2/Phase 3   NCT02727907   Russian Federation;
BCD-054 180 mcg   
   Biocad
      2017   Phase 2/Phase 3   NCT02744222   Russian Federation;
BCD-054 240 mcg   
   Biocad
      2017   Phase 2/Phase 3   NCT02744222   Russian Federation;
BCD-063   
   Biocad
      2013   Phase 3   NCT02753088   -
BCD-132   
   Biocad
      2018   Phase 1   NCT03551275   Russian Federation;
BCD-132,   
   Biocad
      2019   Phase 2   NCT04056897   Russian Federation;
BCG20-0134   
   BTG International Ltd
      2009   Phase 2   EUCTR2009-011585-28-BE   Belgium;European Union;France;Germany;Russian Federation;Spain;
      2009   -   EUCTR2009-011585-28-FR   Belgium;France;Germany;Spain;
      2009   -   EUCTR2009-011585-28-DE   Belgium;European Union;France;Germany;Russian Federation;Spain;
BEAM Regimen   
   Makati Medical Center
      2015   Phase 1   NCT03113162   Philippines;
BETACONNECT   
   Bayer
      2019   -   NCT03808142   Germany;
      2014   -   NCT02247310   Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland;
BETACONNECT auto-injector.   
   Bayer
      2014   -   NCT02121444   Germany;
BETACONNECT device   
   Bayer
      2016   -   NCT02652091   United States;
BETAFERON - 15 FLACONCINI 0.25 MG + 15 FLACONCINI 2 ML   
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
BETAFERON 250 mcg   
   SCHERING
      2007   -   EUCTR2006-005270-47-IT   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
BETAFERON 500 mcg   
   SCHERING
      2007   -   EUCTR2006-005270-47-IT   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
BETAFERON SC 15F 0,25MG 15SIR   
   Universita di Firenze
      2006   -   EUCTR2006-004937-13-IT   Italy;
BETAFERON*15CONFEZ 0,25MG/ML+   
   AZIENDA OSPEDALIERA S. LUIGI GONZAGA
      2011   -   EUCTR2010-023677-19-IT   Italy;
BETAFERON® (interferon beta-1b)   
   Ospedale Regionale di Lugano
      2013   -   EUCTR2012-004040-30-AT   Austria;Switzerland;
BG-12 120   
   Northwestern University
      2013   Phase 2   EUCTR2012-004165-41-GB   United Kingdom;United States;
BG00002   
   BIOGEN IDEC LTD
      2007   -   EUCTR2005-004061-41-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2007   -   EUCTR2005-004061-41-AT   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
      2006   Phase 3   EUCTR2005-004061-41-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2006   Phase 3   EUCTR2005-004061-41-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2006   -   EUCTR2005-004061-41-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2006   -   EUCTR2005-004061-41-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2006   -   EUCTR2005-004061-41-GR   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2005-004061-41-FI   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2006   -   EUCTR2005-004061-41-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2006   -   EUCTR2005-004061-41-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2006   -   EUCTR2005-004061-41-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
   Biogen Idec
      2012   Phase 4   NCT02142205   Russian Federation;
   Biogen Idec Limited
      2011   -   EUCTR2010-024000-10-ES   Belgium;Germany;Italy;Spain;
      2011   -   EUCTR2010-024000-10-DE   Belgium;Germany;Italy;Spain;
      2011   -   EUCTR2010-024000-10-BE   Belgium;Germany;Italy;Spain;
   Biogen Idec Research Limited
      2019   Phase 3   EUCTR2018-002145-11-GB   Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
BG00002 (natalizumab)   
   Biogen
      2010   Phase 3   NCT01058005   Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States;
      2009   Phase 4   NCT00871780   Belgium;Mexico;Poland;Romania;Saudi Arabia;Ukraine;Venezuela;
      2008   Phase 4   NCT00536120   United States;
      2006   Phase 3   NCT00306592   Canada;United States;
BG00002-E (natalizumab high titer)   
   Biogen
      2006   Phase 2   NCT00516893   United States;
BG00012   
   BIOGEN IDEC LTD
      2010   Phase 3   EUCTR2008-004753-14-IT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
      2008   -   EUCTR2006-003696-12-IT   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
   BIOGEN IDEC RESEARCH LIMITED
      2015   Phase 3   EUCTR2014-005624-98-IT   Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
   Biogen
      2009   Phase 1   NCT00837785   Germany;United Kingdom;
      2007   Phase 3   NCT00451451   Australia;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Costa Rica;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Ireland;Israel;Italy;Kazakhstan;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;New Zealand;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States;
      2007   Phase 3   NCT00420212   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Guatemala;India;Israel;Italy;Kazakhstan;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Virgin Islands (U.S.);
   Biogen Idec
      2004   Phase 2   NCT00168701   Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Sweden;Switzerland;Turkey;United Kingdom;
   Biogen Idec Inc.
      2004   -   EUCTR2004-000663-99-SE   Hungary;Sweden;
      2004   -   EUCTR2004-000663-99-HU   Hungary;Sweden;
      2004   -   EUCTR2004-000663-99-CZ   Czech Republic;Hungary;Sweden;
   Biogen Idec Italia S.r.l.
      2015   -   EUCTR2015-000303-21-IT   Italy;
      2013   Phase 3   EUCTR2013-001422-25-IT   Italy;
   Biogen Idec Limited
      2010   Phase 3   EUCTR2008-004753-14-BG   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-004753-14-SK   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-004753-14-LV   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-004753-14-IE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-004753-14-GB   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-004753-14-EE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-004753-14-CZ   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-004753-14-BE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-004753-14-AT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
   Biogen Idec LtD.
      2007   Phase 3   EUCTR2006-003696-12-SK   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom;
   Biogen Idec Ltd.
      2010   Phase 3   EUCTR2008-004753-14-NL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2008-004753-14-GR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
      2009   Phase 3   EUCTR2008-004753-14-FR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
      2009   Phase 3   EUCTR2008-004753-14-ES   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
      2009   Phase 3   EUCTR2008-004753-14-DE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2006-003696-12-BG   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
      2008   -   EUCTR2006-003697-10-BG   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2008   -   EUCTR2006-003696-12-NL   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
      2008   -   EUCTR2006-003696-12-DE   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
      2007   Phase 3   EUCTR2006-003697-10-ES   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   Phase 3   EUCTR2006-003697-10-BE   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   Phase 3   EUCTR2006-003696-12-GB   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom;
      2007   -   EUCTR2006-003697-10-LV   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-IE   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-GR   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-EE   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-DE   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-CZ   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003696-12-SE   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
      2007   -   EUCTR2006-003696-12-GR   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
      2007   -   EUCTR2006-003696-12-CZ   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
      2007   -   EUCTR2006-003696-12-BE   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
      2007   -   EUCTR2006-003696-12-AT   Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
   Biogen Idec Research Limited
      2019   Phase 3   EUCTR2018-000516-22-PT   Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-000516-22-HU   Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-000516-22-EE   Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
      2017   Phase 3   EUCTR2013-002318-11-FR   Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-003282-29-LV   Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
      2016   Phase 3   EUCTR2015-003282-29-DE   Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
      2016   Phase 3   EUCTR2015-003282-29-CZ   Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
      2016   Phase 3   EUCTR2015-003282-29-BG   Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
      2016   Phase 3   EUCTR2015-003282-29-BE   Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
      2016   Phase 3   EUCTR2015-001973-42-PL   Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States;
      2016   Phase 3   EUCTR2015-001973-42-LT   Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States;
      2016   Phase 3   EUCTR2015-001973-42-HR   Austria;Belgium;Bulgaria;Canada;Croatia;Kuwait;Lithuania;Poland;Slovakia;Sweden;Turkey;United States;
      2016   Phase 3   EUCTR2015-001973-42-BG   Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States;
      2016   Phase 3   EUCTR2013-002318-11-DE   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
      2016   -   EUCTR2013-002318-11-ES   Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;
      2015   Phase 3   EUCTR2015-001973-42-BE   Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Kuwait;Lithuania;Poland;Turkey;United States;
      2015   Phase 3   EUCTR2014-004562-22-IT   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
      2015   Phase 3   EUCTR2014-004562-22-DE   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
      2015   Phase 3   EUCTR2014-004562-22-CZ   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
      2015   Phase 3   EUCTR2014-004562-22-BE   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
      2015   Phase 3   EUCTR2014-003021-18-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2015   Phase 3   EUCTR2013-002318-11-PL   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
      2015   Phase 2   EUCTR2014-005003-24-PL   Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
      2015   Phase 2   EUCTR2014-005003-24-LV   Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
      2015   Phase 2   EUCTR2014-005003-24-DE   Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
      2015   Phase 2   EUCTR2014-005003-24-CZ   Australia;Belgium;Bulgaria;Czech Republic;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United States;
      2015   Phase 2   EUCTR2014-005003-24-BG   Australia;Belgium;Bulgaria;Czech Republic;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Poland;Turkey;United Kingdom;United States;
      2015   Phase 2   EUCTR2014-005003-24-BE   Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
      2015   -   EUCTR2014-005624-98-HU   Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
      2015   -   EUCTR2014-004562-22-HU   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
      2015   -   EUCTR2014-003021-18-SK   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2015   -   EUCTR2014-003021-18-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2015   -   EUCTR2014-003021-18-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2015   -   EUCTR2014-003021-18-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2015   -   EUCTR2014-003021-18-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2015   -   EUCTR2014-003021-18-FI   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2015   -   EUCTR2014-003021-18-DK   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2015   -   EUCTR2014-003021-18-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2015   -   EUCTR2014-003021-18-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2015   -   EUCTR2014-003021-18-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-001656-35-SK   Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2014   Phase 4   EUCTR2013-001656-35-SI   Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2014   Phase 4   EUCTR2013-001656-35-PT   Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2014   Phase 4   EUCTR2013-001656-35-IT   Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2014   Phase 4   EUCTR2013-001656-35-HU   Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2014   Phase 4   EUCTR2013-001656-35-FR   Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2014   Phase 4   EUCTR2013-001656-35-ES   Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2014   Phase 4   EUCTR2013-001656-35-CZ   Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2014   Phase 4   EUCTR2013-001656-35-BE   Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2014   Phase 4   EUCTR2013-001656-35-AT   Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2014   Phase 3   EUCTR2013-004533-32-PL   Czech Republic;Japan;Korea, Republic of;Poland;Taiwan;
      2014   Phase 3   EUCTR2013-004533-32-CZ   Czech Republic;Japan;Korea, Republic of;Poland;Taiwan;
      2014   Phase 3   EUCTR2013-002318-11-SE   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-002318-11-HU   Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;
      2014   Phase 3   EUCTR2013-002318-11-GB   Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-002318-11-DK   Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-002318-11-CZ   Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-002318-11-BE   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
      2014   -   EUCTR2013-002318-11-IT   Belgium;Czech Republic;Denmark;France;Hungary;Italy;Poland;Serbia;Sweden;Ukraine;United Kingdom;
      2014   -   EUCTR2013-001895-40-IE   Ireland;United Kingdom;
      2014   -   EUCTR2013-001486-17-DE   Germany;
      -   Phase 3   EUCTR2014-005624-98-EE   Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
      -   Phase 3   EUCTR2014-005624-98-AT   Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
BG00012 (DMF)   
   Biogen
      2013   Phase 4   NCT01873417   United States;
BG00012 (DMF) (Tecfidera®.)   
   Multiple Sclerosis Center of Northeastern New York
      2015   Phase 4   NCT02683863   United States;
BG0002 (natalizumab)   
   Biogen Idec
      2009   -   NCT00818038   United States;
BG9418 (interferon beta 1-a)   
   Biogen
      2008   Phase 3   NCT00784836   United States;
BG9418 (interferon beta-1a)   
   Biogen
      2009   Phase 3   NCT00828204   United States;
   Biogen Idec
      2004   -   NCT00168714   United States;
BGC20-0134   
   BTG International Ltd
      2009   -   EUCTR2009-011585-28-ES   Belgium;France;Germany;Spain;
BGG492   
   Novartis Pharmaceuticals
      2016   Phase 2   NCT01649050   Germany;Russian Federation;
BHT-3009   
   Bayhill Therapeutics
      2006   Phase 2   NCT00382629   -
      2006   -   EUCTR2005-001340-22-CZ   Czech Republic;Finland;United Kingdom;
      2005   Phase 2   EUCTR2005-001340-22-SK   Czech Republic;Finland;Slovakia;United Kingdom;
      2005   -   EUCTR2005-001340-22-GB   Czech Republic;Finland;United Kingdom;
      2005   -   EUCTR2005-001340-22-FI   Czech Republic;Finland;United Kingdom;
BHT-3009-01   
   Bayhill Therapeutics
      2004   Phase 1   NCT00103974   Canada;United States;
BIIB 017   
   BIOGEN IDEC RESEARCH LIMITED
      2019   Phase 3   EUCTR2018-003008-38-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
BIIB017   
   BIOGEN IDEC RESEARCH LIMITED
      2019   Phase 3   EUCTR2018-003008-38-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
   Biogen
      2013   Phase 3   NCT01939002   United States;
   Biogen Idec LTD
      2009   -   EUCTR2008-006333-27-LV   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
   Biogen Idec Limited
      2012   Phase 3   EUCTR2010-024477-39-GR   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2010-024477-39-GB   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2010-024477-39-CZ   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-024477-39-DE   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-024477-39-BG   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2010-024477-39-LV   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2010-024477-39-ES   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2010-024477-39-EE   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2010-024477-39-BE   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2008-006333-27-GR   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
      2010   -   EUCTR2008-006333-27-CZ   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-006333-27-GB   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-006333-27-ES   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
      2009   -   EUCTR2008-006333-27-NL   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2008-006333-27-EE   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2008-006333-27-BG   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2008-006333-27-BE   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      -   -   EUCTR2008-006333-27-DE   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
   Biogen Idec Research Limited
      2020   Phase 3   EUCTR2018-003008-38-DE   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-SK   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-PT   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-HU   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-HR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-GR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-ES   Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
      2019   Phase 3   EUCTR2018-003008-38-CZ   Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
      2019   Phase 3   EUCTR2018-003008-38-BG   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-BE   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-000516-22-PT   Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-000516-22-HU   Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-000516-22-EE   Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
      -   Phase 3   EUCTR2018-003008-38-FR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
   Johns Hopkins University
      2010   Phase 3   NCT01337427   United States;
BIIB017 (Peginterferon beta-1a)   
   Biogen Idec
      2014   Phase 4   NCT02234869   -
BIIB017 (peginterferon beta-1a)   
   Biogen
      2019   Phase 3   NCT03958877   Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2009   Phase 3   NCT00906399   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
BIIB017 (peginterferon beta-1a) Autoinjector   
   Biogen Idec
      2012   Phase 1   NCT01610310   United States;
BIIB017 (peginterferon beta-1a) Pre-filled syringe (PFS)   
   Biogen Idec
      2012   Phase 1   NCT01610310   United States;
BIIB019   
   BIOGEN IDEC RESEARCH LIMITED
      2017   Phase 3   EUCTR2016-002820-10-IT   Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
   BIOGEN IDEC RESEARCH LTD
      2013   Phase 3   EUCTR2012-003176-39-IT   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
   Biogen
      2013   Phase 3   EUCTR2012-003176-39-HU   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2009-015318-23-GB   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
   Biogen Idec Limited
      2011   -   EUCTR2010-023856-97-PL   Czech Republic;Hungary;Poland;Russian Federation;United States;
      2011   -   EUCTR2010-023856-97-HU   Czech Republic;Hungary;Poland;Russian Federation;United States;
      2011   -   EUCTR2010-023856-97-CZ   Czech Republic;Hungary;Poland;United States;
   Biogen Idec Ltd
      2012   Phase 3   EUCTR2009-012500-11-SI   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-012500-11-GB   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-012500-11-FI   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-SE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-IE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-HU   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-DK   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-DE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-CZ   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
   Biogen Idec Ltd.
      2011   Phase 2   EUCTR2009-015318-23-DE   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
      2010   Phase 2   EUCTR2009-015318-23-HU   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
      2010   Phase 2   EUCTR2009-015318-23-CZ   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
      2009   Phase 2   EUCTR2008-005559-46-GB   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2009   -   EUCTR2008-005559-46-HU   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2009   -   EUCTR2008-005559-46-DE   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2009   -   EUCTR2008-005559-46-CZ   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
   Biogen Idec Research Limited
      2017   Phase 3   EUCTR2016-002820-10-GB   Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002820-10-DE   Canada;Germany;Italy;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-SE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-PL   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-IE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-GR   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-GB   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-FR   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-ES   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-DK   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-DE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-CZ   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2012-003176-39-FI   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
BIIB019 (Daclizumab High Yield Process)   
   Biogen
      2010   Phase 3   NCT01064401   Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2009   Phase 2   NCT00870740   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2008   Phase 2   NCT00390221   Australia;Czech Republic;Former Serbia and Montenegro;Germany;Hungary;India;Poland;Russian Federation;Sweden;Turkey;Ukraine;United Kingdom;
BIIB019 (Daclizumab)   
   Biogen
      2013   Phase 3   NCT01797965   Argentina;Australia;Brazil;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2011   Phase 3   NCT01462318   Czech Republic;Hungary;Poland;Russian Federation;United States;
      2010   Phase 2   NCT01051349   Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
BIIB033   
   BIOGEN IDEC RESEARCH LIMITED
      2019   Phase 2   EUCTR2017-001224-22-IT   Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
   Biogen
      2016   Phase 1   NCT02641041   United Kingdom;
      2013   Phase 2   NCT01864148   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2010   Phase 1   NCT01244139   United States;
   Biogen Idec Research Limited
      2013   Phase 2   EUCTR2011-006262-40-NL   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-IT   Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-HU   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-GB   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-ES   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-CZ   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
BIIB033 (ANTI-LINGO)   
   Biogen Idec Research Limited
      2018   Phase 2   EUCTR2017-001224-22-PL   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-001224-22-NL   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-001224-22-DE   Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-001224-22-BE   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-001224-22-HU   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-001224-22-ES   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-001224-22-CZ   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
BIIB033 (ANTI-LINGO) - EV Substance Code SUB118957   
   Biogen Idec Research Limited
      2017   Phase 2   EUCTR2017-001224-22-GB   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
BIIB033 (opicinumab)   
   Biogen
      2017   Phase 2   NCT03222973   Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
      2016   Phase 1   NCT02833142   United States;
BIIB041   
   Biogen Idec Research Limited
      2015   Phase 3   EUCTR2013-003600-40-NL   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003600-40-GB   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003600-40-CZ   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003600-40-BG   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-003600-40-LT   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-003600-40-IT   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-003600-40-FI   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2012   Phase 4   EUCTR2011-003507-38-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2012   Phase 4   EUCTR2011-003507-38-BE   Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2012   Phase 2   EUCTR2012-000368-90-BE   Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
      2012   -   EUCTR2012-000368-90-NL   Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
      2012   -   EUCTR2012-000368-90-GB   Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
      2012   -   EUCTR2011-003507-38-PT   Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2012   -   EUCTR2011-003507-38-NL   Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2012   -   EUCTR2011-003507-38-DK   Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
   Cliniques Universitaires Saint-Luc, Neurologie
      2013   -   EUCTR2012-005076-34-BE   Belgium;
BIIB041 (Fampridine-SR)   
   Biogen Idec
      2010   Phase 3   NCT01235221   Canada;
BIIB041 (PR Fampridine)   
   Biogen
      2012   Phase 2   NCT01597297   Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
BIIB041 (fampridine)   
   Biogen
      2013   Phase 3   NCT01917019   Japan;
BIIB061   
   Biogen
      2021   Phase 2   NCT04079088   -
      2015   Phase 1   NCT02521545   United States;
BIIB133   
   Biogen Idec Research Limited
      2020   Phase 2   EUCTR2019-001967-58-PL   Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States;
      2020   Phase 2   EUCTR2019-001967-58-FR   Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States;
BIRT 2584 XX   
   BOEHRINGER ING.
      2006   -   EUCTR2005-005985-35-IT   Czech Republic;Italy;Netherlands;
   Boehringer Ingelheim
      2006   -   EUCTR2005-005985-35-NL   Czech Republic;Italy;Netherlands;
   Boehringer Ingelheim Ltd
      2006   -   EUCTR2005-005985-35-CZ   Czech Republic;Italy;Netherlands;
BIRT 2584XX   
   BOEHRINGER ING.
      2006   -   EUCTR2005-005985-35-IT   Czech Republic;Italy;Netherlands;
BMMNC   
   Chaitanya Hospital, Pune
      2014   Phase 1/Phase 2   NCT01883661   India;
BMS 188667 (Abatacept)   
   Bristol-Myers Squibb
      2001   Phase 2   NCT00035529   United States;
BNT162b2   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States;
BORAGE OIL GLA   
   PALUPA Medical Ltd
      2016   Phase 3   EUCTR2015-003147-19-GR   Greece;
BOSWELAN   
   University Medical Center Eppendorf
      -   Phase 2   EUCTR2009-014724-32-DE   Germany;
BOTOX®   
   Allergan
      2008   -   EUCTR2006-006299-39-NL   France;Netherlands;
      2008   -   EUCTR2006-006299-39-FR   France;Netherlands;
   Allergan Ltd.
      2013   -   EUCTR2012-000957-30-PT   Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
      2013   -   EUCTR2012-000957-30-GB   Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
      2012   -   EUCTR2012-000957-30-CZ   Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
      2012   -   EUCTR2012-000957-30-BE   Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX   
   Ipsen Innovation
      2016   Phase 3   EUCTR2015-003471-30-PT   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-PL   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-NL   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-IT   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-CZ   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-000507-44-LT   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-FR   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-ES   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-DE   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-BE   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
BX-1   
   Bionorica SE
      2020   Phase 3   EUCTR2018-000001-23-CZ   Czech Republic;Hungary;Spain;
      2019   Phase 3   NCT03756974   Czechia;Germany;Hungary;Poland;Spain;
      2018   Phase 3   EUCTR2018-000001-23-HU   Czech Republic;Hungary;Spain;
      2018   Phase 3   EUCTR2018-000001-23-ES   Hungary;Spain;
Bacille Calmette-Guerin vaccine   
   S. Andrea Hospital
      2019   Phase 2   NCT03888924   Italy;
Bacille of Calmette-Guerin   
   S. Andrea Hospital
      2001   Phase 2/Phase 3   NCT00202410   Italy;
Baclofen   
   DAIICHI SANKYO COMPANY, LIMITED
      -   Phase 4   JPRN-JapicCTI-050031   -
   Osmotica Pharmaceutical US LLC
      2012   Phase 3   NCT01743651   Russian Federation;Ukraine;United States;
Baclofen ER Capsules (GRS)   
   Sun Pharma Advanced Research Company Ltd.
      2016   Phase 3   EUCTR2016-001356-22-HU   Germany;Hungary;Russian Federation;Ukraine;United States;
Baclofen IR   
   Impax Laboratories, LLC
      2009   Phase 2   NCT00914290   United States;
Baclofen Tablets USP   
   Sun Pharma Advanced Research Company Ltd.
      2016   Phase 3   EUCTR2016-001356-22-HU   Germany;Hungary;Russian Federation;Ukraine;United States;
Bafiertam   
   Banner Life Sciences LLC
      2019   Phase 1   NCT04022473   United States;
Balance   
   Ankara Yildirim Beyazit University
      2019   -   NCT04408742   Turkey;
      2019   -   NCT04286828   Turkey;
      2019   -   NCT03945006   Turkey;
      2016   -   NCT03566251   Turkey;
   Biruni University
      2016   -   NCT03436927   -
   East Kent Hospitals University NHS Foundation Trust
      2017   Phase 1   NCT05102682   United Kingdom;
   Gazi University
      2018   -   NCT03584672   -
      2018   -   NCT03501342   Turkey;
   Lama Saad El-Din Mahmoud
      2020   -   NCT04528121   Egypt;
   Marquette University
      2017   -   NCT04719494   -
   October 6 University
      2017   -   NCT03670459   Egypt;
   Somogy Megyei Kaposi Mór Teaching Hospital
      2018   -   NCT04550650   Hungary;
   University of Aarhus
      2016   -   NCT02870023   Denmark;
   University of Colorado, Denver
      2012   -   NCT01698086   United States;
   University of Iowa
      2020   -   NCT04391023   United States;
   University of Nebraska
      2013   -   NCT01816100   United States;
   Wayne State University
      2020   -   NCT03404388   United States;
   Örebro County Council
      2014   -   NCT02209467   Sweden;
      2012   -   NCT01582126   Sweden;
Balance platform therapy   
   University Hospital of Ferrara
      2017   -   NCT03353974   Italy;
Baminercept   
   Biogen Idec
      2010   Phase 1/Phase 2   NCT01181089   Canada;United Kingdom;
Baseline Treatment   
   Hoffmann-La Roche
      2014   Phase 3   NCT02028884   France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Baseline disease modifying therapies (DMTs)   
   Novartis Pharmaceuticals
      2021   Phase 4   NCT04792567   Germany;
Bazedoxifene Acetate   
   Riley Bove, MD
      2019   Phase 2   NCT04002934   United States;
Beetainterferoni -1a   
   Turku University Hospital
      2013   Phase 4   EUCTR2013-004626-28-FI   Finland;
Belimumab   
   Johns Hopkins University
      2021   Phase 2   NCT04767698   United States;
   Tianjin Medical University General Hospital
      2021   Phase 1/Phase 2   NCT05154734   China;
Best Available Therapy (BAT)   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2019   Phase 3   NCT04047628   United Kingdom;United States;
Beta-1b interferoni   
   Schering Oy
      2006   -   EUCTR2005-005211-21-FI   Finland;
Beta-Interferon   
   Genzyme, a Sanofi Company
      2017   Phase 3   NCT03368664   Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Beta-alanine supplementation   
   Hasselt University
      2017   -   NCT03418376   Belgium;
Beta-interferon   
   Sun Yat-sen University
      2006   -   NCT00818103   China;
Betaconnect Autoinjector   
   Bayer
      2015   -   NCT02486640   Germany;
Betaconnect auto-injector   
   Bayer
      2017   -   NCT03134573   Germany;
Betaferon   
   Dansk Multipel Sclerose Center
      2010   -   EUCTR2009-016824-29-DK   Denmark;
   Karolinska Institutet
      2017   Phase 4   EUCTR2017-002634-24-SE   Sweden;
      2017   Phase 4   EUCTR2016-003587-39-SE   Sweden;
   Medical University Innsbruck
      2009   -   EUCTR2009-013284-19-AT   Austria;
   Medizinische Universität Innsbruck
      2014   Phase 4   EUCTR2012-005450-30-AT   Austria;Sweden;
      2014   -   EUCTR2012-005450-30-SE   Austria;Sweden;
   NURON BIOTECH INC.
      2012   -   EUCTR2011-002683-24-IT   Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain;
   Nuron Biotech, Inc.
      2012   -   EUCTR2011-002683-24-HU   Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine;
      2012   -   EUCTR2011-002683-24-ES   Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine;
      2012   -   EUCTR2011-002683-24-BG   Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine;
   Schering Nordiska AB
      2006   -   EUCTR2005-001540-23-SE   Denmark;Sweden;
      2005   -   EUCTR2005-001540-23-DK   Denmark;Sweden;
   Schering Oy
      2006   -   EUCTR2005-005211-21-FI   Finland;
   Turku University Hospital
      2013   Phase 4   EUCTR2013-004626-28-FI   Finland;
Betaferon 250 microgram/mL, powder and solvent for solution for injection.   
   Bayer HealthCare AG
      2013   Phase 4   EUCTR2012-005262-35-ES   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Betaferon 250 microgram/ml   
   Biogen Portugal
      2016   Phase 4   EUCTR2016-000434-21-PT   Portugal;
   Octapharma AG
      2015   Phase 3   EUCTR2012-005086-12-PL   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
      2013   -   EUCTR2012-005086-12-HU   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-DE   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-BG   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-AT   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Betaferon 250 microgram/ml, powder and solvent for solution for injection   
   Bayer AG
      2018   Phase 4   EUCTR2017-001176-31-PT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-FR   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-FI   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-ES   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-DK   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2017   Phase 4   EUCTR2017-001176-31-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
   Bayer HealthCare AG
      2013   Phase 4   EUCTR2012-005262-35-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2013   Phase 4   EUCTR2012-005262-35-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2013   -   EUCTR2012-005262-35-SI   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2013   -   EUCTR2012-005262-35-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2013   -   EUCTR2012-005262-35-FI   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
      2013   -   EUCTR2012-005262-35-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Betaferon 250 microgramos   
   Schering AG
      2007   Phase 3   EUCTR2006-005270-47-ES   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 250mcg   
   Schering AG
      2007   -   EUCTR2006-005270-47-IE   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 250µg   
   Bayer AB, Bayer Health Care, Bayer Schering Pharma
      2007   -   EUCTR2006-005270-47-SE   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
   Bayer Schering Pharma
      2007   -   EUCTR2006-005270-47-SI   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   -   EUCTR2006-005270-47-HU   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      -   -   EUCTR2006-005270-47-DE   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
   Bayer Schering Pharma AG
      2007   -   EUCTR2006-005270-47-LV   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   -   EUCTR2006-005270-47-GR   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   -   EUCTR2006-005270-47-BE   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
   Schering AG
      2007   Phase 3   EUCTR2006-005270-47-FR   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   Phase 3   EUCTR2006-005270-47-FI   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   -   EUCTR2006-005270-47-NL   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   -   EUCTR2006-005270-47-AT   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 500 µg   
   Schering AG
      2007   Phase 3   EUCTR2006-005270-47-ES   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 500mcg   
   Schering AG
      2007   -   EUCTR2006-005270-47-IE   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
   UCL Biomedicine R&D Unit
      2006   -   EUCTR2005-005751-18-GB   United Kingdom;
Betaferon 500µg   
   Bayer AB, Bayer Health Care, Bayer Schering Pharma
      2007   -   EUCTR2006-005270-47-SE   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
   Bayer Schering Pharma
      2007   -   EUCTR2006-005270-47-SI   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   -   EUCTR2006-005270-47-HU   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      -   -   EUCTR2006-005270-47-DE   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
   Bayer Schering Pharma AG
      2007   -   EUCTR2006-005270-47-LV   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   -   EUCTR2006-005270-47-GR   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   -   EUCTR2006-005270-47-BE   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
   Schering AG
      2007   Phase 3   EUCTR2006-005270-47-FR   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   Phase 3   EUCTR2006-005270-47-FI   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   -   EUCTR2006-005270-47-NL   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
      2007   -   EUCTR2006-005270-47-AT   Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon, BAY86-5046   
   Bayer
      2019   -   NCT03808142   Germany;
Betaferon/Betaseron   
   Bayer
      2006   Phase 4   NCT00317941   France;
      2003   Phase 4   NCT00206648   Canada;United States;
Betaferon®   
   University Hospital Motol
      2011   Phase 4   EUCTR2011-001956-12-CZ   Czech Republic;
Betaseron   
   Bayer HealthCare AG
      -   -   EUCTR2014-004613-93-Outside-EU/EEA   China;
   Stuart D Cook MD
      2003   Phase 4   NCT00176592   United States;
   Teva Pharmaceutical Industries
      2004   Phase 4   NCT00202995   Canada;United States;
Betaseron (Interferon beta-1b, BAY86-5046)   
   Bayer
      2010   -   NCT01031459   Canada;United States;
      2002   Phase 2   NCT00893217   United States;
Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG   
   Bayer
      2016   -   NCT02749396   Finland;
Bevacizumab   
   Johns Hopkins University
      2013   Phase 1   NCT01777412   United States;
Bexarotene   
   Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
      2015   Phase 2   EUCTR2014-003145-99-GB   United Kingdom;
Bexsero   
   ALEXION PHARMACEUTICALS INCORPORATED
      2020   Phase 2;Phase 3   EUCTR2019-001829-26-IT   Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
Biological samples   
   Centre Hospitalier Régional d'Orléans
      2021   Phase 4   NCT04952766   France;
Biotin   
   University Hospital, Clermont-Ferrand
      2018   -   NCT03552211   France;
Bisacodyl   
   David Levinthal
      2016   Phase 2   NCT02609607   United States;
Blood sample   
   Centre Hospitalier Universitaire de Saint Etienne
      2020   Phase 2   NCT03983720   France;
   University Hospital, Bordeaux
      2021   -   NCT04798651   France;
Blood samples   
   University Hospital, Bordeaux
      2014   -   NCT02142764   France;
Blood sampling   
   Centre Hospitalier Universitaire de Nimes
      2013   Phase 3   NCT01817166   France;
   Rennes University Hospital
      2021   -   NCT04697407   France;
BodyBio Balance Oil   
   Terry L. Wahls
      2022   -   NCT05007483   United States;
BodyBio PC   
   Terry L. Wahls
      2022   -   NCT05007483   United States;
Bone marrow autologous mesenchymal stem cells transplantation   
   Germans Trias i Pujol Hospital
      2013   Phase 1/Phase 2   NCT02035514   Spain;
Bortezomib   
   Tianjin Medical University General Hospital
      2015   Phase 2   NCT02893111   China;
Boswellia serrata extract PS0201Bo capsules   
   University Medical Center Eppendorf
      -   Phase 2   EUCTR2009-014724-32-DE   Germany;
Boswellic acids (BOSWELAN)   
   Universitätsklinikum Hamburg-Eppendorf
      2011   Phase 2   NCT01450124   Germany;
Botox   
   Krajská nemocnice Liberec, a.s.
      2010   -   EUCTR2009-012431-15-CZ   Czech Republic;
Botox 100 UNT Injection   
   Brigitte Schürch
      2021   Phase 4   NCT04819360   Switzerland;
Botulinum Toxin Type A 200U   
   Allergan
      2009   Phase 3   NCT00876447   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Botulinum Toxin Type A 300U   
   Allergan
      2009   Phase 3   NCT00876447   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Botulinum toxin   
   ALLERGAN
      2008   -   EUCTR2007-000192-42-IT   France;Germany;Italy;Netherlands;Portugal;Spain;United Kingdom;
Botulinum toxin A   
   Sunnybrook Health Sciences Centre
      2006   Phase 3   NCT01091727   Canada;
Botulinum toxin type A   
   Allergan
      2008   -   EUCTR2006-006299-39-NL   France;Netherlands;
      2008   -   EUCTR2006-006299-39-FR   France;Netherlands;
   Ipsen
      2016   Phase 3   NCT02660359   Argentina;Australia;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   NCT02660138   Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Turkey;United States;
      2011   Phase 2   NCT01357980   Austria;Czech Republic;Czechia;France;Germany;Italy;Poland;
Botulinum toxin type A infiltrations   
   Aránzazu Vázquez Doce
      2019   Phase 3   NCT04595045   Spain;
Brimonidine tartrate   
   Biogen
      2016   Phase 4   NCT02568111   -
C1-esterase inhibitor (Cinryze)   
   Michael Levy
      2013   Phase 1   NCT01759602   United States;
C105   
   Cognition Pharmaceuticals, LLC
      2006   Phase 2   NCT00529581   United States;
CALCIO FOLINATO DC.IT   
   AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
      2005   -   EUCTR2005-006071-12-IT   Italy;
CBD   
   Aarhus Universitetshospital
      2018   Phase 2   EUCTR2018-002315-98-DK   Denmark;
CC   
   University of Washington
      2014   -   NCT02137044   United States;
CCI-779   
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
      2005   -   EUCTR2005-000171-18-FI   Finland;
   Wyeth is now a wholly owned subsidiary of Pfizer
      2003   Phase 2   NCT00228397   -
CD   
   Sato Toshiyuki
      2020   Phase 3   JPRN-jRCT2051210017   Japan;
CDP323   
   UCB Pharma
      2008   Phase 1/Phase 2   NCT00726648   United Kingdom;
      2007   Phase 2   NCT00484536   Belgium;Canada;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;United States;
      2007   Phase 2   EUCTR2006-002204-33-ES   Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002204-33-FI   Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
   UCB Pharma S.A.
      2007   Phase 2   EUCTR2006-002204-33-GB   Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
      2007   Phase 2   EUCTR2006-002204-33-FR   Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002204-33-SE   Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002204-33-NL   Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002204-33-HU   Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002204-33-DE   Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2006-002204-33-BE   Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
CELLCEPT   
   CHU de Rennes
      2018   Phase 3   EUCTR2018-001292-21-FR   France;
CETIRIZINE HYDROCHLORIDE   
   Biogen Idec Italia S.r.l.
      2015   -   EUCTR2013-001055-12-IT   Italy;
CGP 77116   
   National Institute of Neurological Disorders and Stroke (NINDS)
      1998   Phase 2   NCT00001781   United States;
CHR-1103 / GBR500   
   Genzyme Corporation
      2015   Phase 2   EUCTR2014-003265-19-PL   Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
      2015   Phase 2   EUCTR2014-001643-20-SE   Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
      2015   Phase 2   EUCTR2014-001643-20-PL   Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
      2015   Phase 2   EUCTR2014-001643-20-DE   Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
CIANOCOBALAMINA FU DC.IT   
   AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
      2005   -   EUCTR2005-006071-12-IT   Italy;
CIC using LoFric Primo   
   Wellspect HealthCare
      2009   -   NCT00913510   Belgium;France;Germany;Netherlands;United Kingdom;
CITOCHINE ED IMMUNOMODULATORI   
   TEVA
      2005   -   EUCTR2004-003943-28-IT   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
CLOSTRIDIUM BOTULINUM TOXIN TYPE A   
   Ipsen Innovation
      2016   Phase 3   EUCTR2015-003471-30-PT   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-PL   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-NL   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-IT   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-CZ   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-000507-44-LT   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-FR   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-ES   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-DE   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-BE   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2012   -   EUCTR2010-023210-31-LT   Austria;Czech Republic;Germany;Italy;Lithuania;
      2012   -   EUCTR2010-023210-31-DE   Austria;Czech Republic;Germany;Italy;Lithuania;
      2012   -   EUCTR2010-023210-31-CZ   Austria;Czech Republic;Germany;Italy;Lithuania;
      2012   -   EUCTR2010-023210-31-AT   Austria;Czech Republic;Germany;Italy;Lithuania;
CNM-Au8   
   Clene Nanomedicine
      2020   Phase 2/Phase 3   NCT04626921   Australia;
      2018   Phase 2   NCT03536559   Australia;Canada;United States;
CNTO 1275   
   Centocor, Inc.
      2004   Phase 2   NCT00207727   Australia;Canada;Czech Republic;Hungary;Poland;United Kingdom;United States;
CO-14   
   PEPTIMMUNE Inc
      2008   -   EUCTR2007-007759-15-HU   Hungary;
COLECALCIFEROL CONCENTRATE (OILY FORM)   
   Javier Olascoaga Urtaza
      2013   Phase 2   EUCTR2012-004602-97-ES   Spain;
COP-1/Copolymer-1   
   TEVA Pharmaceutical Industries Ltd.
      2007   -   EUCTR2004-000463-94-HU   Hungary;Italy;
      2004   -   EUCTR2004-000462-13-HU   Hungary;Italy;
COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE   
   NOVARTIS PHARMA AG
      2021   Phase 3   EUCTR2020-004505-32-IT   France;Germany;Italy;Spain;
COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE   
   TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
      2015   Phase 4   EUCTR2015-000922-12-IT   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN   
   NOVARTIS PHARMA AG
      2021   Phase 3   EUCTR2020-004505-32-IT   France;Germany;Italy;Spain;
COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO   
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
   TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
      2015   Phase 4   EUCTR2015-000922-12-IT   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
COPAXONE 20 mg/ml solución inyectable en jeringa precargada   
   Biogen Idec Limited
      2010   -   EUCTR2009-015556-15-ES   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
COPAXONE*SC 28SIR 20MG/ML   
   Teva Pharmaceuticals Industries Ltd.
      2006   -   EUCTR2006-002037-20-IT   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
COVID-19 mRNA Vaccine (nucleoside modified)   
   Novartis Pharma GmbH
      2021   Phase 4   EUCTR2020-005752-38-DE   Germany;
   Novartis Pharma Vertriebs GmbH
      2021   Phase 4   EUCTR2021-000307-20-DE   Germany;
COVID-19 mRNA vaccine (nucleoside-modified)   
   Novartis Pharma Vertriebs GmbH
      2021   Phase 4   EUCTR2021-000307-20-DE   Germany;
COVID-19 mRNA vaccine Moderna (CX-024414)   
   Novartis Pharma GmbH
      2021   Phase 4   EUCTR2020-005752-38-DE   Germany;
   Novartis Pharma Vertriebs GmbH
      2021   Phase 4   EUCTR2021-000307-20-DE   Germany;
COVID-19 vaccination   
   Sheba Medical Center
      2021   -   NCT05075499   Israel;
COVID19 vaccine   
   Yale University
      2021   -   NCT05286242   United States;
CS-0777 tablets   
   Daiichi Sankyo Inc.
      2008   Phase 1   NCT00616733   United States;
CSF sampling   
   Rennes University Hospital
      2021   -   NCT04697407   France;
CT103A cells   
   Tongji Hospital
      2020   Early Phase 1   NCT04561557   China;
CYCLOPHOSPHAMIDE MONOHYDRATE   
   Uppsala l?ns landsting
      2011   -   EUCTR2010-023560-40-SE   Brazil;Canada;Sweden;United States;
Caffeine   
   Biogen
      2011   Phase 3   NCT01462318   Czech Republic;Hungary;Poland;Russian Federation;United States;
Calcium   
   Centre Hospitalier Universitaire de Nimes
      2016   -   NCT02636829   France;
Calcium and Vitamin D combination   
   Novartis
      2010   Phase 3   NCT01166178   Germany;
Calcium carbonate   
   University Hospital of North Norway
      2008   Phase 4   NCT00785473   Norway;
Calcium levofolinate   
   AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
      2005   -   EUCTR2005-006071-12-IT   Italy;
Cannabidiol   
   GW Pharma Ltd
      2007   Phase 3   EUCTR2006-005910-11-CZ   Czech Republic;Germany;Italy;Spain;United Kingdom;
      2006   Phase 3   EUCTR2005-005265-11-GB   Czech Republic;France;United Kingdom;
      2006   Phase 3   EUCTR2005-005265-11-FR   Czech Republic;France;United Kingdom;
      2006   -   EUCTR2005-005265-11-CZ   Czech Republic;France;United Kingdom;
      2005   Phase 3   EUCTR2004-002509-63-GB   Czech Republic;United Kingdom;
      2005   -   EUCTR2004-002509-63-CZ   Czech Republic;United Kingdom;
   GW Pharma Ltd.
      2011   -   EUCTR2011-000926-31-CZ   Czech Republic;
      2008   Phase 3   EUCTR2006-005910-11-GB   Czech Republic;Germany;Italy;Spain;United Kingdom;
      2008   -   EUCTR2006-005910-11-DE   Germany;Italy;Spain;United Kingdom;
      2007   -   EUCTR2007-002138-13-GB   United Kingdom;
Cannabidiol (CBD)   
   Tiffany J. Braley, MD, MS
      2022   Phase 2   NCT05269628   United States;
Cannabidiol / Dronabinol capsule 5 mg+2,   
   Aarhus Universitetshospital
      2018   Phase 2   EUCTR2018-002315-98-DK   Denmark;
Cannabidiol Botanical Drug Substance (CBD BDS)   
   Almirall Hermal GmbH
      2016   Phase 4   EUCTR2015-004451-40-AT   Austria;Czech Republic;
   GW Pharma Limited
      2022   Phase 3   EUCTR2020-004306-58-LT   Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-003271-18-ES   Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
      2021   Phase 3   EUCTR2020-003271-18-CZ   Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
      2021   Phase 3   EUCTR2019-002625-29-CZ   Czech Republic;Czechia;Poland;United Kingdom;
      2020   Phase 3   EUCTR2019-002625-29-PL   Czech Republic;Czechia;Poland;United Kingdom;
      2020   Phase 3   EUCTR2019-002625-29-GB   Poland;United Kingdom;
   GW Pharma Ltd
      2020   Phase 3   EUCTR2019-002623-14-PL   Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-002623-14-GB   Czech Republic;Poland;Romania;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-002623-14-CZ   Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
Cannabidiol capsule   
   Aarhus Universitetshospital
      2018   Phase 2   EUCTR2018-002315-98-DK   Denmark;
Cannabis   
   Centre hospitalier de l'Université de Montréal (CHUM)
      2021   Phase 3   NCT05092191   -
Cannabis Based Medicine Extract (Sativex)   
   AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
      2004   -   EUCTR2005-000393-47-IT   Italy;
Cannabis, Medical   
   OMNI Medical Services, LLC
      2018   Phase 2   NCT03944447   United States;
Cannador   
   Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research)
      2006   Phase 3   EUCTR2005-005263-29-GB   United Kingdom;
Capacity of muscular oxygen extraction   
   Centre Hospitalier Universitaire de Saint Etienne
      2020   Phase 2   NCT03983720   France;
Capsules with 160 mg Teavigo (at least EGCG)   
   Charite University, Berlin, Germany
      2011   -   NCT01417312   Germany;
Carbamazepine   
   Stine Maarbjerg, MD PhD
      2012   -   NCT04371575   -
Carbidopa   
   University of Miami
      2018   Phase 1   NCT03266965   United States;
Carmustine   
   Fred Hutchinson Cancer Research Center
      2008   Phase 2   NCT00716066   United States;
Carmustine, etoposide, cytarabine, and melphalan (BEAM)   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2006   Phase 2   NCT00288626   United States;
Carnosine, capsulle, 2 g/day, 8 weeks   
   University of Novi Sad, Faculty of Sport and Physical Education
      2019   -   NCT03995810   Serbia;
Cellular therapy with EBV specific autologous CTL infusion   
   Nantes University Hospital
      2021   Phase 1   NCT02912897   France;
Ceralifimod   
   Merck KGaA
      2014   Phase 3   EUCTR2013-002351-15-AT   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-003126-83-HU   Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-003126-83-GR   Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-003126-83-ES   Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-003126-83-DE   Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-003126-83-BG   Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-PT   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-LV   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-HU   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-ES   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-EE   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-BG   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Ceralifmod   
   Merck KGaA
      2014   Phase 3   EUCTR2013-002351-15-AT   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-PT   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-LV   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-HU   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-ES   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-EE   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2014   -   EUCTR2013-002351-15-BG   Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Cerebro-spinal fluid   
   University Hospital, Bordeaux
      2021   -   NCT04798651   France;
Cesamet™ (nabilone)   
   NEMA Research, Inc.
      2006   Phase 4   NCT00381264   United States;
Ceterizine   
   Genzyme, a Sanofi Company
      2017   Phase 3   NCT03368664   Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      2015   Phase 1   NCT02583594   Spain;
Cetirizina Mylan Generics   
   Biogen Idec Italia S.r.l.
      2015   -   EUCTR2013-001055-12-IT   Italy;
Cetirizine   
   Genzyme, a Sanofi Company
      2014   Phase 4   NCT02205489   Belgium;France;Netherlands;Spain;
   Icahn School of Medicine at Mount Sinai
      2014   Phase 1/Phase 2   NCT02865018   United States;
Charcoal   
   Sanofi
      2013   Phase 3   NCT01863888   Belgium;Germany;Netherlands;
Cholecalciferol   
   Academic MS Center Limburg
      2014   Phase 2   NCT02096133   Netherlands;
   Johns Hopkins University
      2010   Phase 1   NCT01024777   United States;
   University Hospital of North Norway
      2008   Phase 4   NCT00785473   Norway;
Cholecalciferol (Vitamin D3)   
   Merck KGaA
      2009   Phase 2   NCT01198132   France;
Cholecalciferol, Vitamin D3   
   Merck Serono
      2011   -   EUCTR2010-020328-23-LV   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2011   -   EUCTR2010-020328-23-LT   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2011   -   EUCTR2010-020328-23-EE   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2011   -   EUCTR2010-020328-23-DE   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2010   Phase 2   EUCTR2010-020328-23-DK   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2010   -   EUCTR2010-020328-23-FI   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
   Merck Serono SA - Geneva, an affiliate of Merck KGaA
      2012   Phase 2   EUCTR2010-020328-23-PT   Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2011   -   EUCTR2010-020328-23-AT   Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
   Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
      2011   -   EUCTR2010-020328-23-BE   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
   Merck Serono The Netherlands - a division of Merck B.V.
      2011   -   EUCTR2010-020328-23-NL   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Cholestyramine   
   Sanofi
      2014   Phase 1   NCT02046629   China;
      2013   Phase 3   NCT01863888   Belgium;Germany;Netherlands;
Circadin ( INN= Melatonin)   
   North Bristol NHS Trust
      2013   Phase 2   EUCTR2012-004183-21-GB   United Kingdom;
Citalopram   
   Novartis Pharmaceuticals
      2011   Phase 4   NCT01436643   Germany;
Cladribina   
   MERCK KGAA
      2019   Phase 4   EUCTR2019-000069-19-IT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Cladribina oral   
   Serono International, S.A.
      2007   -   EUCTR2006-003366-33-ES   Italy;Spain;
Cladribine   
   Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
      2019   Phase 3   EUCTR2019-001505-24-NO   Norway;
   EMD Serono
      2008   Phase 3   NCT00725985   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2005   Phase 3   NCT00213135   Canada;Switzerland;
   EMD Serono Research & Development Institute, Inc.
      2019   Phase 4   NCT03961204   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
      2008   Phase 3   NCT00641537   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;Former Serbia and Montenegro;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2006   Phase 2   NCT00436826   Italy;Russian Federation;Spain;United States;
   Helse Bergen HF, Haukeland University Hospital
      2018   Phase 3   EUCTR2017-001362-25-DK   Denmark;Netherlands;
   MERCK SERONO INTERNATIONAL SA
      2008   -   EUCTR2006-003366-33-IT   Italy;Spain;
   MERCK SERONO SA
      2008   -   EUCTR2007-000381-20-IT   Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
      2005   -   EUCTR2004-005148-28-IT   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
   Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
      2019   Phase 1   NCT04086225   Germany;Poland;
   Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
      2019   -   NCT04934800   Austria;Greece;Italy;Norway;Poland;Portugal;Switzerland;
   Merck KGaA
      2008   Phase 1   NCT00938366   -
   Merck KGaA, Darmstadt, Germany
      2019   Phase 1   NCT03745144   Germany;Poland;
   Merck Serono International S.A.
      2006   -   EUCTR2004-005148-28-LT   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-FI   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-EE   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-DK   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-CZ   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-BE   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
   Merck Serono International, a branch of Laboratoires Serono S.A.
      2005   Phase 3   EUCTR2004-005148-28-GB   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
   Merck Serono International, a branch of Laboratories Serono S.A.
      2005   -   EUCTR2004-005148-28-DE   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
   Oslo University Hospital
      2019   Phase 3   NCT04121403   Norway;
   Queen Mary University of London
      2020   Phase 2   EUCTR2018-005038-39-GB   United Kingdom;
   Serono International S.A.
      2006   Phase 3   EUCTR2004-005148-28-SK   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
      2006   -   EUCTR2004-005148-28-LV   Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
      2005   -   EUCTR2004-005148-28-AT   Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
   Serono International, S.A.
      2007   -   EUCTR2006-003366-33-ES   Italy;Spain;
   University of Texas Southwestern Medical Center
      2020   Phase 4   NCT04178005   United States;
   Washington University School of Medicine
      2019   Phase 4   NCT03963375   United States;
Cladribine (MAVENCLAD®)   
   Queen Mary University of London
      2021   Phase 2/Phase 3   NCT04695080   United Kingdom;
Cladribine Oral Tablet   
   Claudio Gobbi
      2020   -   NCT04640818   Switzerland;
Cladribine Tablet   
   MERCK SERONO SA
      2011   Phase 3   EUCTR2009-017978-21-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands;
Cladribine Tablets   
   EMD Serono Research & Development Institute, Inc.
      2019   -   NCT03933215   United States;
      2019   -   NCT03933202   United States;
   Keith Edwards, M.D.
      2020   Phase 4   NCT04550455   United States;
Cladribine tablets   
   MERCK KGAA
      2021   Phase 4   EUCTR2020-003995-42-IT   Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland;
      2021   Phase 4   EUCTR2020-003874-30-IT   Austria;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain;
   Merck Healthcare KGaA
      2021   Phase 4   EUCTR2020-003995-42-HU   Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;
      2021   Phase 4   EUCTR2020-003995-42-CZ   Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;
      2021   Phase 4   EUCTR2020-003874-30-HU   Hungary;
      2021   Phase 4   EUCTR2020-003874-30-DK   Denmark;Hungary;
      2021   Phase 4   EUCTR2020-003874-30-CZ   Czech Republic;Denmark;Hungary;Italy;
      2020   Phase 4   EUCTR2020-003995-42-FI   Australia;Canada;Finland;Germany;Israel;
      2020   Phase 4   EUCTR2020-003995-42-DE   Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Poland;
   Merck KGaA
      2019   Phase 4   EUCTR2019-000069-19-SE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
      2019   Phase 4   EUCTR2019-000069-19-PT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
      2019   Phase 4   EUCTR2019-000069-19-PL   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
      2019   Phase 4   EUCTR2019-000069-19-LT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
      2019   Phase 4   EUCTR2019-000069-19-HR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
      2019   Phase 4   EUCTR2019-000069-19-ES   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
      2019   Phase 4   EUCTR2019-000069-19-EE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
      2019   Phase 4   EUCTR2019-000069-19-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
      2019   Phase 4   EUCTR2019-000069-19-BG   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
   Merck Serono S.A. - Geneva
      2012   Phase 3   EUCTR2009-017978-21-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2012   Phase 3   EUCTR2009-017978-21-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2012   Phase 3   EUCTR2009-017978-21-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-LV   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-FI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   Phase 3   EUCTR2009-017978-21-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   -   EUCTR2009-017978-21-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2011   -   EUCTR2009-017978-21-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-017978-21-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
   Merck, S.L.
      2019   Phase 4   EUCTR2019-000069-19-AT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Clemastine   
   University of California, San Francisco
      2014   Phase 2   NCT02040298   United States;
Clemastine Milstein 1 mg, tabletten   
   Amsterdam University Medical Center
      2022   Phase 3   EUCTR2021-003677-66-NL   Netherlands;
Clemastine fumarate   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2017   Phase 1/Phase 2   NCT03109288   United States;
Cnp-MS-0601   
   Bionorica research GmbH
      2007   Phase 3   EUCTR2006-004255-38-DK   Austria;Denmark;Germany;
      2007   -   EUCTR2006-004255-38-DE   Austria;Germany;
      2007   -   EUCTR2006-004255-38-AT   Austria;Germany;
Coconut oil   
   University of Iowa
      2010   Phase 1   NCT01381354   United States;
Coconut oil and epigallocatechin gallate   
   Fundación Universidad Católica de Valencia San Vicente Mártir
      2018   Phase 2   NCT03740295   Spain;
Coenzyme Q   
   University of Iowa
      2010   Phase 1   NCT01381354   United States;
Colecalciferol   
   AZIENDA OSPEDALIERA S. LUIGI GONZAGA
      2011   -   EUCTR2010-023677-19-IT   Italy;
   MERCK SERONO SA
      2011   -   EUCTR2010-020328-23-IT   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
   University of Turku
      2008   Phase 4   NCT01339676   Finland;
      2008   Phase 2/Phase 3   NCT01432704   -
Combination Product: ofatumumab with AI   
   Novartis Pharmaceuticals
      2018   Phase 2   NCT03560739   Austria;Bulgaria;Czechia;Estonia;Latvia;Lithuania;Russian Federation;Spain;United States;
Combination Product: ofatumumab with PRF   
   Novartis Pharmaceuticals
      2018   Phase 2   NCT03560739   Austria;Bulgaria;Czechia;Estonia;Latvia;Lithuania;Russian Federation;Spain;United States;
Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion   
   Novartis Pharma Vertriebs GmbH
      2021   Phase 4   EUCTR2021-000307-20-DE   Germany;
Continued Ocrelizumab   
   Johns Hopkins University
      2021   Phase 2   NCT04767698   United States;
Copaxone   
   Amphia Ziekenhuis
      2009   -   EUCTR2009-013129-41-NL   Netherlands;
   Bayer
      2003   Phase 3   NCT00099502   Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States;
   Biogen Idec Limited
      2010   -   EUCTR2009-015556-15-SI   Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
      2010   -   EUCTR2009-015556-15-SE   Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
      2010   -   EUCTR2009-015556-15-PT   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-NL   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-LV   Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
      2010   -   EUCTR2009-015556-15-HU   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-GR   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-GB   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-FI   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-DK   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-DE   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-CZ   Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
      2010   -   EUCTR2009-015556-15-AT   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
   Biogen Idec Ltd.
      2008   -   EUCTR2006-003697-10-BG   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   Phase 3   EUCTR2006-003697-10-ES   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   Phase 3   EUCTR2006-003697-10-BE   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-LV   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-IE   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-GR   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-EE   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-DE   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-CZ   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
   EMD Serono
      2013   Phase 2   NCT01963611   Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
   Glostrup Hospital, Dep. of Neurology
      2009   -   EUCTR2006-001827-21-DK   Denmark;
   Karolinska Institutet
      2017   Phase 4   EUCTR2017-002634-24-SE   Sweden;
      2017   Phase 4   EUCTR2016-003587-39-SE   Sweden;
   Merck KGaA
      2014   Phase 2   EUCTR2013-002283-25-GB   Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
      2014   -   EUCTR2013-002283-25-PL   Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
      2014   -   EUCTR2013-002283-25-GR   Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
      2014   -   EUCTR2013-002283-25-ES   Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
      2014   -   EUCTR2013-002283-25-BG   Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2013-002283-25-IT   Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
      2013   -   EUCTR2013-002283-25-HU   Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
      2013   -   EUCTR2013-002283-25-FI   Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
      2013   -   EUCTR2013-002283-25-CZ   Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
   Merck Serono S.A. - Geneva
      2010   -   EUCTR2009-016087-37-GB   France;Ireland;Italy;Spain;United Kingdom;
      2009   -   EUCTR2009-016087-37-ES   France;Ireland;Italy;Spain;United Kingdom;
   Nancy Hammond, MD
      2007   -   NCT00490906   United States;
   Novartis Pharma Services AG
      2012   -   EUCTR2011-001437-16-DE   Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
   Peptimmune Inc.
      2010   Phase 2   EUCTR2009-012716-40-SK   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
      2010   Phase 2   EUCTR2009-012716-40-DE   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
      2010   -   EUCTR2009-012716-40-PL   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
      2010   -   EUCTR2009-012716-40-FR   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
      2010   -   EUCTR2009-012716-40-CZ   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
      2010   -   EUCTR2009-012716-40-BG   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
      2009   -   EUCTR2009-012716-40-EE   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
   Philipps-Universität Marburg
      2010   -   EUCTR2009-011088-35-DE   Germany;
   SYNTHON BV
      2011   -   EUCTR2011-000888-27-IT   Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States;
   Stuart D Cook MD
      2003   Phase 4   NCT00176592   United States;
   Synthon BV
      2012   -   EUCTR2011-000888-27-GR   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-000888-27-DE   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2011   Phase 3   EUCTR2011-000888-27-RO   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2011-000888-27-GB   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2011-000888-27-EE   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2011-000888-27-CZ   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2011-000888-27-BG   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
   The Walton Centre for Neurology and Neurosurgery
      2005   Phase 4   EUCTR2004-004903-39-GB   United Kingdom;
   Turku University Hospital
      2013   Phase 4   EUCTR2013-004626-28-FI   Finland;
   University at Buffalo
      2007   -   NCT00937157   United States;
   University of California, Los Angeles
      2007   Phase 2   NCT00451204   Canada;United States;
   Università Popolare Homo & Natura
      2015   Phase 1   NCT02632591   Italy;
   VU University Medical Center
      2014   -   EUCTR2014-001012-19-NL   Netherlands;
Copaxone 20 mg/ml   
   Octapharma AG
      2015   Phase 3   EUCTR2012-005086-12-PL   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
      2013   -   EUCTR2012-005086-12-HU   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-DE   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-BG   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-AT   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
   Teva Pharmaceutical Industries, Ltd
      2016   Phase 4   EUCTR2015-000922-12-PL   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-FR   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-ES   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-DE   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-BE   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-IE   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-HR   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-FI   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-AT   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
Copaxone 20 mg/ml Solution for Injection, pre-filled syringe   
   Teva Pharmaceutical Industries, Ltd.
      2007   -   EUCTR2006-002037-20-EE   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   Phase 3   EUCTR2006-002037-20-FI   Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   Phase 3   EUCTR2006-002037-20-ES   Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-LV   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-LT   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-HU   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-GB   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-DE   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-CZ   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-BE   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 20 mg/ml solución para inyección en jeringa precargada   
   Teva Pharmaceutical Industries, Ltd.
      2006   Phase 3   EUCTR2006-002037-20-ES   Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes   
   Teva Pharmaceutical Industries, Ltd.
      2006   -   EUCTR2006-002037-20-CZ   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 20mg/ml Solution for Injection, pre-filled syringe   
   Teva Pharmaceutical Industries, Ltd.
      2006   -   EUCTR2006-002037-20-LT   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 40 mg/ml   
   Teva Pharmaceutical Industries, Ltd
      2016   Phase 4   EUCTR2015-000922-12-PL   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-FR   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-ES   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-DE   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-BE   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-IE   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-HR   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-FI   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-AT   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
Copaxone 40 mg/ml solution for injection, pre-filled syringe   
   Università degli Studi Aldo Moro
      2019   Phase 3   EUCTR2017-005129-18-IT   Italy;
Copaxone subcutaneous injection syringe   
   TAKEDA PHARMACEUTICAL COMPANY LTD.
      2015   -   JPRN-JapicCTI-153058   -
Copaxone-Teva   
   Biocad
      2013   Phase 3   NCT02753088   -
Copaxone®   
   Teva Branded Pharmaceutical Products R&D, Inc.
      2015   Phase 4   NCT02499900   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Puerto Rico;Russian Federation;Spain;Turkey;United States;
Copolymer 1   
   National Center for Research Resources (NCRR)
      1991   Phase 3   NCT00004814   -
Corticosteroid   
   University of New Mexico
      2019   Phase 1/Phase 2   NCT03752307   United States;
Corticosteroids & tanCART19/20   
   Chinese PLA General Hospital
      2018   Phase 1   NCT03605238   China;
Cranberry   
   Rennes University Hospital
      2006   Phase 3   NCT00280592   France;
Creatine   
   University of Iowa
      2010   Phase 1   NCT01381354   United States;
Curcumin   
   Merck KGaA, Darmstadt, Germany
      2012   Phase 2   NCT01514370   Italy;
Cyclophosfamide   
   Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
      2006   -   EUCTR2006-002562-19-IT   Italy;
Cyclophosphamide   
   AZIENDA OSPEDALIERA DI PADOVA
      -   Phase 1   EUCTR2008-005773-35-IT   Italy;
   Baylor College of Medicine
      1999   Phase 2   NCT00040482   United States;
   Fred Hutchinson Cancer Research Center
      1997   Phase 1   NCT00014755   United States;
   Hadassah Medical Organization
      2015   -   NCT02529839   -
   Helse Bergen HF, Haukeland University Hospital
      2018   Phase 3   EUCTR2017-001362-25-DK   Denmark;Netherlands;
   Northwestern Memorial Hospital
      2001   Phase 1   NCT00017628   United States;
   Northwestern University
      2019   Phase 2/Phase 3   NCT03829566   United States;
      2017   Phase 3   NCT03342638   United States;
   OSPEDALE S. RAFFAELE
      2007   Phase 2   EUCTR2007-000586-38-IT   Italy;
   Seah Lim M.D.
      2012   Phase 2   NCT01679041   United States;
   Stony Brook University
      2003   Phase 2   NCT00296205   United States;
Cyclophosphamide (drug)   
   University Hospital, Bordeaux
      2005   Phase 3   NCT00241254   France;
Cyclophosphamide and ATG   
   Haukeland University Hospital
      2018   Phase 3   NCT03477500   Denmark;Netherlands;Norway;Sweden;
Cyclophosphamide and fludarabine   
   Tongji Hospital
      2020   Early Phase 1   NCT04561557   China;
Cyclophosphamide monohydrate   
   Sheffield Teaching Hospitals
      2020   Phase 3   EUCTR2019-001549-42-GB   United Kingdom;
Cyclophosphamide/Glatiramer acetate   
   Johns Hopkins University
      2010   Phase 2   NCT00939549   United States;
Cymbalta   
   Eli Lilly and Company
      2008   -   EUCTR2008-002560-34-BE   Belgium;
Cytarabine   
   Fred Hutchinson Cancer Research Center
      2008   Phase 2   NCT00716066   United States;
Cytolytic CD4+ T cells   
   ImCyse S.A
      2014   Phase 1;Phase 2   EUCTR2014-001081-99-BE   Belgium;
Cápsulas de Laquinimod   
   Teva Pharmaceutical Industries Ltd
      2008   -   EUCTR2007-005450-23-ES   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Células madre mesenquimales   
   Fundació Clínic per a la Recerca Biomèdica
      -   -   EUCTR2009-016442-74-ES   Spain;
D Mannose   
   University College, London
      2015   Phase 1   NCT02490046   United Kingdom;
D-BIOTINA   
   MEDDAY PHARMACEUTICALS
      2017   Phase 3   EUCTR2016-000700-29-IT   Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
D-Biotin   
   MEDDAY PHARMACEUTICALS
      2017   Phase 3   EUCTR2016-000700-29-IT   Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
D-aspartate   
   Merck KGaA, Darmstadt, Germany
      2018   Phase 2   NCT03387046   Germany;Italy;
DAC HYP   
   BIOGEN IDEC RESEARCH LIMITED
      2017   Phase 3   EUCTR2016-002820-10-IT   Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
   Biogen Idec Research Limited
      2017   Phase 3   EUCTR2016-002820-10-GB   Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002820-10-DE   Canada;Germany;Italy;United Kingdom;United States;
DAC-HYP   
   National Institute of Neurological Disorders and Stroke (NINDS)
      2010   Phase 1   NCT01143441   United States;
DC-TAB   
   Delta Crystallon B.V.
      2012   -   EUCTR2011-004475-36-BG   Bulgaria;
DEMESTRIL SEPTEM   
   OSPEDALI CIVILI DI LIONE
      2007   -   EUCTR2006-005460-30-IT   Italy;
DEXTROMETHORPHAN HYDROBROMIDE   
   Avanir Pharmaceuticals, Inc.
      2012   Phase 2   EUCTR2011-002178-22-GB   Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
      2012   -   EUCTR2011-002178-22-PL   Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
      2012   -   EUCTR2011-002178-22-CZ   Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
DIBASE   
   AZIENDA OSPEDALIERA S. LUIGI GONZAGA
      2011   -   EUCTR2010-023677-19-IT   Italy;
DIMETIL-FUMARATO   
   FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
      2017   Phase 4   EUCTR2017-000559-26-IT   Israel;Italy;Switzerland;United States;
DMT   
   Merck KGaA
      2012   -   NCT01601119   United Kingdom;
   VU University Medical Center
      2020   -   NCT04260711   Netherlands;
DMT continuation   
   Rennes University Hospital
      2019   Phase 3   NCT03653273   France;
DPA-714 PET/MRI   
   University of Alabama at Birmingham
      2019   Phase 1   NCT03759522   United States;
DUOC-01   
   Joanne Kurtzberg, MD
      2021   Phase 1   NCT04943289   United States;
DYSPORT*SC IM 2FL 500U   
   IPSEN INNOVATION
      2012   -   EUCTR2010-023210-31-IT   Austria;Czech Republic;Germany;Italy;Lithuania;
DYSPORT®   
   Ipsen Innovation
      2016   Phase 3   EUCTR2015-003471-30-PT   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-PL   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-NL   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-IT   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
      2016   Phase 3   EUCTR2015-003471-30-CZ   Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
Daclizumab   
   Biogen
      2017   Phase 3   NCT02881567   Canada;France;Germany;Italy;Puerto Rico;United Kingdom;United States;
   Biogen Idec Research Limited
      2017   Phase 3   EUCTR2016-002820-10-GB   Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002820-10-DE   Canada;Germany;Italy;United Kingdom;United States;
   National Institute of Neurological Disorders and Stroke (NINDS)
      2003   Phase 2   NCT00071838   United States;
   Protein Design Labs, Inc.
      2006   -   EUCTR2005-001567-55-DE   Germany;Spain;United Kingdom;
      2005   Phase 2   EUCTR2005-001567-55-GB   Austria;Germany;Spain;United Kingdom;
      2005   -   EUCTR2005-001567-55-ES   Germany;Spain;United Kingdom;
      2005   -   EUCTR2005-001567-55-AT   Austria;Germany;Spain;United Kingdom;
Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)   
   PDL BioPharma, Inc.
      2005   Phase 2   NCT00109161   Canada;United States;
Daclizumab HYP   
   BIOGEN IDEC LTD
      2010   -   EUCTR2009-012500-11-IT   Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
Daclizumab HYP (DAC HYP   
   BIOGEN IDEC RESEARCH LTD
      2013   Phase 3   EUCTR2012-003176-39-IT   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Daclizumab HYP (DAC HYP)   
   Biogen
      2013   Phase 3   EUCTR2012-003176-39-HU   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 2   EUCTR2009-015318-23-GB   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
   Biogen Idec Limited
      2011   -   EUCTR2010-023856-97-PL   Czech Republic;Hungary;Poland;Russian Federation;United States;
      2011   -   EUCTR2010-023856-97-HU   Czech Republic;Hungary;Poland;Russian Federation;United States;
      2011   -   EUCTR2010-023856-97-CZ   Czech Republic;Hungary;Poland;United States;
   Biogen Idec Ltd
      2012   Phase 3   EUCTR2009-012500-11-SI   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-012500-11-GB   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-012500-11-FR   Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2009-012500-11-FI   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-012500-11-ES   Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-012500-11-SE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-IE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-HU   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-GR   Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-012500-11-DK   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-DE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2009-012500-11-CZ   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2006   Phase 2   EUCTR2006-001161-42-GB   Czech Republic;Germany;Hungary;Sweden;United Kingdom;
   Biogen Idec Ltd.
      2011   Phase 2   EUCTR2009-015318-23-DE   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
      2010   Phase 2   EUCTR2009-015318-23-HU   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
      2010   Phase 2   EUCTR2009-015318-23-CZ   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
      2009   Phase 2   EUCTR2008-005559-46-GB   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2009   -   EUCTR2008-005559-46-HU   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2009   -   EUCTR2008-005559-46-DE   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2009   -   EUCTR2008-005559-46-CZ   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2008   -   EUCTR2006-001161-42-HU   Germany;Hungary;Sweden;United Kingdom;
      2008   -   EUCTR2006-001161-42-DE   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Sweden;Ukraine;United Kingdom;
      2006   -   EUCTR2006-001161-42-SE   Germany;Hungary;Sweden;United Kingdom;
      2006   -   EUCTR2006-001161-42-CZ   Czech Republic;Germany;Hungary;Sweden;United Kingdom;
   Biogen Idec Research Limited
      2013   Phase 3   EUCTR2012-003176-39-SE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-PL   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-IE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-GR   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-GB   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-FR   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-ES   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-DK   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-DE   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-003176-39-CZ   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2012-003176-39-FI   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Daclizumab High Yield Process   
   Biogen Idec Ltd.
      2011   Phase 2   EUCTR2009-015318-23-DE   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
      2010   Phase 2   EUCTR2009-015318-23-HU   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
      2010   Phase 2   EUCTR2009-015318-23-CZ   Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
Daclizumab wih Greek suffix   
   Biogen Idec Ltd
      2012   Phase 3   EUCTR2009-012500-11-SI   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Daclizumab with Greek suufix   
   Biogen Idec Ltd.
      2009   Phase 2   EUCTR2008-005559-46-GB   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2009   -   EUCTR2008-005559-46-HU   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2009   -   EUCTR2008-005559-46-DE   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
      2009   -   EUCTR2008-005559-46-CZ   Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
Dalfampridine   
   Acorda Therapeutics
      2012   -   NCT01535664   United States;
   Johns Hopkins University
      2014   Phase 2   NCT02166346   United States;
   Oregon Health and Science University
      2011   Phase 2   NCT01444300   United States;
   State University of New York at Buffalo
      2011   Phase 2/Phase 3   NCT02006160   United States;
   VA Office of Research and Development
      2015   Phase 2   NCT02391961   United States;
   Washington University School of Medicine
      2011   Phase 2/Phase 3   NCT01337986   United States;
Dalfampridine ER   
   Brown, Theodore R., M.D., MPH
      2010   Phase 4   NCT01356940   United States;
Dalfampridine-ER   
   Acorda Therapeutics
      2011   Phase 3   NCT01328379   United States;
Dantrolene   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2017   Phase 1/Phase 2   NCT03109288   United States;
Darifenacin   
   Bayer Vital GmbH
      2006   -   EUCTR2006-002361-39-DE   Germany;
Darifenacin (BAY79-4998)   
   Bayer
      2007   Phase 2   NCT00845338   Germany;
Dekristol 20000 IE   
   Merja Soilu Häninen
      2007   -   EUCTR2007-001958-99-FI   Finland;
Dekristol® 400-Tabletten   
   Charité - Universitätsmedizin Berlin
      2011   Phase 2   EUCTR2011-002785-20-DE   Germany;
Dekristol®-Tablette 1 (400 IE)   
   Charité - Universitätsmedizin Berlin
      2011   Phase 2   EUCTR2011-002785-20-DE   Germany;
Delta-9-tetrahydrocannabinol   
   GW Pharma Ltd
      2007   Phase 3   EUCTR2006-005910-11-CZ   Czech Republic;Germany;Italy;Spain;United Kingdom;
      2006   Phase 3   EUCTR2005-005265-11-GB   Czech Republic;France;United Kingdom;
      2006   Phase 3   EUCTR2005-005265-11-FR   Czech Republic;France;United Kingdom;
      2006   -   EUCTR2005-005265-11-CZ   Czech Republic;France;United Kingdom;
      2005   Phase 3   EUCTR2004-002509-63-GB   Czech Republic;United Kingdom;
      2005   -   EUCTR2004-002509-63-CZ   Czech Republic;United Kingdom;
   GW Pharma Ltd.
      2011   -   EUCTR2011-000926-31-CZ   Czech Republic;
      2008   Phase 3   EUCTR2006-005910-11-GB   Czech Republic;Germany;Italy;Spain;United Kingdom;
      2008   -   EUCTR2006-005910-11-DE   Germany;Italy;Spain;United Kingdom;
      2007   -   EUCTR2007-002138-13-GB   United Kingdom;
Desloratadine given orally   
   Hoffmann-La Roche
      2022   Phase 3   NCT05232825   Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Dexamethason   
   Department of Neurology UMCG
      2006   -   EUCTR2006-003113-40-NL   Netherlands;
Dexamethasone   
   Department of Neurology UMCG
      2006   -   EUCTR2006-003113-40-NL   Netherlands;
Dexamethasone given orally   
   Hoffmann-La Roche
      2022   Phase 3   NCT05232825   Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Dexamethasone soduim phosphate   
   Hadassah Medical Organization
      2008   Phase 1   NCT00674141   Israel;
Dexchlorpheniramine   
   Genzyme, a Sanofi Company
      2017   Phase 3   NCT03368664   Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      2015   Phase 1   NCT02583594   Spain;
Dexrazoxane (DRZ) plus Mitoxantrone (MX)   
   PD Dr. Andrew Chan
      2012   Phase 2   NCT01627938   Germany;
Dextromethorphan   
   Biogen
      2011   Phase 3   NCT01462318   Czech Republic;Hungary;Poland;Russian Federation;United States;
Dextromethorphan hydrobromide 20 mg and quinidine sulfate   
   Avanir Pharmaceuticals
      2007   Phase 3   NCT00573443   Argentina;Brazil;United States;
Dextromethorphan hydrobromide 30 mg and quinidine sulfate   
   Avanir Pharmaceuticals
      2007   Phase 3   NCT00573443   Argentina;Brazil;United States;
Dextromethorphan/Quinidine   
   Avanir Pharmaceuticals, Inc.
      2012   Phase 2   EUCTR2011-002178-22-GB   Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
      2012   -   EUCTR2011-002178-22-PL   Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
      2012   -   EUCTR2011-002178-22-CZ   Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
Dextrometorfano/Quinidina   
   Avanir Pharmaceuticals, Inc.
      2011   Phase 2   EUCTR2011-002178-22-ES   Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States;
Diazoxide   
   NEUROTEC PHARMA, S.L
      2011   -   EUCTR2010-023048-34-DE   Germany;Spain;
Diclofenac sodium topical gel   
   Brown, Theodore R., M.D., MPH
      2011   Phase 4   NCT01454791   United States;
Dietary Supplement: vitamin A   
   Tehran University of Medical Sciences
      2010   Phase 4   NCT01705457   Iran, Islamic Republic of;
Dimethyl Fumarate (DMF)   
   Genesis Pharma CNS & Specialty
      2016   -   NCT03101735   Greece;
   Hikma Pharmaceuticals LLC
      2021   -   NCT04468165   Algeria;Egypt;Jordan;
Dimethyl fumarate   
   Anders Svenningsson
      2016   Phase 3   NCT02746744   Sweden;
   Banner Life Sciences LLC
      2017   Phase 1   NCT04570670   -
   Biogen
      2021   -   NCT04756687   France;
      2016   Phase 3   NCT02555215   Belgium;Bulgaria;Czech Republic;Czechia;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
      2016   Phase 3   NCT02428218   -
      2016   -   NCT02969304   Germany;
      2015   Phase 4   NCT02472938   -
      2015   Phase 4   NCT02471560   Norway;
      2015   Phase 4   NCT02410278   United States;
      2015   Phase 4   NCT02343159   United States;
      2015   Phase 4   NCT02090348   -
      2015   Phase 3   NCT02525874   Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;Turkey;United States;
      2015   Phase 3   NCT02430532   Austria;Belgium;Czech Republic;Netherlands;Poland;Slovakia;Sweden;United States;
      2015   Phase 3   NCT02428231   Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
      2015   Phase 2   NCT02410200   Belgium;Bulgaria;Czech Republic;Czechia;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
      2015   Phase 2   NCT02097849   United States;
      2015   -   NCT02519413   United States;
      2015   -   NCT02323269   Canada;
      2014   Phase 4   NCT02125604   Germany;
      2014   Phase 4   NCT02090413   Ireland;United Kingdom;
      2014   Phase 3   NCT02579681   Italy;
      2014   Phase 3   NCT02283853   Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
      2014   -   NCT02159573   United States;
      2013   Phase 4   NCT01930708   Austria;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
      2013   Phase 3   NCT01838668   Czech Republic;Czechia;Japan;Korea, Republic of;Poland;Taiwan;
      2013   -   NCT02047097   Argentina;Australia;Austria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Switzerland;United Kingdom;United States;
      2013   -   NCT01911767   Australia;Canada;France;Germany;Ireland;Italy;Poland;Spain;United Kingdom;United States;
      2013   -   NCT01903291   United States;
      2010   Phase 2   NCT01156311   United States;
      2009   Phase 3   NCT00835770   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;North Macedonia;Poland;Puerto Rico;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
   Biogen Idec Inc.
      2004   -   EUCTR2004-000663-99-SE   Hungary;Sweden;
      2004   -   EUCTR2004-000663-99-HU   Hungary;Sweden;
      2004   -   EUCTR2004-000663-99-CZ   Czech Republic;Hungary;Sweden;
   Biogen Idec Italia S.r.l.
      2015   -   EUCTR2015-000303-21-IT   Italy;
   Fondation Ophtalmologique Adolphe de Rothschild
      2017   Phase 4   NCT02901106   France;
   Multiple Sclerosis Center of Northeastern New York
      2015   Phase 4   NCT03092544   United States;
   Northwestern University
      2013   Phase 2   EUCTR2012-004165-41-GB   United Kingdom;United States;
   Oregon Health and Science University
      2016   -   NCT02644083   United States;
   University Hospital Muenster
      2015   Phase 4   NCT02461069   Germany;
   University at Buffalo
      2015   -   NCT02686684   -
   Virginia Simnad
      2015   -   NCT02736279   United States;
Dimethyl fumarate [DMF]   
   Biogen Idec Italia S.r.l.
      2013   Phase 3   EUCTR2013-001422-25-IT   Italy;
Dimetilfumarato   
   Biogen Idec Italia S.r.l.
      2013   Phase 3   EUCTR2013-001422-25-IT   Italy;
Diphenhydramine IV   
   Hoffmann-La Roche
      2022   Phase 3   NCT05232825   Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Diphenydramine   
   Genzyme, a Sanofi Company
      2017   Phase 3   NCT03368664   Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Diroximel Fumarate (DRF)   
   Alkermes, Inc.
      2017   Phase 3   EUCTR2017-001294-16-PL   Germany;Poland;United States;
Diroximel fumarate   
   Alkermes, Inc.
      2019   Phase 3   EUCTR2017-001294-16-DE   Germany;Poland;United States;
   Hanna Jerome Thomas
      2021   Phase 3   JPRN-jRCT2051210115   China;Japan;
Dirucotide   
   Eli Lilly and Company
      2007   Phase 2/Phase 3   NCT00870155   Canada;Denmark;Estonia;Finland;Germany;Latvia;Netherlands;Spain;Sweden;United Kingdom;
      2006   Phase 2/Phase 3   NCT00869986   Bulgaria;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2004   Phase 2/Phase 3   NCT00869726   Canada;Denmark;Estonia;Finland;Germany;Latvia;Netherlands;Spain;Sweden;United Kingdom;
Dirucotide acetate   
   BioMS Technology Corp
      2007   -   EUCTR2004-002571-16-GB   Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2004-002571-16-FI   Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2004-002571-16-EE   Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2004-002571-16-DK   Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-002571-16-SE   Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Discontinuation of disease modifying therapy   
   University of Colorado, Denver
      2017   Phase 4   NCT03073603   United States;
Disease Modifying therapy   
   Novartis Pharmaceuticals
      2012   Phase 4   NCT01623596   Puerto Rico;United States;
Disease modifying treatment (DMT)   
   Novartis Pharmaceuticals
      2022   Phase 4   NCT05090371   United States;
Domperidone   
   University of Calgary
      2015   Phase 2   NCT02493049   Canada;
      2015   Phase 2   NCT02308137   Canada;
Donepezil   
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      1999   Phase 3   NCT00062972   United States;
   Neurology Unit
      2005   -   EUCTR2005-003410-15-SE   Sweden;
   OSPEDALE S. RAFFAELE
      2008   -   EUCTR2008-001940-38-IT   Italy;
Donepezil HCI (drug)   
   Neurognostics
      2004   Phase 4   NCT00315367   United States;
Dosing Interruption of Natalizumab   
   Berkovich, Regina MD, PhD Inc.
      2019   Phase 4   NCT04048577   United States;
Dotarem 0,5mmol/ml,   
   Universitätsklinikum Erlangen
      2010   -   EUCTR2009-014857-34-DE   Germany;
Dronabinol   
   Bionorica Research GmbH
      2007   Phase 3   NCT00959218   Germany;
   Bionorica SE
      2018   Phase 3   EUCTR2018-000001-23-ES   Hungary;Spain;
   Bionorica research GmbH
      2007   Phase 3   EUCTR2006-004255-38-DK   Austria;Denmark;Germany;
      2007   -   EUCTR2006-004255-38-DE   Austria;Germany;
      2007   -   EUCTR2006-004255-38-AT   Austria;Germany;
   Echo Pharmaceuticals B.V.
      2011   -   EUCTR2010-022033-28-NL   Netherlands;
   Plymouth Hospitals NHS Trust
      2006   -   EUCTR2005-002728-33-GB   United Kingdom;
Dronabinol 25 mg/ml, oral drops   
   Bionorica SE
      2020   Phase 3   EUCTR2018-000001-23-CZ   Czech Republic;Hungary;Spain;
      2018   Phase 3   EUCTR2018-000001-23-HU   Czech Republic;Hungary;Spain;
Dronabinol capsule 2,   
   Aarhus Universitetshospital
      2018   Phase 2   EUCTR2018-002315-98-DK   Denmark;
Drug - SHR1459   
   Reistone Biopharma Company Limited
      2020   Phase 2   NCT04670770   China;
Duloxetine   
   Brown, Theodore R., M.D., MPH
      2007   Phase 2/Phase 3   NCT00457730   United States;
Duloxetine Hydrochloride (HCI)   
   Eli Lilly and Company
      2008   Phase 3   NCT00755807   Belgium;Canada;Poland;United States;
Dynamic Contrast-Enhanced Magnetic Resonance Imaging   
   University of Southern California
      2011   -   NCT02967380   United States;
Dynamic Vessel Analyzer (DVA)   
   Medical University of Vienna
      2018   -   NCT03401879   Austria;
Dysport   
   Aránzazu Vázquez Doce
      2018   Phase 3   EUCTR2018-003231-30-ES   Spain;
   Ipsen Innovation
      2012   -   EUCTR2010-023210-31-LT   Austria;Czech Republic;Germany;Italy;Lithuania;
      2012   -   EUCTR2010-023210-31-DE   Austria;Czech Republic;Germany;Italy;Lithuania;
      2012   -   EUCTR2010-023210-31-CZ   Austria;Czech Republic;Germany;Italy;Lithuania;
      2012   -   EUCTR2010-023210-31-AT   Austria;Czech Republic;Germany;Italy;Lithuania;
Dysport®   
   Ipsen Innovation
      2016   Phase 3   EUCTR2015-000507-44-LT   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-FR   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-ES   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-DE   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
      2016   Phase 3   EUCTR2015-000507-44-BE   Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
EBIXA   
   AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI
      2007   -   EUCTR2007-000503-15-IT   Italy;
   HOSPICES CIVILS DE LYON
      2015   Phase 2   EUCTR2014-005548-17-FR   France;
   OSPEDALE S. RAFFAELE
      2008   Phase 2   EUCTR2008-000490-37-IT   Italy;
ECP002A   
   Echo Pharmaceuticals B.V.
      2011   -   EUCTR2010-022033-28-NL   Netherlands;
EGb 761® (Tanakan®)   
   Ipsen
      2003   Phase 3   NCT00276341   France;
EHP-101 25 mg BID   
   Emerald Health Pharmaceuticals
      2021   Phase 2   NCT04909502   -
EHP-101 25 mg OD   
   Emerald Health Pharmaceuticals
      2021   Phase 2   NCT04909502   -
EHP-101 50 mg BID   
   Emerald Health Pharmaceuticals
      2021   Phase 2   NCT04909502   -
EHP-101 50 mg OD   
   Emerald Health Pharmaceuticals
      2021   Phase 2   NCT04909502   -
EK-12   
   Bosnalijek D.D
      2019   Phase 3   NCT03283397   Turkey;
ELND002   
   Elan Pharmaceuticals
      2010   Phase 1   NCT01318421   -
      2010   Phase 1   NCT01144351   Canada;United States;
EMD 28162   
   Academic MS Center Limburg
      -   Phase 2   EUCTR2014-000728-97-NL   Netherlands;
   Merck Serono
      2011   -   EUCTR2010-020328-23-EE   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
      2011   -   EUCTR2010-020328-23-DE   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
   Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
      2011   -   EUCTR2010-020328-23-BE   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
   Merck Serono The Netherlands - a division of Merck B.V.
      2011   -   EUCTR2010-020328-23-NL   Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
EMSELEX 15 mg Retardtabletten   
   Bayer Vital GmbH
      2006   -   EUCTR2006-002361-39-DE   Germany;
EMSELEX 7,5 mg Retardtabletten   
   Bayer Vital GmbH
      2006   -   EUCTR2006-002361-39-DE   Germany;
ENA713   
   Novartis Pharma GmbH
      -   -   EUCTR2008-007015-32-DE   Germany;
ENDOXAN BAXTER   
   AZIENDA OSPEDALIERA DI PADOVA
      -   Phase 1   EUCTR2008-005773-35-IT   Italy;
   OSPEDALE S. RAFFAELE
      2007   Phase 2   EUCTR2007-000586-38-IT   Italy;
EPARMEFOLIN 30 CPR 0,1/0,   
   AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
      2005   -   EUCTR2005-006071-12-IT   Italy;
EPO   
   Sun Yat-sen University
      2006   -   NCT00818103   China;
ESTRADIOL HEMIHYDRATE   
   Irina Elovaara
      2015   -   EUCTR2014-005129-10-FI   Finland;
ETIMS   
   Universitätsklinikum Hamburg-Eppendorf
      2010   Phase 1/Phase 2   NCT01414634   -
ETIMS (EDC-fixed autologous PBMCs coupled with 7 immunodominant myelin peptides in MS patients)   
   University Medical Center Hamburg-Eppendorf
      2009   -   EUCTR2008-004408-29-DE   Germany;
EU/1/08/454/001-002, EU/1/08/454/005-007   
   University Hospital Motol
      2011   Phase 4   EUCTR2011-001956-12-CZ   Czech Republic;
EU/1/95/003/005-010   
   University Hospital Motol
      2011   Phase 4   EUCTR2011-001956-12-CZ   Czech Republic;
EU/1/97/033/002   
   University Hospital Motol
      2011   Phase 4   EUCTR2011-001956-12-CZ   Czech Republic;
EU/1/98/063/001-003   
   University Hospital Motol
      2011   Phase 4   EUCTR2011-001956-12-CZ   Czech Republic;
EU/1/98/063/004-006   
   University Hospital Motol
      2011   Phase 4   EUCTR2011-001956-12-CZ   Czech Republic;
EXTAVIA*SC 15FL 250MCG/ML+15SI   
   AZIENDA OSPEDALIERA S. LUIGI GONZAGA
      2011   -   EUCTR2010-023677-19-IT   Italy;
Early Harvest Extra Virgin Olive Oil   
   Aristotle University Of Thessaloniki
      2018   -   NCT04120675   Greece;
Early Highly Effective Therapies Group   
   The Cleveland Clinic
      2019   Phase 4   NCT03535298   United Kingdom;United States;
Eculizumab   
   Alexion Pharmaceuticals
      2020   Phase 2/Phase 3   NCT04155424   Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
      2015   Phase 3   NCT02003144   Argentina;Australia;Austria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States;
      2014   Phase 3   NCT01892345   Argentina;Australia;Austria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States;
   Mayo Clinic
      2009   Phase 1/Phase 2   NCT00904826   United States;
Elezanumab   
   AbbVie
      2019   Phase 2   NCT03737812   Canada;United States;
      2018   Phase 2   NCT03737851   Canada;United States;
Encapsulated Baclofen   
   Impax Laboratories, LLC
      2007   Phase 3   NCT00488839   Canada;Estonia;Latvia;Ukraine;United States;
Encapsulated Simvastatin tablets   
   Imperial College London
      2007   Phase 2   EUCTR2006-006347-31-GB   United Kingdom;
Endoxan - ciclofosfamide   
   Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
      2006   -   EUCTR2006-002562-19-IT   Italy;
Enriched Hematopoetic Stem Cell Infusion   
   Talaris Therapeutics Inc.
      2014   -   NCT02084121   United States;
Enspryng   
   F. HOFFMANN - LA ROCHE LTD.
      2021   Phase 3   EUCTR2021-001088-26-IT   Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States;
      2021   Phase 3   EUCTR2020-003413-35-IT   Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   F. Hoffmann-La Roche Ltd
      2021   Phase 3   EUCTR2020-003413-35-HU   Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-003413-35-BG   Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2020-003413-35-PL   Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Epigallocatechin-gallate (Sunphenon)   
   Charite University, Berlin, Germany
      2007   Phase 1/Phase 2   NCT00525668   Germany;
Epo   
   IFSgGmbH, Institute for clinical research
      2006   -   EUCTR2005-005592-14-DE   Germany;
Epoetin alfa   
   IFSgGmbH, Institute for clinical research
      2006   -   EUCTR2005-005592-14-DE   Germany;
Epoetin beta   
   Walton Centre for Neurology and Neurosurgery
      2008   -   EUCTR2008-005125-11-GB   United Kingdom;
Equal   
   GENEURO SA
      2016   Phase 2   EUCTR2015-004059-29-IT   Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
Erypo/Erypo FS   
   IFSgGmbH, Institute for clinical research
      2006   -   EUCTR2005-005592-14-DE   Germany;
Erythropoietin   
   Rigshospitalet, Denmark
      2009   Phase 2   NCT01144117   Denmark;
Escalation Therapies Group   
   The Cleveland Clinic
      2019   Phase 4   NCT03535298   United Kingdom;United States;
Escitalopram   
   University of South Carolina
      2009   Phase 3   NCT00965497   United States;
Escitalopram oxalate antidepressant   
   Weill Medical College of Cornell University
      2004   Phase 4   NCT00151294   United States;
Esomeprazole   
   Genzyme, a Sanofi Company
      2014   Phase 4   NCT02205489   Belgium;France;Netherlands;Spain;
Essential - hydroxytyrosol   
   University of Iowa
      2010   Phase 1   NCT01381354   United States;
Essential fatty acids   
   National Center for Complementary and Integrative Health (NCCIH)
      1999   Phase 1/Phase 2   NCT00010842   United States;
Estradiol   
   Hospices Civils de Lyon
      2005   Phase 3   NCT00127075   France;
   OSPEDALI CIVILI DI LIONE
      2007   -   EUCTR2006-005460-30-IT   Italy;
Estriol   
   University of California, Los Angeles
      2011   Phase 2   NCT01466114   United States;
      2007   Phase 2   NCT00451204   Canada;United States;
Estroprogestins   
   S. Andrea Hospital
      2002   Phase 2   NCT00151801   Italy;
Eszopiclone   
   University of Vermont
      2006   -   NCT00594087   United States;
Etifoxine   
   Imperial College London
      2018   -   NCT03850301   United Kingdom;
Etoposide   
   Fred Hutchinson Cancer Research Center
      2008   Phase 2   NCT00716066   United States;
Evobrutinib   
   EMD Serono Research & Development Institute, Inc.
      2019   Phase 3   NCT04032171   Germany;United States;
      2019   Phase 3   NCT04032158   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
   MERCK HEALTHCARE KGaA
      2020   Phase 3   EUCTR2019-004980-36-IT   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
   Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
      2020   Phase 3   NCT04338061   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Latvia;Lithuania;Malaysia;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United States;
      2020   Phase 3   NCT04338022   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Exelon transdermales Pflaster   
   Novartis Pharma GmbH
      -   -   EUCTR2008-007015-32-DE   Germany;
Exergame   
   University of Arizona
      2014   -   NCT02777060   United States;
Experimental Glatiramer Acetate   
   Teva Pharmaceutical Industries
      2009   Phase 3   NCT00947752   United States;
Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS   
   University of British Columbia
      1996   -   NCT04472975   -
Extavia   
   Karolinska Institutet
      2017   Phase 4   EUCTR2017-002634-24-SE   Sweden;
      2017   Phase 4   EUCTR2016-003587-39-SE   Sweden;
   Medizinische Universität Innsbruck
      2014   Phase 4   EUCTR2012-005450-30-AT   Austria;Sweden;
      2014   -   EUCTR2012-005450-30-SE   Austria;Sweden;
   NOVARTIS PHARMA AG
      2021   Phase 3   EUCTR2020-004505-32-IT   France;Germany;Italy;Spain;
   Novartis Farma S.p.A.
      2012   -   EUCTR2010-023023-19-DE   Germany;Italy;
   Novartis Pharma Services AG
      2012   -   EUCTR2011-001437-16-DE   Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Extavia (interferon beta-1b), Novartis Pharma AG   
   Bayer
      2016   -   NCT02749396   Finland;
Extavia 250 microgram/ml   
   Octapharma AG
      2013   -   EUCTR2012-005086-12-HU   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-DE   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-BG   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-AT   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Extavia 250 micrograms/ml   
   Biogen Portugal
      2016   Phase 4   EUCTR2016-000434-21-PT   Portugal;
Extavia®   
   Charite Universitaetsmedizin Berlin
      2012   Phase 3   EUCTR2011-004787-30-DE   Germany;
   University Hospital Motol
      2011   Phase 4   EUCTR2011-001956-12-CZ   Czech Republic;
Extended release fampridine   
   Clinique Neuro-Outaouais
      2013   Phase 4   NCT02146534   Canada;
Extended-release oxycodone   
   University of Rochester
      2007   Phase 4   NCT00414453   United States;
Extended-release quetiapine fumarate   
   University of Calgary
      2014   Phase 1/Phase 2   NCT02087631   Canada;
Extracorporeal Photopheresis   
   University of Utah
      2014   -   NCT02296346   United States;
F-18 3F4AP   
   Massachusetts General Hospital
      2021   Phase 1   NCT04699747   United States;
F-18 FEDAA1106 (BAY85-8101)   
   Bayer
      2009   Phase 1   NCT01031199   Australia;Sweden;
FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)   
   IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
      2016   Phase 4   EUCTR2014-004650-34-IT   Italy;
FINGOLIMOD HYDROCHLORIDE   
   Biogen Idec Research Limited
      2015   Phase 4   EUCTR2013-004622-29-DK   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2015   Phase 4   EUCTR2013-004622-29-DE   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-SE   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-GB   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-ES   Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-CZ   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   -   EUCTR2013-004622-29-IT   Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
   NOVARTIS FARMA
      2013   -   EUCTR2012-000835-18-IT   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   NOVARTIS FARMA S.p.A
      2013   -   EUCTR2012-005507-40-IT   Italy;
   NOVARTIS PHARMA SERVICES AG
      2021   Phase 3   EUCTR2020-002700-39-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Novartis Farma
      2013   -   EUCTR2011-005677-23-IT   Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
   Novartis Farma S.p.A.
      2012   -   EUCTR2010-023023-19-DE   Germany;Italy;
   Novartis Farma SpA
      2014   -   EUCTR2013-002660-17-IT   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
   Novartis Farmaceutica S.A.
      2013   -   EUCTR2011-005677-23-ES   Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
   Novartis Pharma GmbH
      -   -   EUCTR2011-001692-39-DE   Germany;
   Novartis Pharma S.A.S
      2011   Phase 4   EUCTR2011-001280-49-FR   France;
   Novartis Pharma Service AG
      2015   Phase 3   EUCTR2011-005677-23-HR   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-GB   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-EE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2011-005677-23-RO   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-DE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-BG   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
      2013   -   EUCTR2011-005677-23-LV   Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
   Novartis Pharma Services AG
      2015   -   EUCTR2013-002660-17-PT   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
      2015   -   EUCTR2013-002660-17-DK   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
      2014   Phase 3   EUCTR2011-005677-23-PL   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-NL   Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-AT   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2011-005677-23-SE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-SK   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-LT   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-001442-15-SE   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2012   -   EUCTR2011-001437-16-DE   Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
      2011   -   EUCTR2011-001442-15-HU   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2011   -   EUCTR2011-001442-15-GR   Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
      2011   -   EUCTR2011-001442-15-GB   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2011   -   EUCTR2011-001442-15-FI   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2011   -   EUCTR2011-001442-15-DE   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2011   -   EUCTR2011-001442-15-CZ   Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
      2011   -   EUCTR2011-001442-15-AT   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
   Universitätsklinikum Münster
      2014   -   EUCTR2013-004616-21-DE   Germany;
FISH OIL, RICH IN OMEGA-3-ACIDS   
   PALUPA Medical Ltd
      2016   Phase 3   EUCTR2015-003147-19-GR   Greece;
FISH OIL,RICH IN OMEGA 3 ACIDS   
   PALUPA Medical Ltd
      2016   Phase 3   EUCTR2015-003147-19-GR   Greece;
FLUOXETINE HYDROCHLORIDE   
   Novartis Pharma GmbH
      -   -   EUCTR2011-001692-39-DE   Germany;
FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE   
   NOVARTIS PHARMA AG
      2018   Phase 2   EUCTR2017-004702-17-IT   Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
FTY720   
   NOVARTIS FARMA S.p.A
      2013   -   EUCTR2012-005507-40-IT   Italy;
   NOVARTIS PHARMA SERVICES AG
      2021   Phase 3   EUCTR2020-002700-39-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Novartis
      2010   Phase 3   NCT01127750   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2007   Phase 2   NCT00537082   Japan;
      2003   Phase 2   NCT00333138   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
   Novartis Farma
      2013   -   EUCTR2011-005677-23-IT   Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
   Novartis Farma S.p.A.
      2012   -   EUCTR2010-023023-19-DE   Germany;Italy;
   Novartis Farmaceutica S.A.
      2013   -   EUCTR2012-000835-18-ES   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2011-005677-23-ES   Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
   Novartis Farmacéutica S.A
      2008   -   EUCTR2007-002627-32-ES   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
   Novartis Farmacéutica, S.A.
      2011   -   EUCTR2011-001442-15-ES   Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-ES   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
   Novartis Pharma AG
      2013   -   EUCTR2012-000835-18-BE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-000835-18-FR   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   -   EUCTR2007-002627-32-HU   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2007-002627-32-DK   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2009   Phase 3   EUCTR2007-002627-32-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2009   -   EUCTR2007-004122-24-HU   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2009   -   EUCTR2007-004122-24-GR   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2009   -   EUCTR2007-004122-24-EE   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2007-002627-32-FR   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-NL   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-CZ   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-BE   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-002627-32-NL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2008   -   EUCTR2007-002627-32-FI   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2008   -   EUCTR2007-002627-32-BE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2007   -   EUCTR2005-000365-19-HU   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
      2006   -   EUCTR2005-000365-19-CZ   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
   Novartis Pharma GmbH
      2012   Phase 4   EUCTR2012-000674-31-DE   Germany;Switzerland;
      2012   Phase 4   EUCTR2012-000653-32-DE   Germany;
      2012   -   EUCTR2012-002637-11-DE   Germany;
      2011   -   EUCTR2011-002969-38-DE   Germany;
   Novartis Pharma S.A.S
      2011   Phase 4   EUCTR2011-001280-49-FR   France;
   Novartis Pharma Service AG
      2015   Phase 3   EUCTR2011-005677-23-HR   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-GB   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-EE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2011-005677-23-RO   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-DE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-BG   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
      2013   -   EUCTR2011-005677-23-LV   Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
   Novartis Pharma Services AG
      2014   Phase 3   EUCTR2012-000835-18-DK   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-PL   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-NL   Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-AT   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2012-000835-18-PL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2014   -   EUCTR2011-005677-23-SE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-000835-18-DE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-SK   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-LT   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-NL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-HU   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-GB   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2010-020515-37-NO   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2012   -   EUCTR2012-000835-18-SE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   -   EUCTR2012-000835-18-FI   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-020515-37-IE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-020515-37-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   -   EUCTR2011-001442-15-DE   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2011   -   EUCTR2010-020515-37-DK   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-019029-32-SK   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-SK   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-SE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-GR   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-FR   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-FI   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-EE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of;
      2010   Phase 3   EUCTR2010-020515-37-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 2   EUCTR2010-019029-32-GR   Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 2   EUCTR2010-019029-32-BE   Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-SE   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-PT   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-NL   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-IE   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-HU   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-GB   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-FI   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-DK   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-DE   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-CZ   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-AT   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019028-30-GB   Finland;France;Spain;United Kingdom;
      2010   -   EUCTR2010-019028-30-FR   Belgium;Finland;France;Spain;United Kingdom;
      2010   -   EUCTR2010-019028-30-FI   Finland;France;Spain;United Kingdom;
      2010   -   EUCTR2010-019028-30-BE   Belgium;Finland;France;Spain;United Kingdom;
      2009   -   EUCTR2008-002096-27-AT   Austria;Lithuania;Poland;United Kingdom;
      2009   -   EUCTR2007-002627-32-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2008   Phase 3   EUCTR2005-000365-19-GB   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2008-002096-27-PL   Austria;Lithuania;Poland;United Kingdom;
      2008   -   EUCTR2008-002096-27-LT   Austria;Lithuania;Poland;United Kingdom;
      2008   -   EUCTR2008-002096-27-GB   Austria;Lithuania;Poland;United Kingdom;
      2007   -   EUCTR2006-000704-17-HU   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2007   -   EUCTR2006-000704-17-BE   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2007   -   EUCTR2005-000365-19-IE   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
      2007   -   EUCTR2005-000365-19-GR   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
      2007   -   EUCTR2005-000365-19-EE   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
      2006   Phase 3   EUCTR2006-000704-17-GR   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   Phase 3   EUCTR2005-000365-19-SK   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
      2006   -   EUCTR2006-000704-17-PT   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   -   EUCTR2006-000704-17-GB   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   -   EUCTR2006-000704-17-DE   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   -   EUCTR2006-000704-17-AT   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   -   EUCTR2005-000365-19-FI   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
      2006   -   EUCTR2005-000365-19-DE   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
      2005   -   EUCTR2005-000365-19-SE   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
      -   -   EUCTR2007-002627-32-DE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Pharmaceuticals
      2013   Phase 3   NCT01779934   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 4   NCT01585298   Germany;
      2008   Phase 3   NCT00731692   Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Services Pharma AG
      2008   -   EUCTR2007-002627-32-SE   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
   NovartisPharma Services AG
      2007   -   EUCTR2005-000365-19-LT   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
   Universitätsklinikum Münster
      2014   -   EUCTR2013-004616-21-DE   Germany;
FTY720D   
   NOVARTIS FARMA
      2013   -   EUCTR2012-000835-18-IT   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   -   EUCTR2011-000770-60-IT   Italy;
      2011   -   EUCTR2010-024017-31-IT   Italy;
      2010   Phase 3   EUCTR2010-020515-37-IT   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-023023-19-IT   Germany;Italy;
      2010   -   EUCTR2010-019029-32-IT   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-002627-32-IT   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-000704-17-IT   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
   Novartis Farma SpA
      2014   -   EUCTR2013-002660-17-IT   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
   Novartis Farmaceutica S.A.
      2013   -   EUCTR2012-000835-18-ES   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Farmacéutica S.A
      2008   -   EUCTR2007-002627-32-ES   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
   Novartis Farmacéutica, S.A.
      2010   Phase 3   EUCTR2010-020515-37-ES   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
   Novartis Pharma AG
      2013   -   EUCTR2012-000835-18-BE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-000835-18-FR   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   -   EUCTR2007-002627-32-HU   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2007-002627-32-DK   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2009   Phase 3   EUCTR2007-002627-32-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2009   -   EUCTR2007-004122-24-HU   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2009   -   EUCTR2007-004122-24-GR   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2009   -   EUCTR2007-004122-24-FI   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2007-002627-32-FR   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-NL   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-FR   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-CZ   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-BE   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-002627-32-NL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2008   -   EUCTR2007-002627-32-FI   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2008   -   EUCTR2007-002627-32-BE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2007   -   EUCTR2005-000365-19-HU   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
      2006   -   EUCTR2005-000365-19-CZ   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
   Novartis Pharma Services AG
      2015   -   EUCTR2013-002660-17-PT   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
      2015   -   EUCTR2013-002660-17-DK   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
      2013   Phase 3   EUCTR2012-000835-18-DE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-NL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-GB   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2010-020515-37-NO   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2012   -   EUCTR2012-000835-18-SE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   -   EUCTR2012-000835-18-FI   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-020515-37-IE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-020515-37-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   -   EUCTR2010-020515-37-DK   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-019029-32-SK   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-SK   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-SE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-GR   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-FR   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-FI   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-EE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of;
      2010   Phase 3   EUCTR2010-020515-37-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 2   EUCTR2010-019029-32-GR   Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 2   EUCTR2010-019029-32-BE   Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-SE   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-PT   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-NL   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-IE   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-HU   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-GB   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-FI   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-DK   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-DE   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-CZ   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-AT   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019028-30-GB   Finland;France;Spain;United Kingdom;
      2010   -   EUCTR2010-019028-30-FR   Belgium;Finland;France;Spain;United Kingdom;
      2010   -   EUCTR2010-019028-30-FI   Finland;France;Spain;United Kingdom;
      2010   -   EUCTR2010-019028-30-BE   Belgium;Finland;France;Spain;United Kingdom;
      2009   -   EUCTR2008-002096-27-AT   Austria;Lithuania;Poland;United Kingdom;
      2009   -   EUCTR2007-002627-32-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2008   Phase 3   EUCTR2005-000365-19-GB   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2008-002096-27-PL   Austria;Lithuania;Poland;United Kingdom;
      2008   -   EUCTR2008-002096-27-LT   Austria;Lithuania;Poland;United Kingdom;
      2008   -   EUCTR2008-002096-27-GB   Austria;Lithuania;Poland;United Kingdom;
      -   -   EUCTR2007-002627-32-DE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Services Pharma AG
      2008   -   EUCTR2007-002627-32-SE   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Famciclovir   
   Queen Mary University London
      2019   Phase 2   EUCTR2019-000169-19-GB   United Kingdom;
   Queen Mary University of London
      2020   Phase 2   NCT05283551   United Kingdom;
Fampridine   
   Amsterdam University Medical Center
      2022   Phase 3   EUCTR2021-003677-66-NL   Netherlands;
   Biogen
      2015   -   NCT01532154   France;Germany;United Kingdom;United States;
      2014   Phase 3   NCT02219932   Argentina;Bulgaria;Czech Republic;Finland;Germany;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2012   Phase 4   NCT01480076   Australia;Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;United Kingdom;United States;
      2012   -   NCT01480063   Argentina;Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Lebanon;Netherlands;Norway;Portugal;Spain;United Arab Emirates;
   Centre Hospitalier Universitaire de Besancon
      2014   Phase 4   NCT02849782   France;
   Cliniques Universitaires Saint-Luc, Neurologie
      2013   -   EUCTR2012-005076-34-BE   Belgium;
   Genesis Pharma CNS & Specialty
      2017   -   NCT03164018   Greece;
   University College Dublin
      2014   Phase 4   NCT02208050   Ireland;
   University of Southern Denmark
      2018   -   NCT03847545   Denmark;
Fampridine SR   
   London Health Sciences Centre
      2012   Phase 2/Phase 3   NCT01667497   Canada;
Fampridine-SR   
   Acorda Therapeutics
      2007   Phase 3   NCT00649792   Canada;United States;
      2007   Phase 3   NCT00483652   Canada;United States;
      2006   Phase 3   NCT00648908   Canada;United States;
      2005   Phase 3   NCT00127530   Canada;United States;
   University of Southern Denmark
      2012   Phase 4   NCT01656148   Denmark;
Fampridine-SR b.i.d. (Twice Daily)   
   Acorda Therapeutics
      2003   Phase 3   NCT00654927   Canada;United States;
Fampyra   
   BIOGEN IDEC RESEARCH LTD
      2012   -   EUCTR2012-000368-90-IT   Belgium;Canada;Italy;Netherlands;Switzerland;United Kingdom;
      2012   -   EUCTR2011-003507-38-IT   Australia;Denmark;Italy;Netherlands;Portugal;United Kingdom;
   Biogen Idec Research Limited
      2015   Phase 3   EUCTR2013-003600-40-NL   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003600-40-GB   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003600-40-CZ   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003600-40-BG   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-003600-40-LT   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-003600-40-IT   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-003600-40-FI   Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
      2012   Phase 4   EUCTR2011-003507-38-GB   Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2012   Phase 4   EUCTR2011-003507-38-BE   Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2012   Phase 2   EUCTR2012-000368-90-BE   Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
      2012   -   EUCTR2012-000368-90-NL   Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
      2012   -   EUCTR2012-000368-90-GB   Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
      2012   -   EUCTR2011-003507-38-PT   Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2012   -   EUCTR2011-003507-38-NL   Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2012   -   EUCTR2011-003507-38-DK   Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
   Cliniques Universitaires Saint-Luc, Neurologie
      2013   -   EUCTR2012-005076-34-BE   Belgium;
   Medical University of Vienna
      2015   -   EUCTR2014-003498-41-AT   Austria;
   Odense University Hospital
      2013   Phase 4   EUCTR2013-001409-10-DK   Denmark;
   St. Vincent's University Hospital
      2012   Phase 4   EUCTR2011-002561-38-IE   Ireland;
   Sønderjylland Hospital, department of neurology
      2013   Phase 4   EUCTR2011-002959-34-DK   Denmark;
      2012   -   EUCTR2011-006151-10-DK   Denmark;
   Vestre Viken Hospital Trust
      2012   -   NCT01720849   Norway;
Fampyra 10 mg prolonged-release tablets   
   Amsterdam University Medical Center
      2022   Phase 3   EUCTR2021-003677-66-NL   Netherlands;
   CHDR
      2015   -   EUCTR2015-000182-31-NL   Netherlands;
Fampyra 10mg prolonged release tablets   
   Walton Centre Foundation Trust
      2013   Phase 4   EUCTR2013-000529-30-GB   United Kingdom;
Fatigue   
   University Hospital, Strasbourg, France
      2019   Phase 2   NCT03910738   France;
Febuxostat   
   Tsukuba International Clinical Pharmacology Clinic
      2016   -   JPRN-UMIN000024312   Japan;
Fecal Microbial Transplants   
   Lawson Health Research Institute
      2020   Phase 2   NCT04150549   -
Fecal Microbiota Transplantation (FMT) of FMP30 Donor Stool   
   Jeffrey Gelfand
      2018   Phase 1   NCT03594487   United States;
Fecal microbial transplant (FMT)   
   Griffin Hospital
      2019   Early Phase 1   NCT04096443   United States;
Fecal microbiota   
   Lawson Health Research Institute
      2017   Phase 2   NCT03183869   Canada;
Femoston 1/10   
   Irina Elovaara
      2015   -   EUCTR2014-005129-10-FI   Finland;
Femoston 2/10   
   Irina Elovaara
      2015   -   EUCTR2014-005129-10-FI   Finland;
Fenebrutinib   
   Hoffmann-La Roche
      2022   Phase 2   NCT05119569   -
      2021   Phase 3   NCT04586023   Austria;Brazil;Bulgaria;Canada;Denmark;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Turkey;United Kingdom;United States;
      2021   Phase 3   NCT04586010   Argentina;China;Finland;Germany;Hong Kong;Hungary;Italy;Netherlands;Peru;Portugal;Russian Federation;Spain;Switzerland;Taiwan;Ukraine;United States;
      2020   Phase 3   NCT04544449   Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Feraheme   
   Stanford University
      2014   -   NCT01973517   United States;
Ferumoxytol   
   National Institute of Neurological Disorders and Stroke (NINDS)
      2015   Phase 1   NCT02511028   United States;
Fexofenadine   
   Rigshospitalet, Denmark
      2021   Phase 3   NCT04688788   Denmark;
Filgrastim   
   Fred Hutchinson Cancer Research Center
      1997   Phase 1   NCT00014755   United States;
   Northwestern Memorial Hospital
      2001   Phase 1   NCT00017628   United States;
   OSPEDALE S. RAFFAELE
      2007   Phase 2   EUCTR2007-000586-38-IT   Italy;
   Sheffield Teaching Hospitals
      2020   Phase 3   EUCTR2019-001549-42-GB   United Kingdom;
Fingolimob   
   NOVARTIS PHARMA SERVICES AG
      2021   Phase 3   EUCTR2020-002700-39-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Fingolimob (FTY)   
   University Hospital, Clermont-Ferrand
      2016   Phase 4   NCT02769689   France;
Fingolimod   
   Biogen
      2014   Phase 4   NCT02342704   Australia;Czech Republic;Czechia;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
   FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
      2016   Phase 4   EUCTR2016-000708-26-IT   Italy;
   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
      2017   Phase 4   NCT03345940   Italy;
   Heinrich-Heine University, Duesseldorf
      2013   Phase 4   NCT01755871   Germany;
   Hoffmann-La Roche
      2022   Phase 3   NCT05123703   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
   Isfahan University of Medical Sciences
      2015   Phase 2/Phase 3   NCT02939079   -
   Mitsubishi Tanabe Pharma Corporation
      2014   Phase 1   NCT02193217   United Kingdom;
   NOVARTIS FARMA
      2011   -   EUCTR2011-000770-60-IT   Italy;
      2010   Phase 3   EUCTR2010-020515-37-IT   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-IT   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-002627-32-IT   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
      2006   -   EUCTR2006-000704-17-IT   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
   Northwestern University
      2013   Phase 2   EUCTR2012-004165-41-GB   United Kingdom;United States;
   Novartis
      2011   -   NCT01281657   Canada;United States;
      2010   Phase 3   NCT01199861   Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom;
      2008   Phase 3   NCT00662649   Australia;Belgium;Canada;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom;
      2008   Phase 2   NCT00670449   Japan;
      2006   Phase 3   NCT00355134   Australia;Austria;Canada;Lithuania;Poland;Romania;Turkey;United Kingdom;United States;
      2006   Phase 3   NCT00340834   Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States;
      2006   Phase 3   NCT00289978   Australia;Belgium;Canada;Czech Republic;Finland;France;Germany;Greece;Israel;Italy;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom;
   Novartis Farmaceutica S.A.
      2013   -   EUCTR2012-000835-18-ES   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Farmacéutica S.A
      2008   -   EUCTR2007-002627-32-ES   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
   Novartis Farmacéutica S.A.
      2011   Phase 3   EUCTR2011-003484-30-ES   Australia;Spain;
   Novartis Farmacéutica, S.A.
      2010   Phase 3   EUCTR2010-020515-37-ES   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
   Novartis Pharma AG
      2013   -   EUCTR2012-000835-18-BE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2012-000835-18-FR   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   -   EUCTR2007-002627-32-HU   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2007-002627-32-DK   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2009   Phase 3   EUCTR2007-002627-32-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2009   -   EUCTR2007-004122-24-IE   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2009   -   EUCTR2007-004122-24-EE   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2007-002627-32-FR   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-002627-32-NL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2008   -   EUCTR2007-002627-32-FI   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2008   -   EUCTR2007-002627-32-BE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2007   -   EUCTR2005-000365-19-HU   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
      2006   -   EUCTR2005-000365-19-CZ   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
   Novartis Pharma GmbH
      2011   Phase 3   EUCTR2010-022066-28-DE   Germany;
   Novartis Pharma K.K.
      2019   -   JPRN-JapicCTI-194838   Japan;
   Novartis Pharma Services AG
      2014   Phase 3   EUCTR2012-000835-18-DK   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-000835-18-DE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-NL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-HU   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-GB   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   Phase 3   EUCTR2010-020515-37-NO   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2012   -   EUCTR2012-000835-18-SE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   -   EUCTR2012-000835-18-FI   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-020515-37-IE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-020515-37-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   -   EUCTR2010-020515-37-DK   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-SK   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-SE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-GR   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-FR   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-FI   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-EE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of;
      2010   Phase 3   EUCTR2010-020515-37-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   -   EUCTR2010-019028-30-GB   Finland;France;Spain;United Kingdom;
      2010   -   EUCTR2010-019028-30-FR   Belgium;Finland;France;Spain;United Kingdom;
      2010   -   EUCTR2010-019028-30-FI   Finland;France;Spain;United Kingdom;
      2010   -   EUCTR2010-019028-30-BE   Belgium;Finland;France;Spain;United Kingdom;
      2009   -   EUCTR2008-002096-27-AT   Austria;Lithuania;Poland;United Kingdom;
      2009   -   EUCTR2007-002627-32-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2008   Phase 3   EUCTR2005-000365-19-GB   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2008-002096-27-PL   Austria;Lithuania;Poland;United Kingdom;
      2008   -   EUCTR2008-002096-27-LT   Austria;Lithuania;Poland;United Kingdom;
      2008   -   EUCTR2008-002096-27-GB   Austria;Lithuania;Poland;United Kingdom;
      2007   -   EUCTR2006-000704-17-HU   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2007   -   EUCTR2006-000704-17-BE   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   Phase 3   EUCTR2006-000704-17-GR   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   Phase 3   EUCTR2005-000365-19-SK   Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
      2006   -   EUCTR2006-000704-17-PT   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   -   EUCTR2006-000704-17-GB   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   -   EUCTR2006-000704-17-DE   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   -   EUCTR2006-000704-17-AT   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      -   -   EUCTR2007-002627-32-DE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Pharmaceuticals
      2021   Phase 4   NCT04667949   China;
      2021   Phase 3   NCT04926818   Australia;Austria;Belgium;France;Germany;India;Latvia;Mexico;Poland;Portugal;Russian Federation;Slovakia;Spain;Turkey;United States;
      2020   Phase 4   NCT04480853   Taiwan;
      2020   -   NCT05141669   United States;
      2017   Phase 4   NCT03257358   United States;
      2016   Phase 4   NCT02720107   Germany;
      2015   Phase 4   NCT02373098   Turkey;
      2014   Phase 4   NCT02232061   Belgium;Germany;Italy;
      2014   Phase 3   NCT01941004   -
      2013   Phase 4   NCT01621269   Germany;
      2013   Phase 3   NCT01892722   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2012   Phase 4   NCT01705236   Germany;Switzerland;
      2012   Phase 4   NCT01623596   Puerto Rico;United States;
      2012   Phase 4   NCT01578330   Turkey;
      2012   Phase 4   NCT01534182   Russian Federation;
      2012   Phase 3   NCT01633112   Argentina;Brazil;Canada;Chile;Mexico;Puerto Rico;United States;
      2012   Phase 3   NCT01497262   Argentina;Brazil;Colombia;Costa Rica;Jordan;Malaysia;Mexico;Panama;Peru;
      2011   Phase 4   NCT01436643   Germany;
      2011   Phase 4   NCT01420055   France;
      2011   Phase 4   NCT01333501   Germany;Italy;
      2011   Phase 4   NCT01317004   Italy;
      2011   Phase 4   NCT01310166   Germany;
      2011   Phase 3   NCT01499667   Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Switzerland;
      2011   -   NCT01442194   Argentina;Australia;Canada;Chile;Mexico;Puerto Rico;United States;
      2011   -   NCT01285479   Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Cyprus;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Sweden;Switzerland;United Arab Emirates;United Kingdom;United States;
      2010   Phase 4   NCT01216072   Canada;Puerto Rico;United States;
      2010   Phase 3   NCT01201356   Argentina;Australia;Austria;Belgium;Brazil;Canada;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Services Pharma AG
      2008   -   EUCTR2007-002627-32-SE   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
   University Hospital Muenster
      2014   Phase 4   NCT02325440   Germany;
   Università Popolare Homo & Natura
      2015   Phase 1   NCT02632591   Italy;
   VU University Medical Center
      2014   -   EUCTR2014-001012-19-NL   Netherlands;
Fingolimod (FTY720)   
   Novartis Pharmaceuticals
      2011   Phase 4   NCT01498887   Australia;Spain;
Fingolimod Hydrochloride   
   Novartis Pharma GmbH
      2012   Phase 4   EUCTR2012-000674-31-DE   Germany;Switzerland;
      2012   Phase 4   EUCTR2012-000653-32-DE   Germany;
      2012   -   EUCTR2012-002637-11-DE   Germany;
      2011   -   EUCTR2011-002969-38-DE   Germany;
Fingolimod hydrochloride   
   Novartis Pharma AG
      2009   -   EUCTR2007-004122-24-HU   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2009   -   EUCTR2007-004122-24-GR   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2009   -   EUCTR2007-004122-24-FI   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-SE   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-NL   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-GB   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-FR   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-CZ   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-BE   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
   Novartis Pharma Services AG
      2014   -   EUCTR2012-000835-18-PL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   -   EUCTR2010-019029-32-SK   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 2   EUCTR2010-019029-32-GR   Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   Phase 2   EUCTR2010-019029-32-BE   Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-SE   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-PT   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-NL   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-IE   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-HU   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-GB   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-FI   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-DK   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-DE   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-CZ   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2010-019029-32-AT   Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-SK   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2007-004122-24-DE   Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
Fingolimodi   
   Turku University Hospital
      2014   Phase 4   EUCTR2014-000296-12-FI   Finland;
      2013   Phase 4   EUCTR2013-004626-28-FI   Finland;
Fingolmod   
   Novartis Farma SpA
      2014   -   EUCTR2013-002660-17-IT   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
   Novartis Pharma Services AG
      2015   -   EUCTR2013-002660-17-PT   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
      2015   -   EUCTR2013-002660-17-DK   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Firategrast   
   GlaxoSmithKline
      2007   Phase 2   NCT00469378   Belgium;Czech Republic;Denmark;Norway;Sweden;
      2006   Phase 2   NCT00395317   Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom;
Firategrast (USAN approved name)   
   GlaxoSmithKline Research & Development Ltd
      2007   Phase 2   EUCTR2006-007057-42-CZ   Belgium;Czech Republic;Denmark;Sweden;
      2007   Phase 2   EUCTR2006-002633-20-GB   Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
      2007   Phase 2   EUCTR2006-002633-20-FR   Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
      2007   -   EUCTR2006-007057-42-SE   Czech Republic;Denmark;Sweden;
      2007   -   EUCTR2006-007057-42-DK   Czech Republic;Denmark;Sweden;
      2007   -   EUCTR2006-007057-42-BE   Belgium;Czech Republic;Denmark;Sweden;
      2007   -   EUCTR2006-002633-20-LT   Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
      2007   -   EUCTR2006-002633-20-IT   Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
      2006   -   EUCTR2006-002633-20-NL   Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
      2006   -   EUCTR2006-002633-20-FI   Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
      2006   -   EUCTR2006-002633-20-DE   Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
      2006   -   EUCTR2006-002633-20-AT   Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
   GlaxoSmithKline S.A
      2006   Phase 2   EUCTR2006-002633-20-ES   Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom;
Firategrast gastro-retentive solution   
   GlaxoSmithKline
      2011   Phase 1   NCT01416363   Australia;
Firategrast immediate release tablet   
   GlaxoSmithKline
      2011   Phase 1   NCT01416363   Australia;
Firategrast modified release tablet   
   GlaxoSmithKline
      2011   Phase 1   NCT01416363   Australia;
First line DMT   
   Novartis Pharmaceuticals
      2021   Phase 3   NCT04788615   France;Germany;Spain;United Kingdom;
Fish oil concentrate   
   Oregon Health and Science University
      2005   Phase 1/Phase 2   NCT00122954   United States;
Fludarabine   
   AZIENDA OSPEDALIERA DI PADOVA
      -   Phase 1   EUCTR2008-005773-35-IT   Italy;
   Hadassah Medical Organization
      2015   -   NCT02529839   -
   Seah Lim M.D.
      2012   Phase 2   NCT01679041   United States;
Flumazenil   
   Institut National de la Santé Et de la Recherche Médicale, France
      2019   -   NCT03825601   -
   Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
      2013   -   JPRN-UMIN000011111   Japan;
Fluoxetin Hexal   
   Novartis Pharma GmbH
      -   -   EUCTR2011-001692-39-DE   Germany;
Fluoxetine   
   Novartis Pharmaceuticals
      2011   Phase 4   NCT01436643   Germany;
   University College, London
      2014   Phase 2   NCT01910259   United Kingdom;
Fluoxetine hydrochloride   
   UCL
      2014   Phase 2   EUCTR2012-005394-31-GB   United Kingdom;
Flupirtin   
   Charité-Universitätsmedizin Berlin
      2007   Phase 2   EUCTR2006-005262-39-DE   Germany;
Flupirtine   
   Charite University, Berlin, Germany
      2007   Phase 2   NCT00623415   Germany;
Flupirtinmaleat   
   Charité-Universitätsmedizin Berlin
      2007   Phase 2   EUCTR2006-005262-39-DE   Germany;
FolateScan (Technetium Tc 99mEC20)   
   Mayo Clinic
      2006   Phase 2   NCT00588393   United States;
Formulation A   
   GlaxoSmithKline
      2007   Phase 1   NCT00548769   Czech Republic;Czechia;Germany;Poland;
Formulation B   
   GlaxoSmithKline
      2007   Phase 1   NCT00548769   Czech Republic;Czechia;Germany;Poland;
Formulation C   
   GlaxoSmithKline
      2007   Phase 1   NCT00548769   Czech Republic;Czechia;Germany;Poland;
Formulation D   
   GlaxoSmithKline
      2007   Phase 1   NCT00548769   Czech Republic;Czechia;Germany;Poland;
Four-point cane (FPC)   
   Rowan University
      2014   -   NCT02227524   United States;
Fourier Domain Doppler Optical Coherence Tomography (FDOCT)   
   Medical University of Vienna
      2018   -   NCT03401879   Austria;
Full Spectrum vitamin   
   University of Iowa
      2010   Phase 1   NCT01381354   United States;
Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody   
   Chugai Pharmaceutical Co. Ltd
      2015   Phase 3   EUCTR2013-003752-21-HU   France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
      2015   -   EUCTR2013-003752-21-ES   France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003752-21-IT   France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;
G-CSF   
   Northwestern University
      2019   Phase 2/Phase 3   NCT03829566   United States;
      2017   Phase 3   NCT03342638   United States;
G2-SFM (IFN-beta-1a from clone 484-39,FBS-free process)   
   Serono International SA
      2005   Phase 3   EUCTR2004-003799-13-GB   Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-003799-13-ES   Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-003799-13-DK   Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-003799-13-SE   Ireland;Lithuania;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-003799-13-LT   Ireland;Lithuania;Spain;Sweden;United Kingdom;
      -   Phase 3   EUCTR2004-003799-13-IE   Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
GA   
   TEVA
      2004   -   EUCTR2004-000463-94-IT   Hungary;Italy;
      2004   -   EUCTR2004-000462-13-IT   Hungary;Italy;
   Teva Pharmaceutical Industries Ltd.
      2010   Phase 3   EUCTR2009-018084-27-IT   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Lithuania;United Kingdom;
   Teva Pharmaceutical Industries, Ltd.
      2010   Phase 3   EUCTR2009-018084-27-LT   Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-018084-27-HU   Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-018084-27-GB   Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-018084-27-EE   Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-018084-27-DE   Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-018084-27-CZ   Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2009-018084-27-BG   Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
      2007   -   EUCTR2006-002037-20-EE   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   Phase 3   EUCTR2006-002037-20-FI   Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   Phase 3   EUCTR2006-002037-20-ES   Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-LV   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-LT   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-HU   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-GB   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-DE   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-CZ   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
      2006   -   EUCTR2006-002037-20-BE   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
   Teva Pharmaceuticals Industries Ltd.
      2006   -   EUCTR2006-002037-20-IT   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
GA 20 mg/mL   
   Teva Pharmaceutical Industries
      2013   Phase 3   NCT01874145   United States;
GA 40 mg/mL   
   Teva Pharmaceutical Industries
      2013   Phase 3   NCT01874145   United States;
GA Depot   
   Mapi Pharma Ltd.
      2019   Phase 3   NCT04121221   Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Russian Federation;Ukraine;United States;
      2019   Phase 3   EUCTR2018-000284-93-EE   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Israel;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2019   Phase 3   EUCTR2018-000284-93-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Montenegro;Russian Federation;Ukraine;United States;
      2014   Phase 1/Phase 2   NCT02212886   Israel;
GA Depot 25mg once monthly   
   Mapi Pharma Ltd.
      2017   Phase 2   NCT03362294   Israel;Moldova, Republic of;
GA Depot 40mg once monthly   
   Mapi Pharma Ltd.
      2017   Phase 2   NCT03362294   Israel;Moldova, Republic of;
GADOVIST 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado   
   Institut Diagnostic per la Imatge
      2010   -   EUCTR2009-016140-39-ES   Spain;
GBP   
   Charité University Medicine Berlin
      2010   Phase 4   EUCTR2008-005167-33-DE   Germany;
GDC-0853   
   F. Hoffmann-La Roche Ltd
      2022   Phase 2   EUCTR2021-003772-14-HR   Croatia;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia;
GDC-0853 RO7010939   
   F. Hoffmann-La Roche Ltd
      2021   Phase 3   EUCTR2019-003919-53-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-003919-53-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-003919-53-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-003919-53-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-003919-53-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-003919-53-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-003919-53-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-003919-53-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GILENYA   
   CHU de Rennes
      2018   Phase 3   EUCTR2018-001292-21-FR   France;
GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE   
   F. HOFFMANN - LA ROCHE LTD.
      2021   Phase 3   EUCTR2020-004128-41-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE   
   F. HOFFMANN - LA ROCHE LTD.
      2021   Phase 3   EUCTR2020-004128-41-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE   
   FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
      2017   Phase 4   EUCTR2017-000559-26-IT   Israel;Italy;Switzerland;United States;
GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE   
   FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
      2016   Phase 4   EUCTR2016-000708-26-IT   Italy;
GLATIRAMER ACETATE   
   Amphia Ziekenhuis
      2009   -   EUCTR2009-013129-41-NL   Netherlands;
   Biogen Idec
      2010   -   EUCTR2009-017490-38-DE   Germany;Spain;
   Biogen Idec Limited
      2010   -   EUCTR2009-015556-15-SI   Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
      2010   -   EUCTR2009-015556-15-SE   Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
      2010   -   EUCTR2009-015556-15-PT   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-NL   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-LV   Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
      2010   -   EUCTR2009-015556-15-HU   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-GR   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-GB   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-FI   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-ES   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-DK   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-DE   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-015556-15-CZ   Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
      2010   -   EUCTR2009-015556-15-AT   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
   Biogen Idec Ltd.
      2007   Phase 3   EUCTR2006-003697-10-BE   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-LV   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
   Karolinska Institutet
      2017   Phase 4   EUCTR2017-002634-24-SE   Sweden;
      2017   Phase 4   EUCTR2016-003587-39-SE   Sweden;
   Mapi Pharma Ltd.
      2019   Phase 3   EUCTR2018-000284-93-EE   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Israel;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2019   Phase 3   EUCTR2018-000284-93-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Montenegro;Russian Federation;Ukraine;United States;
   Novartis Pharma GmbH
      2021   Phase 4   EUCTR2020-005752-38-DE   Germany;
   Peptimmune Inc.
      2010   Phase 2   EUCTR2009-012716-40-SK   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
      2010   Phase 2   EUCTR2009-012716-40-DE   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
      2010   -   EUCTR2009-012716-40-PL   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
      2010   -   EUCTR2009-012716-40-FR   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
      2010   -   EUCTR2009-012716-40-CZ   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
      2010   -   EUCTR2009-012716-40-BG   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
      2009   -   EUCTR2009-012716-40-EE   Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
   Teva Pharmaceutical Industries, Ltd
      2016   Phase 4   EUCTR2015-000922-12-PL   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-FR   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-ES   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-DE   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2016   Phase 4   EUCTR2015-000922-12-BE   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-IE   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-HR   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-FI   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
      2015   Phase 4   EUCTR2015-000922-12-AT   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
   Turku University Hospital
      2013   Phase 4   EUCTR2013-004626-28-FI   Finland;
GLATIRAMER ACETATO   
   TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
      2015   Phase 4   EUCTR2015-000922-12-IT   Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
GLATIRAMERO ACETATO   
   Biogen Idec Limited
      2010   -   EUCTR2009-015556-15-ES   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
   Teva Pharmaceutical Industries, Ltd.
      2006   Phase 3   EUCTR2006-002037-20-ES   Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
GNbAC1   
   GENEURO SA
      2017   Phase 2   EUCTR2016-004935-18-IT   Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
   GeNeuro Australia PTY Ltd
      2018   Phase 1   NCT03574428   Australia;
   GeNeuro Innovation SAS
      2021   Phase 2   EUCTR2021-001973-21-SE   Sweden;
      2020   Phase 2   EUCTR2019-004822-15-SE   Sweden;
      2012   Phase 2   NCT01639300   Switzerland;
      2011   Phase 1   NCT01699555   -
   GeNeuro SA
      2017   Phase 2   EUCTR2016-004935-18-PL   Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2017   Phase 2   EUCTR2016-004935-18-HU   Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2017   Phase 2   EUCTR2016-004935-18-HR   Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2017   Phase 2   EUCTR2016-004935-18-ES   Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2017   Phase 2   EUCTR2016-004935-18-DE   Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2017   Phase 2   EUCTR2016-004935-18-CZ   Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2017   Phase 2   EUCTR2016-004935-18-BG   Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2016   Phase 2   NCT02782858   Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2016   Phase 2   EUCTR2015-004059-29-PL   Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2016   Phase 2   EUCTR2015-004059-29-HU   Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2016   Phase 2   EUCTR2015-004059-29-HR   Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2016   Phase 2   EUCTR2015-004059-29-ES   Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2016   Phase 2   EUCTR2015-004059-29-EE   Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2016   Phase 2   EUCTR2015-004059-29-DE   Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2016   Phase 2   EUCTR2015-004059-29-CZ   Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
      2016   Phase 2   EUCTR2015-004059-29-BG   Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
GNbAC1 Monoclonal Antibody   
   GeNeuro SA
      2017   Phase 2   NCT03239860   Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
GSK1223249   
   GlaxoSmithKline
      2011   Phase 1   NCT01435993   Germany;Italy;Norway;
      2010   Phase 1   NCT01424423   Australia;
GSK1841157   
   GlaxoSmithKline Research and Development Limited
      2012   -   EUCTR2011-002333-19-CZ   Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
      2011   Phase 2   EUCTR2011-002333-19-DK   Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
      2011   -   EUCTR2011-002333-19-NL   Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
      2011   -   EUCTR2011-002333-19-DE   Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
   GlaxoSmithKline SA
      2011   Phase 2   EUCTR2011-002333-19-ES   Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
GSK2018682   
   GlaxoSmithKline
      2010   Phase 1   NCT01431937   Australia;
      2010   Phase 1   NCT01387217   Australia;
GSK2018682 CD2 Capsule   
   GlaxoSmithKline
      2010   Phase 1   NCT01466322   Australia;
GSK2018682 CD3 micronised Tablet   
   GlaxoSmithKline
      2010   Phase 1   NCT01466322   Australia;
GSK2018682 CD3 non-micronised Tablet in fed state   
   GlaxoSmithKline
      2010   Phase 1   NCT01466322   Australia;
GSK239512   
   GlaxoSmithKline
      2013   Phase 2   NCT01772199   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   Phase 1   NCT01802931   Australia;
   GlaxoSmithKline Research & Development Ltd
      2013   Phase 2   EUCTR2012-003627-38-GB   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   Phase 2   EUCTR2012-003627-38-BG   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   -   EUCTR2012-003627-38-SE   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   -   EUCTR2012-003627-38-DE   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   -   EUCTR2012-003627-38-CZ   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
   GlaxoSmithKline, S.A.
      2012   -   EUCTR2012-003627-38-ES   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
GSK2395612   
   GlaxoSmithKline Research & Development Ltd
      2013   Phase 2   EUCTR2012-003627-38-BG   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   -   EUCTR2012-003627-38-SE   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   -   EUCTR2012-003627-38-DE   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
      2013   -   EUCTR2012-003627-38-CZ   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
   GlaxoSmithKline, S.A.
      2012   -   EUCTR2012-003627-38-ES   Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
GSK3888130B   
   GlaxoSmithKline
      2021   Phase 1   NCT05131971   United Kingdom;
GTR.ace   
   SYNTHON BV
      2011   -   EUCTR2011-000888-27-IT   Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States;
   Synthon BV
      2012   -   EUCTR2011-000888-27-GR   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-000888-27-DE   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2011   Phase 3   EUCTR2011-000888-27-RO   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2011-000888-27-GB   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2011-000888-27-EE   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2011-000888-27-CZ   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2011-000888-27-BG   Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
GW-1000-02   
   GW Pharma Ltd
      2007   Phase 3   EUCTR2006-005910-11-CZ   Czech Republic;Germany;Italy;Spain;United Kingdom;
      2006   Phase 3   EUCTR2005-005265-11-GB   Czech Republic;France;United Kingdom;
      2006   Phase 3   EUCTR2005-005265-11-FR   Czech Republic;France;United Kingdom;
      2006   -   EUCTR2005-005265-11-CZ   Czech Republic;France;United Kingdom;
      2005   Phase 3   EUCTR2004-002509-63-GB   Czech Republic;United Kingdom;
      2005   -   EUCTR2004-002509-63-CZ   Czech Republic;United Kingdom;
   GW Pharma Ltd.
      2008   Phase 3   EUCTR2006-005910-11-GB   Czech Republic;Germany;Italy;Spain;United Kingdom;
      2008   -   EUCTR2006-005910-11-DE   Germany;Italy;Spain;United Kingdom;
      2007   -   EUCTR2007-002138-13-GB   United Kingdom;
   GW Pharmaceuticals Ltd.
      2002   Phase 3   NCT01606176   United Kingdom;
      2002   Phase 3   NCT01606137   United Kingdom;
      2001   Phase 3   NCT01610713   United Kingdom;
      2001   Phase 3   NCT01610700   United Kingdom;
      2001   Phase 3   NCT01610687   United Kingdom;
GYLENIA   
   NOVARTIS FARMA
      2011   -   EUCTR2011-001442-15-IT   Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom;
GYLENIA 0,   
   Novartis Farmaceutica S.A.
      2013   -   EUCTR2012-000835-18-ES   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
GZ402668   
   Genzyme, a Sanofi Company
      2014   Phase 1   NCT02282826   Germany;
   Sanofi
      2016   Phase 1   NCT02977533   Germany;
GZ402673   
   Genzyme Corporation
      2017   Phase 3   EUCTR2016-003100-30-PT   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-NO   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-NL   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-GR   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-GB   Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-ES   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-DE   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-BE   Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      2017   Phase 3   EUCTR2016-003100-30-AT   Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      2015   Phase 3;Phase 4   EUCTR2013-003884-71-NL   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2015   Phase 3;Phase 4   EUCTR2013-003884-71-DK   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2015   -   EUCTR2013-003884-71-BE   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
      2014   Phase 4   EUCTR2014-000092-62-NL   Belgium;France;Netherlands;Spain;Switzerland;
      2014   Phase 4   EUCTR2014-000092-62-FR   Belgium;France;Netherlands;Spain;Switzerland;
      2014   Phase 4   EUCTR2014-000092-62-ES   Belgium;France;Netherlands;Spain;Switzerland;
      2014   Phase 4   EUCTR2014-000092-62-BE   Belgium;France;Netherlands;Spain;Switzerland;
      2014   Phase 3;Phase 4   EUCTR2013-003884-71-IT   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
      2014   Phase 3;Phase 4   EUCTR2013-003884-71-HR   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2014   Phase 3;Phase 4   EUCTR2013-003884-71-DE   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2014   Phase 3;Phase 4   EUCTR2013-003884-71-CZ   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2013-003884-71-ES   Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
      -   Phase 3   EUCTR2016-003100-30-PL   Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
      -   Phase 3   EUCTR2016-003100-30-Outside-EU/EEA   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      -   Phase 3   EUCTR2016-003100-30-FR   Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      -   Phase 3   EUCTR2016-003100-30-BG   Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
   Genzyme GmbH
      2016   Phase 3   EUCTR2016-000464-42-DE   Germany;
Gabapentin   
   Hospices Civils de Lyon
      2012   Phase 2   NCT01744444   France;
Gabapentine   
   Charité University Medicine Berlin
      2010   Phase 4   EUCTR2008-005167-33-DE   Germany;
   HOSPICES CIVILS DE LYON
      2015   Phase 2   EUCTR2014-005548-17-FR   France;
Gadobenate Dimeglumine   
   University of Southern California
      2011   -   NCT02967380   United States;
Gadobutrol   
   University of Southern California
      2011   -   NCT02967380   United States;
Gadolinium   
   Rennes University Hospital
      2009   -   NCT01567553   France;
Gadolinium-based contrast   
   Stanford University
      2014   -   NCT01973517   United States;
Gadopentetate   
   University of Southern California
      2011   -   NCT02967380   United States;
Gadoteric acid   
   Universitätsklinikum Erlangen
      2010   -   EUCTR2009-014857-34-DE   Germany;
Gadoteridol   
   University of Maryland, Baltimore
      2018   -   NCT03396822   United States;
Gadovist 1.0 mmol/ml Injektionslösung   
   Universitätsklinikum Erlangen
      2010   -   EUCTR2009-014857-34-DE   Germany;
Genotropin   
   University of Leipzig
      -   Phase 2   EUCTR2006-006465-16-DE   Germany;
GentleCath™ Air catheter   
   ConvaTec Inc.
      2021   -   NCT04847609   -
Gilenya   
   Biogen Idec Research Limited
      2015   Phase 4   EUCTR2013-004622-29-DK   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2015   Phase 4   EUCTR2013-004622-29-DE   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-SE   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-GB   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-ES   Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-004622-29-CZ   Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
      2014   -   EUCTR2013-004622-29-IT   Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
   F. Hoffmann-La Roche Ltd
      2022   Phase 3   EUCTR2020-004128-41-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-004128-41-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-004128-41-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-004128-41-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-004128-41-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-004128-41-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2020-004128-41-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2020-004128-41-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2020-004128-41-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
   Jochen Vehoff
      2013   Phase 4   NCT02048072   Switzerland;
   Karolinska Institutet
      2017   Phase 4   EUCTR2017-002634-24-SE   Sweden;
      2017   Phase 4   EUCTR2016-003587-39-SE   Sweden;
   McGill University
      2012   -   NCT02137707   Canada;
   NOVARTIS FARMA
      2011   -   EUCTR2011-001442-15-IT   Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom;
   NOVARTIS FARMA S.p.A
      2013   -   EUCTR2012-005507-40-IT   Italy;
   Northwestern University
      2013   Phase 2   EUCTR2012-004165-41-GB   United Kingdom;United States;
   Novartis Farma
      2013   -   EUCTR2011-005677-23-IT   Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
   Novartis Farma S.p.A.
      2012   -   EUCTR2010-023023-19-DE   Germany;Italy;
   Novartis Farma SpA
      2014   -   EUCTR2013-002660-17-IT   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
   Novartis Farmaceutica S.A.
      2013   -   EUCTR2011-005677-23-ES   Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
   Novartis Farmacéutica S.A.
      2011   Phase 3   EUCTR2011-003484-30-ES   Australia;Spain;
   Novartis Pharma AG
      2012   Phase 3   EUCTR2012-000835-18-FR   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2008   -   EUCTR2007-002627-32-NL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2008   -   EUCTR2007-002627-32-BE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
   Novartis Pharma GmbH
      2012   Phase 4   EUCTR2012-000674-31-DE   Germany;Switzerland;
      2012   Phase 4   EUCTR2012-000653-32-DE   Germany;
      2012   -   EUCTR2012-002637-11-DE   Germany;
      2011   Phase 3   EUCTR2010-022066-28-DE   Germany;
      2011   -   EUCTR2011-002969-38-DE   Germany;
      -   -   EUCTR2011-001692-39-DE   Germany;
   Novartis Pharma S.A.S
      2011   Phase 4   EUCTR2011-001280-49-FR   France;
   Novartis Pharma Service AG
      2015   Phase 3   EUCTR2011-005677-23-HR   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-GB   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-EE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2011-005677-23-RO   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-DE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-BG   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
      2013   -   EUCTR2011-005677-23-LV   Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
   Novartis Pharma Services AG
      2015   -   EUCTR2013-002660-17-PT   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
      2015   -   EUCTR2013-002660-17-DK   Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
      2014   Phase 3   EUCTR2012-000835-18-DK   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-PL   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-NL   Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005677-23-AT   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2012-000835-18-PL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2014   -   EUCTR2011-005677-23-SE   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2012-000835-18-DE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-SK   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-005677-23-LT   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-NL   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2013   -   EUCTR2012-000835-18-HU   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   -   EUCTR2012-000835-18-SE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2012   -   EUCTR2011-001442-15-SE   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2012   -   EUCTR2011-001437-16-DE   Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-020515-37-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2011   -   EUCTR2011-001442-15-GR   Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
      2011   -   EUCTR2011-001442-15-GB   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2011   -   EUCTR2011-001442-15-DE   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2011   -   EUCTR2011-001442-15-AT   Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-SE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2010   Phase 3   EUCTR2010-020515-37-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-FI   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-EE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2010   Phase 3   EUCTR2010-020515-37-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      2009   -   EUCTR2007-002627-32-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
   Novartis Services Pharma AG
      2008   -   EUCTR2007-002627-32-SE   Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
   Sakari Simula
      2012   Phase 4   EUCTR2012-002694-66-FI   Finland;
   Sheffield Teaching Hospitals NHS Foundation Trust
      2013   Phase 2/Phase 3   NCT03133403   United Kingdom;
   Turku University Hospital
      2014   Phase 4   EUCTR2014-000296-12-FI   Finland;
      2013   Phase 4   EUCTR2013-004626-28-FI   Finland;
   University of Southern California
      2013   -   NCT02225977   United States;
   Universitätsklinikum Münster
      2014   -   EUCTR2013-004616-21-DE   Germany;
   VU University Medical Center
      2014   -   EUCTR2014-001012-19-NL   Netherlands;
Gilenya / Imusera   
   Novartis Pharma K.K.
      2019   -   JPRN-JapicCTI-194838   Japan;
Gilenya 0,5 mg Hartkapseln   
   Novartis Pharma Services AG
      2010   Phase 3   EUCTR2010-020515-37-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
      -   -   EUCTR2007-002627-32-DE   Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Gilenya®   
   Charite Universitaetsmedizin Berlin
      2012   Phase 3   EUCTR2011-004787-30-DE   Germany;
   Charité - Universitätsmedizin Berlin
      2013   Phase 4   EUCTR2012-000411-91-DE   Germany;
   Universitätsklinikum Hamburg-Eppendorf
      2013   -   NCT03216915   Germany;
Gileyna   
   Stony Brook University
      2013   -   NCT02141022   United States;
Ginkgo biloba   
   National Center for Complementary and Integrative Health (NCCIH)
      1999   Phase 1/Phase 2   NCT00010842   United States;
   VA Office of Research and Development
      2009   Phase 2   NCT00841321   United States;
Ginseng   
   Isfahan University of Medical Sciences
      2010   Phase 2   NCT01712373   Iran, Islamic Republic of;
Glatiramer Acetate   
   Biogen
      2007   Phase 3   NCT00451451   Australia;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Costa Rica;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Ireland;Israel;Italy;Kazakhstan;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;New Zealand;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States;
   Biogen Idec Ltd.
      2008   -   EUCTR2006-003697-10-BG   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-IE   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-GR   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-DE   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
      2007   -   EUCTR2006-003697-10-CZ   Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
   Cinnagen
      2015   -   NCT04928313   -
   Isfahan University of Medical Sciences
      2017   Phase 2/Phase 3   NCT03315923   Iran, Islamic Republic of;
   Teva Pharmaceutical Industries
      2012   Phase 3   NCT01578785   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2005   Phase 4   NCT00203047   Canada;United States;
      2004   Phase 4   NCT00202995   Canada;United States;
   The Walton Centre for Neurology and Neurosurgery
      2005   Phase 4   EUCTR2004-004903-39-GB   United Kingdom;
   University of Colorado, Denver
      2012   Phase 2   NCT01569451   United States;
Glatiramer Acetate (Copaxone®)   
   Synthon BV
      2011   Phase 3   NCT01489254   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States;
Glatiramer Acetate (DB)   
   Teva Pharmaceutical Industries
      2004   Phase 3   NCT00666224   Argentina;Australia;Austria;Denmark;Finland;France;Germany;Hungary;Israel;Italy;New Zealand;Norway;Romania;Spain;Sweden;United Kingdom;United States;
Glatiramer Acetate (GA)   
   Sanofi
      2007   Phase 2   NCT00475865   Austria;Canada;Germany;Italy;United Kingdom;United States;
   Teva Pharmaceutical Industries
      2006   Phase 3   NCT00337779   Argentina;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;Spain;United Kingdom;United States;
Glatiramer Acetate (GTR)   
   Synthon BV
      2011   Phase 3   NCT01489254   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States;
Glatiramer Acetate (OL)   
   Teva Pharmaceutical Industries
      2004   Phase 3   NCT00666224   Argentina;Australia;Austria;Denmark;Finland;France;Germany;Hungary;Israel;Italy;New Zealand;Norway;Romania;Spain;Sweden;United Kingdom;United States;
Glatiramer Acetate [GA]   
   Sanofi
      2007   Phase 2   NCT00811395   Austria;Canada;Germany;Italy;Spain;United Kingdom;United States;
Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b   
   Teva Neuroscience, Inc.
      2008   -   NCT00819000   United States;
Glatiramer Acetate, N-Acetylcysteine   
   Teva Pharmaceutical Industries
      2004   Phase 2   NCT00203099   Canada;
Glatiramer acetate   
   AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
      2009   -   EUCTR2009-010661-23-IT   Italy;
   Amphia Hospital
      2009   Phase 4   NCT00910598   Netherlands;
   BIOGEN IDEC LTD
      2010   -   EUCTR2009-015556-15-IT   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
   Biogen
      2021   Phase 2   NCT04079088   -
      2010   Phase 3   NCT01058005   Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States;
      2010   Phase 2   NCT01071083   Germany;Spain;United States;
   Biogen Idec Ltd.
      2007   Phase 3   EUCTR2006-003697-10-ES   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
   FONDAZIONE DON CARLO GNOCCHI ONLUS
      2011   -   EUCTR2011-000150-31-IT   Italy;
   Fred Lublin
      2005   Phase 3   NCT00211887   Canada;United States;
   Genzyme, a Sanofi Company
      2017   Phase 3   NCT03368664   Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
   Glostrup Hospital, Dep. of Neurology
      2009   -   EUCTR2006-001827-21-DK   Denmark;
   ISTITUTO C. MONDINO
      2007   -   EUCTR2008-007162-32-IT   Italy;
   NOVARTIS FARMA
      2011   -   EUCTR2010-024017-31-IT   Italy;
   National Institute of Allergy and Infectious Diseases (NIAID)
      2001   -   NCT00039988   United States;
   Novartis Pharmaceuticals
      2012   Phase 3   NCT01633112   Argentina;Brazil;Canada;Chile;Mexico;Puerto Rico;United States;
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
   Philipps-Universität Marburg
      2010   -   EUCTR2009-011088-35-DE   Germany;
   Sanofi
      2003   Phase 4   NCT00267319   Czech Republic;
   Sheba Medical Center
      2006   -   NCT00331747   Israel;
   TEVA
      2004   -   EUCTR2004-000759-40-IT   Italy;
      2004   -   EUCTR2004-000463-94-IT   Hungary;Italy;
      2004   -   EUCTR2004-000462-13-IT   Hungary;Italy;
   TEVA ITALIA srl
      2004   -   EUCTR2004-000762-13-IT   Italy;
   Takeda
      2015   -   NCT03209479   Japan;
   Teva Branded Pharmaceutical Products R&D, Inc.
      1994   Phase 4   NCT00203021   United States;
   Teva Pharmaceutical Industries
      2003   Phase 2   NCT00202982   United States;
   Teva Pharmaceuticals Industries Ltd.
      2006   -   EUCTR2006-002037-20-IT   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
   University of California, San Francisco
      2008   -   NCT00819195   United States;
   VU University Medical Center
      2014   -   EUCTR2014-001012-19-NL   Netherlands;
Glatiramer acetate (GA)   
   Novartis Pharmaceuticals
      2012   Phase 4   NCT01534182   Russian Federation;
   Teva Branded Pharmaceutical Products R&D, Inc.
      2010   Phase 3   NCT01067521   Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Turkey;Ukraine;United Kingdom;United States;
Glatiramer acetate 150mg enteric coated tablets   
   TEVA Pharmaceutical Industries Ltd.
      2007   -   EUCTR2004-000463-94-HU   Hungary;Italy;
Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets   
   TEVA Pharmaceutical Industries Ltd.
      2004   -   EUCTR2004-000462-13-HU   Hungary;Italy;
Glatiramer acetate 20 mg, with mitoxantrone   
   Teva Pharmaceutical Industries
      2003   Phase 2   NCT00203073   Canada;United States;
Glatiramer acetate injection with oral cetirizine hydrochloride   
   Teva Pharmaceutical Industries
      2004   Phase 4   NCT00240032   United States;
Glatiramer acetate with minocycline   
   Teva Pharmaceutical Industries
      2004   Phase 2   NCT00203112   Canada;
Glatiramer acetate, (Copaxone®)   
   Neurognostics
      2006   -   NCT00398528   United States;
Glatiramer acetato   
   NOVARTIS PHARMA AG
      2021   Phase 3   EUCTR2020-004505-32-IT   France;Germany;Italy;Spain;
   Teva Pharmaceutical Industries, Ltd.
      2006   Phase 3   EUCTR2006-002037-20-ES   Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
   Teva Pharmaceuticals Industries Ltd.
      2006   -   EUCTR2006-002037-20-IT   Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato   
   BTG International Ltd
      2009   -   EUCTR2009-011585-28-ES   Belgium;France;Germany;Spain;
Glucose   
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      1999   Phase 3   NCT00062972   United States;
   Slovak Academy of Sciences
      2017   -   NCT03052595   Slovakia;
Glutamate and aspartate   
   University Hospital, Caen
      2007   -   NCT02523703   -
Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate   
   BTG International Ltd
      2009   Phase 2   EUCTR2009-011585-28-BE   Belgium;European Union;France;Germany;Russian Federation;Spain;
      2009   -   EUCTR2009-011585-28-FR   Belgium;France;Germany;Spain;
      2009   -   EUCTR2009-011585-28-DE   Belgium;European Union;France;Germany;Russian Federation;Spain;
Gold   
   Children's Hospital of Chongqing Medical University
      2017   -   ChiCTR-DND-17013749   China;
   Huashan Hospital, Fudan University
      2020   -   ChiCTR2000040363   China;
   The First Hospital of Jilin University
      2020   Phase 0   ChiCTR2000034098   China;
Gold nanocrystals   
   Clene Nanomedicine
      2019   Phase 2   NCT03993171   United States;
Granulocyte-colony stimulating factor (G-CSF) and prednisone   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2006   Phase 2   NCT00288626   United States;
Guanabenz   
   National Institute of Neurological Disorders and Stroke (NINDS)
      2015   Phase 1   NCT02423083   United States;
H.P. Acthar Gel (repository corticotropin injection)   
   The University of Texas Health Science Center, Houston
      2013   Phase 4   NCT01888354   United States;
H5G1.1-mAb   
   Alexion Pharmaceuticals Inc.
      2020   Phase 2;Phase 3   EUCTR2019-001829-26-DE   Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
      2019   Phase 2;Phase 3   EUCTR2019-001829-26-ES   Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)   
   ALEXION PHARMACEUTICALS INCORPORATED
      2020   Phase 2;Phase 3   EUCTR2019-001829-26-IT   Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
HB-adMSCs   
   Hope Biosciences Stem Cell Research Foundation
      2021   Phase 2   NCT05116540   United States;
HBM9161 Injection   
   Harbour BioMed (Guangzhou) Co. Ltd.
      2020   Phase 1   NCT04227470   China;
HMR 1726D   
   Sanofi-Aventis recherche & développement
      2008   -   EUCTR2007-003997-24-GB   Austria;Italy;Spain;United Kingdom;
      2007   -   EUCTR2007-003997-24-ES   Austria;Italy;Spain;United Kingdom;
      2007   -   EUCTR2007-003997-24-AT   Austria;Italy;Spain;United Kingdom;
   Sanofi-aventis recherche & développement
      2010   -   EUCTR2007-004452-36-SK   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2007-004452-36-SE   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2007-004452-36-GR   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2007-004452-36-GB   Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-004452-36-FR   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-004452-36-ES   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-004452-36-EE   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-004452-36-DE   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
   sanofi-aventis recherche & développement
      2009   -   EUCTR2007-004452-36-AT   Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2008   Phase 3   EUCTR2007-004452-36-BE   Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-004452-36-NL   Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-004452-36-CZ   Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
HMR1726   
   Aventis Pharmaceuticals Inc.
      2006   -   EUCTR2004-000555-42-PT   Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
   GENZYME CORPORATION
      2020   Phase 3   EUCTR2020-000637-41-IT   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2017   Phase 3   EUCTR2011-005249-12-IT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States;
   Genzyme Corporation
      2021   Phase 3   EUCTR2020-000644-55-DE   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000637-41-AT   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000644-55-SK   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-PT   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-NL   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-LV   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-HU   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-GR   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-GB   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-FR   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000644-55-CZ   Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000637-41-SE   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-PL   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-LT   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-FI   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-DK   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-DE   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-CZ   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2020-000637-41-BG   Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
      2017   Phase 3   EUCTR2011-005249-12-SI   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2011-005249-12-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2011-005249-12-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States;
      2015   Phase 3   EUCTR2011-005249-12-LT   Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2015   -   EUCTR2011-005249-12-PL   Australia;Belgium;Canada;China;Estonia;Greece;Israel;Lebanon;Lithuania;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-001439-34-IT   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-001439-34-GR   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   Phase 4   EUCTR2013-001439-34-GB   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005249-12-GR   Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005249-12-GB   Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005249-12-ES   Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005249-12-EE   Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States;
      2014   Phase 3   EUCTR2011-005249-12-BE   Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2014   -   EUCTR2013-001439-34-DE   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-001439-34-BE   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2014   -   EUCTR2013-001439-34-AT   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2013   Phase 4   EUCTR2013-001439-34-SE   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2013   Phase 4   EUCTR2013-001439-34-FI   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
      2013   Phase 4   EUCTR2013-001439-34-ES   Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
      2013   -   EUCTR2012-005324-16-NL   Belgium;Germany;Netherlands;
      2013   -   EUCTR2012-005324-16-DE   Belgium;Germany;Netherlands;
      2013   -   EUCTR2012-005324-16-BE   Belgium;Germany;Netherlands;
      -   Phase 3   EUCTR2011-005249-12-Outside-EU/EEA   Australia;Bosnia and Herzegovina;Canada;China;Israel;Lebanon;Morocco;Russian Federation;Tunisia;Turkey;United States;
      -   Phase 3   EUCTR2011-005249-12-IE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States;
      -   Phase 3   EUCTR2011-005249-12-FR   Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States;
      -   Phase 3   EUCTR2011-005249-12-BG   Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
   Sanofi-Aventis US, Inc.
      2004   -   EUCTR2004-000555-42-AT   Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
   Sanofi-aventis US, Inc
      2008   Phase 3   EUCTR2004-000555-42-GB   Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
      2005   -   EUCTR2004-000555-42-DK   Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
      2004   -   EUCTR2004-000555-42-SE   Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
      2004   -   EUCTR2004-000555-42-NO   Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
   sanofi-aventis Recherche & De`veloppement
      2004   -   EUCTR2004-000555-42-IT   Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
   sanofi-aventis Recherche & Dévelopment
      2009   -   EUCTR2008-006226-34-FR   Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
   sanofi-aventis U.S Inc
      2007   -   EUCTR2004-000555-42-CZ   Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
   sanofi-aventis group
      2011   -   EUCTR2010-023172-12-GR   Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
   sanofi-aventis recherche et development
      2012   -   EUCTR2010-023172-12-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-023172-12-SK   Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2011   Phase 3   EUCTR2010-023172-12-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-023172-12-BE   Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-023172-12-SE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
      2011   -   EUCTR2010-023172-12-PT   Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-023172-12-NO   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
      2011   -   EUCTR2010-023172-12-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
      2011   -   EUCTR2010-023172-12-IT   Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-023172-12-GB   Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-023172-12-FI   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
      2011   -   EUCTR2010-023172-12-ES   Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-023172-12-EE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
      2011   -   EUCTR2010-023172-12-DK   Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
      2011   -   EUCTR2010-023172-12-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
      2011   -   EUCTR2010-023172-12-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-006226-34-GR   Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom;
      2009   -   EUCTR2008-006226-34-IT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
      2009   -   EUCTR2008-006226-34-ES   Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
      2009   -   EUCTR2008-006226-34-BE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
   sanofi-aventis recherche et developpement
      2010   -   EUCTR2008-006226-34-GB   Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
      2009   -   EUCTR2008-006226-34-HU   Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
      2009   -   EUCTR2008-006226-34-DE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
      2009   -   EUCTR2008-006226-34-CZ   Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
HMR1726D   
   Sanofi-Aventis recherche & de'veloppement
      2008   -   EUCTR2007-003997-24-IT   Austria;Italy;Spain;United Kingdom;
   Sanofi-Aventis recherche & développement
      2008   -   EUCTR2007-003997-24-GB   Austria;Italy;Spain;United Kingdom;
      2007   -   EUCTR2007-003997-24-ES   Austria;Italy;Spain;United Kingdom;
      2007   -   EUCTR2007-003997-24-AT   Austria;Italy;Spain;United Kingdom;
   Sanofi-aventis U.S. Inc
      2007   -   EUCTR2006-003134-14-IT   Germany;Italy;Spain;
      2007   -   EUCTR2004-000555-42-EE   Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
   Sanofi-aventis U.S. Inc.
      2007   Phase 2   EUCTR2006-004893-29-GB   Austria;Germany;Italy;United Kingdom;
      2007   Phase 2   EUCTR2006-003134-14-ES   Germany;Italy;Spain;
      2007   -   EUCTR2006-004893-29-IT   Austria;Germany;Italy;United Kingdom;
      2007   -   EUCTR2006-004893-29-AT   Austria;Germany;Italy;United Kingdom;
      2007   -   EUCTR2006-003134-14-DE   Germany;Italy;Spain;
      -   -   EUCTR2006-004893-29-DE   Austria;Germany;Italy;United Kingdom;
   Sanofi-aventis recherche & développement
      2010   -   EUCTR2007-004452-36-SK   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2007-004452-36-SE   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2007-004452-36-GR   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2007-004452-36-GB   Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2008   Phase 3   EUCTR2006-001152-12-FR   Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
      2008   -   EUCTR2007-004452-36-FR   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-004452-36-ES   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-004452-36-EE   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2007-004452-36-DE   Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2006-001152-12-SK   Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
   sanofi-aventis recherche de veloppement
      2007   -   EUCTR2006-003361-14-IT   Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
   sanofi-aventis recherche & developpement
      2011   -   EUCTR2011-001160-21-DE   Austria;Canada;Germany;Russian Federation;Ukraine;
      2011   -   EUCTR2011-001160-21-AT   Austria;Canada;Germany;Russian Federation;Ukraine;
   sanofi-aventis recherche & développement
      2009   -   EUCTR2007-004452-36-AT   Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2006-003361-14-EE   Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2009   -   EUCTR2006-003361-14-CZ   Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2006-001152-12-LT   Australia;Austria;Belarus;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2006-001152-12-DE   Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
      2008   Phase 3   EUCTR2007-004452-36-BE   Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2008   Phase 3   EUCTR2006-003361-14-PT   Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2006-001152-12-BG   Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
      2008   -   EUCTR2007-004452-36-NL   Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2007-004452-36-CZ   Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2006-003361-14-NL   Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2006-003361-14-DK   Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2008   -   EUCTR2006-001152-12-HU   Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
      2008   -   EUCTR2006-001152-12-EE   Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
      2007   Phase 3   EUCTR2006-003361-14-SE   Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2007   Phase 3   EUCTR2006-003361-14-GB   Austria;Canada;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2007   Phase 3   EUCTR2006-001152-12-GB   Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
      2007   Phase 3   EUCTR2006-001152-12-FI   Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
      2007   Phase 3   EUCTR2006-001152-12-CZ   Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
      2007   -   EUCTR2006-003361-14-DE   Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Poland;Portugal;Russian Federation;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2007   -   EUCTR2006-001152-12-DK   Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
      2007   -   EUCTR2006-001152-12-AT   Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
      2006   Phase 3   EUCTR2006-003361-14-FI   Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
      2006   -   EUCTR2006-003361-14-AT   Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
HP184   
   sanofi-aventis Recherche & Développement
      2009   Phase 2   EUCTR2008-001999-67-FR   Finland;France;Germany;Spain;
      2009   Phase 2   EUCTR2008-001999-67-ES   Finland;France;Germany;Spain;
      2009   -   EUCTR2008-001999-67-FI   Finland;France;Germany;Spain;
      2009   -   EUCTR2008-001999-67-DE   Finland;France;Germany;Spain;
HUMAN LEUCOCYTE INTERFERON-ALPHA   
   Dansk Multipel Sclerose Center
      2010   -   EUCTR2009-016824-29-DK   Denmark;
Helminth ova   
   University of Wisconsin, Madison
      2008   Phase 1   NCT00645749   United States;
Hematopoetic stem cell infusion   
   Talaris Therapeutics Inc.
      2007   Phase 1/Phase 2   NCT00497952   United States;
Hematopoietic Stem Cell Therapy   
   Northwestern University
      2005   Phase 2   NCT00273364   United States;
Hematopoietic stem cell transplantation   
   Northwestern University
      2003   Phase 1/Phase 2   NCT00278655   United States;
Hematopoietic stem cell transplantation (HSCT)   
   Sheffield Teaching Hospitals NHS Foundation Trust
      2013   Phase 2/Phase 3   NCT03133403   United Kingdom;
Heterologous booster   
   Griffin Hospital
      2021   -   NCT05081271   -
Hiberix   
   ALEXION PHARMACEUTICALS INCORPORATED
      2020   Phase 2;Phase 3   EUCTR2019-001829-26-IT   Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
Hidrocloruro de fingolimod   
   Novartis Farmacéutica, S.A.
      2011   -   EUCTR2011-001442-15-ES   Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
High Dose Aspirin (1300 mg/day)   
   Mayo Clinic
      2007   Phase 3   NCT00467584   United States;
High Phenolic Extra Virgin Olive Oil   
   University of Cyprus
      2021   -   NCT04787497   -
High/Low Sodium Diet   
   Yale University
      2014   -   NCT02282878   United States;
Histamine   
   University of Nottingham
      2008   Phase 2   NCT00630383   United Kingdom;
Home based balance training   
   University of Arizona
      2014   -   NCT02777060   United States;
Homologous booster   
   Griffin Hospital
      2021   -   NCT05081271   -
Hookworm larvae   
   University of Nottingham
      2011   Phase 2   NCT01470521   United Kingdom;
HuL001   
   HuniLife Biotechnology, Inc.
      2021   Phase 1   NCT04540770   Taiwan;
HuMax-CD20   
   Genmab A/S
      2008   Phase 2   EUCTR2007-004223-38-DE   Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
      2008   -   EUCTR2007-004223-38-BE   Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
   GlaxoSmithKline
      2008   -   EUCTR2007-004223-38-DK   Czech Republic;Denmark;Germany;Sweden;United Kingdom;
   GlaxoSmithKline AB
      2008   -   EUCTR2007-004223-38-SE   Czech Republic;Denmark;Germany;Sweden;United Kingdom;
   GlaxoSmithKline UK
      2009   Phase 2   EUCTR2007-004223-38-GB   Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
   GlaxoSmithKline s.r.o.
      2008   -   EUCTR2007-004223-38-CZ   Czech Republic;Denmark;Germany;Sweden;United Kingdom;
Human Neural Stem Cells   
   Casa Sollievo della Sofferenza IRCCS
      2017   Phase 1   NCT03282760   Italy;Switzerland;
Human anti-IL-12 IgG1 Mab   
   Centocor B.V.
      2005   Phase 2   EUCTR2004-000145-38-GB   Czech Republic;Hungary;United Kingdom;
      2004   Phase 2   EUCTR2004-000145-38-CZ   Czech Republic;Hungary;United Kingdom;
      2004   -   EUCTR2004-000145-38-HU   Czech Republic;Hungary;United Kingdom;
Human anti-IL-12 Mab   
   Centocor B.V.
      2005   Phase 2   EUCTR2004-000145-38-GB   Czech Republic;Hungary;United Kingdom;
      2004   Phase 2   EUCTR2004-000145-38-CZ   Czech Republic;Hungary;United Kingdom;
      2004   -   EUCTR2004-000145-38-HU   Czech Republic;Hungary;United Kingdom;
Human anti-LINGO-1 monoclonal antibody   
   Biogen Idec Research Limited
      2013   Phase 2   EUCTR2011-006262-40-NL   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-IT   Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-HU   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-GB   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-CZ   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Human autologous mesenchymal stem cells   
   SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
      -   -   EUCTR2015-000137-78-AT   Austria;
Human fetal-derived Neural Stem Cells (hNSCs)   
   IRCCS San Raffaele
      2017   Phase 1   NCT03269071   Italy;
Human interferon beta 1a (Rebif)   
   Aaron Boster
      2006   Phase 0   NCT00618527   United States;
Human interferon beta-1a and glatiramer acetate   
   EMD Serono
      2004   Phase 4   NCT00078338   Argentina;Austria;Brazil;France;Germany;Italy;Netherlands;Russian Federation;Spain;Switzerland;United Kingdom;United States;
Human monoclonal antibody (CNTO 1275) to interleukin-12p40   
   Centocor B.V.
      2005   Phase 2   EUCTR2004-000145-38-GB   Czech Republic;Hungary;United Kingdom;
      2004   Phase 2   EUCTR2004-000145-38-CZ   Czech Republic;Hungary;United Kingdom;
      2004   -   EUCTR2004-000145-38-HU   Czech Republic;Hungary;United Kingdom;
Human normal immunoglobulin   
   Octapharma AG
      2015   Phase 3   EUCTR2012-005086-12-PL   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
      2013   -   EUCTR2012-005086-12-HU   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-DE   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-BG   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-AT   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Human recombinant growth hormone   
   University of Leipzig
      -   Phase 2   EUCTR2006-006465-16-DE   Germany;
Hydrogen peroxide   
   Tehran University of Medical Sciences
      2012   -   NCT02463318   Iran, Islamic Republic of;
Hydroxychloroquine   
   University of Calgary
      2016   Phase 2   NCT02913157   Canada;
Hydroxychloroquine and Indapamide   
   University of Calgary
      2021   Phase 2   NCT05013463   -
Hydroxyurea   
   S. Andrea Hospital
      2011   Phase 2/Phase 3   NCT01103583   Italy;
Hyperimmune caprine serum against HIV lysate   
   Daval International Limited
      2009   Phase 2   NCT01228396   United Kingdom;
IFA Incomplete Freund's Adjuvant   
   Immune Response BioPharma, Inc.
      2020   Phase 2   NCT02149706   United States;
      2020   Phase 1   NCT02200718   United States;
IFN beta 1a 44 mcg TIW   
   Merck KGaA, Darmstadt, Germany
      2012   Phase 2   NCT01514370   Italy;
IFN beta-1a   
   BIOGEN IDEC RESEARCH LIMITED
      2019   Phase 3   EUCTR2018-003008-38-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
   Biogen Idec Research Limited
      2020   Phase 3   EUCTR2018-003008-38-DE   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-SK   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-PT   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-HU   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-HR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-GR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-ES   Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
      2019   Phase 3   EUCTR2018-003008-38-CZ   Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
      2019   Phase 3   EUCTR2018-003008-38-BG   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-BE   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      -   Phase 3   EUCTR2018-003008-38-FR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
   Merck KGaA, Darmstadt, Germany
      2018   Phase 2   NCT03387046   Germany;Italy;
IFN ß-1a   
   BIOGEN IDEC RESEARCH LIMITED
      2019   Phase 3   EUCTR2018-003008-38-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
   Biogen Idec Research Limited
      2020   Phase 3   EUCTR2018-003008-38-DE   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-SK   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-PT   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-HU   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-HR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-GR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-ES   Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
      2019   Phase 3   EUCTR2018-003008-38-CZ   Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
      2019   Phase 3   EUCTR2018-003008-38-BG   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      2019   Phase 3   EUCTR2018-003008-38-BE   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
      -   Phase 3   EUCTR2018-003008-38-FR   Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
IFN-beta-1a (Rebif®)   
   Waukesha Memorial Hospital
      2008   -   NCT00391352   United States;
IFN-beta-1a, (Avonex®)   
   Neurognostics
      2006   -   NCT00398528   United States;
IFN-ß-1a (Rebif®)   
   Waukesha Memorial Hospital
      2008   -   NCT00391352   United States;
IFN-ß-1a, (Avonex®)   
   Neurognostics
      2006   -   NCT00398528   United States;
IL2   
   Assistance Publique - Hôpitaux de Paris
      2016   Phase 2   NCT02424396   France;
IM90838   
   Immunic AG
      2022   Phase 2   EUCTR2021-000048-23-NL   Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2022   Phase 2   EUCTR2021-000048-23-DE   Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2021   Phase 2   EUCTR2021-000048-23-BG   Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;
IMATINIB MESILATE   
   Department of Clinical Neuroscience, Karolinska Institutet
      2020   Phase 2   EUCTR2018-000620-34-DE   Germany;Sweden;
      2018   Phase 2   EUCTR2018-000620-34-SE   Sweden;
IMMUNOGLOBULIN G   
   Octapharma AG
      2015   Phase 3   EUCTR2012-005086-12-PL   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
      2013   -   EUCTR2012-005086-12-HU   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-DE   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-BG   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
      2013   -   EUCTR2012-005086-12-AT   Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
IMMUNOSUPPRESSIVE AGENTS   
   Actelion Pharmaceuticals Ltd
      2010   -   EUCTR2009-011470-15-IT   Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
IMS001   
   ImStem Biotechnology
      2021   Phase 1   NCT04956744   United States;
IMU-838   
   Immunic AG
      2022   Phase 3   EUCTR2021-000028-36-BG   Albania;Belarus;Bulgaria;Colombia;Georgia;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Ukraine;United States;
      2022   Phase 2   EUCTR2021-000048-23-NL   Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2022   Phase 2   EUCTR2021-000048-23-DE   Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
      2021   Phase 2   NCT05054140   Bulgaria;Poland;Ukraine;United States;
      2021   Phase 2   EUCTR2021-000048-23-BG   Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;
      2018   Phase 2   EUCTR2018-001896-19-BG   Bulgaria;Poland;Romania;Ukraine;
IMU-838 (30 mg/day)   
   Immunic AG
      2019   Phase 2   NCT03846219   Bulgaria;Poland;Romania;Ukraine;
IMU-838 (45 mg/day)   
   Immunic AG
      2019   Phase 2   NCT03846219   Bulgaria;Poland;Romania;Ukraine;
IMU-838 tablets   
   Immunic AG
      2022   Phase 3   NCT05201638   -
      2021   Phase 3   NCT05134441   -
INF beta-1a   
   Bosnalijek D.D
      2019   Phase 3   NCT03283397   Turkey;
INN COLECALCIFEROL   
   Merja Soilu Häninen
      2007   -   EUCTR2007-001958-99-FI   Finland;
INT131   
   InteKrin Therapeutics, Inc.
      2015   Phase 2   NCT02638038   -
INTERFERON BETA - 1A   
   BIOGEN IDEC RESEARCH LIMITED
      2019   Phase 3   EUCTR2018-003008-38-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
INTERFERON BETA-1A (Avonex®)   
   Teva Pharmaceutical Industries Ltd
      2008   -   EUCTR2007-005450-23-LT   Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
INTERFERON BETA1A   
   Biogen Idec Limited
      2010   -   EUCTR2009-015556-15-ES   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
   Biogen Idec Ltd
      2010   Phase 3   EUCTR2009-012500-11-ES   Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
   Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
      2009   Phase 3   EUCTR2008-004954-34-ES   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain;
   Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
      2006   -   EUCTR2006-002982-38-ES   Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
   sanofi-aventis recherche et development
      2009   -   EUCTR2008-006226-34-ES   Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
INTERFERONE BETA 1B   
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
IPX056   
   Impax Laboratories, LLC
      2009   Phase 2   NCT00914290   United States;
      2007   Phase 3   NCT00488839   Canada;Estonia;Latvia;Ukraine;United States;
IPX056-   
   IMPAX Laboratories, Inc.
      2007   -   EUCTR2007-000236-16-LV   Estonia;Latvia;
      2007   -   EUCTR2007-000236-16-EE   Estonia;Latvia;
IR902   
   The Immune Response Corporation
      2007   Phase 2   EUCTR2006-003384-30-SK   Slovakia;
IS (B cell depletion therapy)   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States;
IS (MMF or MPA)   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States;
IS (MTX)   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States;
IV methylprednisolone   
   Biogen Idec
      2003   Phase 4   NCT00112034   United States;
   Fred Lublin
      2003   Phase 3   NCT00418145   United States;
IV methylprednisolone (steroids)   
   University of Colorado, Denver
      2013   Phase 4   NCT01838174   United States;
IVIg   
   Northwestern University
      2019   Phase 2/Phase 3   NCT03829566   United States;
      2017   Phase 3   NCT03342638   United States;
Ibudilast   
   MediciNova
      2013   Phase 2   NCT01982942   United States;
Ibuprofen   
   Genzyme, a Sanofi Company
      2014   Phase 4   NCT02205489   Belgium;France;Netherlands;Spain;
Ibuprofen Sandoz 400 mg Filmtabletten   
   Merck Serono International SA
      2007   -   EUCTR2006-005972-42-DE   France;Germany;
Idebenone   
   National Institute of Allergy and Infectious Diseases (NIAID)
      2013   Phase 1/Phase 2   NCT01854359   United States;
      2009   Phase 1/Phase 2   NCT00950248   United States;
Imatinib Mesylate   
   Tomas Olsson
      2018   Phase 2   NCT03674099   Denmark;Germany;Norway;Sweden;
Immune Globulin IV [Human], Caprylate/Chromatography Purified   
   Grifols Therapeutics Inc.
      2002   Phase 2   NCT00220779   Austria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Poland;Slovakia;Sweden;United Kingdom;United States;
Immune globulin   
   National Institute of Neurological Disorders and Stroke (NINDS)
      1993   Phase 3   NCT00004744   -
Immunoadsorption   
   University Hospital Muenster
      2018   -   NCT04450030   Germany;
Immunoglobulin   
   Octapharma AG
      2008   -   EUCTR2008-004579-22-AT   Austria;
Impact   
   Fondazione Don Carlo Gnocchi Onlus
      2018   -   NCT04881422   Italy;
   Nelson Mandela Metropolitan University
      2011   Phase 0   NCT01453868   United States;
   University Hospital, Strasbourg, France
      2019   Phase 2   NCT03910738   France;
   University of Alabama at Birmingham
      2022   -   NCT05165238   -
IncabotulinumtoxinA   
   Multiple Sclerosis Center of Northeastern New York
      2013   Phase 4   NCT01968902   United States;
Incobotulinum toxin A   
   Pôle Saint Hélier
      2014   -   NCT04265092   -
Inebilizumab   
   MedImmune LLC
      2018   Phase 2;Phase 3   EUCTR2014-000253-36-NL   Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
      2017   Phase 2;Phase 3   EUCTR2014-000253-36-HU   Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
      2015   Phase 2;Phase 3   EUCTR2014-000253-36-DE   Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
      2015   Phase 2;Phase 3   EUCTR2014-000253-36-BG   Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
      2015   Phase 2/Phase 3   NCT02200770   Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
      2014   Phase 2;Phase 3   EUCTR2014-000253-36-PL   Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
      2014   Phase 2;Phase 3   EUCTR2014-000253-36-EE   Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
      2014   Phase 2;Phase 3   EUCTR2014-000253-36-CZ   Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
   Sato Toshiyuki
      2020   Phase 3   JPRN-jRCT2051210017   Japan;
Influenza Vaccine   
   Hoffmann-La Roche
      2015   Phase 3   NCT02545868   Canada;United States;
Influenza vaccine   
   Sanofi
      2011   Phase 2   NCT01403376   Austria;Canada;Germany;Russian Federation;Ukraine;
Inhaled Cannabis   
   University of California, Davis
      2004   Phase 1/Phase 2   NCT00682929   United States;
Injectable MS DMT   
   Biogen
      2015   Phase 4   NCT02471560   Norway;
Injection of autologous bone marrow derived mesenchymal stem cells   
   Hadassah Medical Organization
      2006   Phase 1/Phase 2   NCT00781872   -
Injection of cell free media   
   Royan Institute
      2011   Phase 1/Phase 2   NCT01377870   Iran, Islamic Republic of;
Inosine   
   National Center for Complementary and Integrative Health (NCCIH)
      2002   Phase 2   NCT00067327   United States;
   Tsukuba International Clinical Pharmacology Clinic
      2016   -   JPRN-UMIN000024312   Japan;
Insulin   
   Johns Hopkins University
      2017   Phase 1/Phase 2   NCT02988401   United States;
Inteferone Beta-1A   
   OSPEDALE SAN RAFFAELE
      2018   Phase 4   EUCTR2016-004819-12-IT   Italy;
Interferon Beta 1   
   University of Turin, Italy
      1999   Phase 3   NCT00473213   -
Interferon Beta 1a pegilado   
   Biogen Idec Limited
      2011   -   EUCTR2010-024477-39-ES   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Interferon Beta Therapy   
   Biogen
      2021   -   NCT04655222   Germany;
Interferon Beta-1A Prefilled Syringe   
   Cinnagen
      2017   Phase 3   NCT05242133   Iran, Islamic Republic of;
Interferon beta   
   Heidelberg University
      2006   Phase 3   NCT00344253   Germany;
Interferon beta - 1a (IFN)   
   Novartis Pharmaceuticals
      2012   Phase 4   NCT01534182   Russian Federation;
Interferon beta -1b   
   EMD Serono
      2006   Phase 3   NCT00428584   United States;
Interferon beta 1-a   
   Biogen
      2010   Phase 2   NCT01071083   Germany;Spain;United States;
   Fred Lublin
      2005   Phase 3   NCT00211887   Canada;United States;
   Merck Healthcare KGaA
      2020   Phase 3   EUCTR2018-004701-11-BG   Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-004700-19-BG   Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)   
   Bayer
      2011   -   NCT01071694   Korea, Republic of;
Interferon beta 1B   
   Charite Universitaetsmedizin Berlin
      2012   Phase 3   EUCTR2011-004787-30-DE   Germany;
Interferon beta 1a   
   Biogen Idec Limited
      2012   Phase 3   EUCTR2010-024477-39-GR   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2010-024477-39-GB   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2010-024477-39-CZ   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-024477-39-DE   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   Phase 3   EUCTR2010-024477-39-BG   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2010-024477-39-LV   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2010-024477-39-EE   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2011   -   EUCTR2010-024477-39-BE   Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2010   -   EUCTR2008-006333-27-CZ   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-006333-27-GB   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2008-006333-27-NL   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2008-006333-27-EE   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2008-006333-27-BG   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2009   -   EUCTR2008-006333-27-BE   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      -   -   EUCTR2008-006333-27-DE   Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
   Biogen Idec Ltd
      2009   -   EUCTR2008-003098-42-CZ   Czech Republic;
   Merck KGaA
      2005   -   NCT01142518   -
      2005   -   NCT01142453   -
   MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
      2002   Phase 4   NCT00037115   United States;
      2001   Phase 4   NCT00037102   United States;
   Rennes University Hospital
      2010   Phase 3   NCT02937285   France;
   Revalesio Corporation
      2013   Phase 2   NCT01714089   United States;
   Trio Medicines Ltd.
      2001   Phase 1   NCT01863069   United Kingdom;
   UCL Biomedicine R&D Unit
      2006   -   EUCTR2005-005751-18-GB   United Kingdom;
Interferon beta 1a 30 ug IM once weekly   
   Beth Israel Deaconess Medical Center
      2001   Phase 4   NCT00179478   Canada;United States;
Interferon beta 1a, oral doxycycline   
   Louisiana State University Health Sciences Center Shreveport
      2003   Phase 4   NCT00246324   United States;
Interferon beta 1b   
   Novartis Pharmaceuticals
      2011   Phase 4   NCT01333501   Germany;Italy;
   Schering AG
      2007   Phase 3   EUCTR2006-005270-47-ES   Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
   UCL Biomedicine R&D Unit
      2006   -   EUCTR2005-005751-18-GB   United Kingdom;
   University Hospital Inselspital, Berne
      2005   Phase 2   NCT00942591   Switzerland;
Interferon beta 1b (Betaseron, BAY86-5046)   
   Bayer
      2003   Phase 2   NCT00235989   United States;
Interferon beta treatment to add-on atorvastatin treatment   
   Charite University, Berlin, Germany
      2003   Phase 2   NCT00616187   -
Interferon beta type 1a   
   Biogen
      2019   Phase 3   NCT03958877   Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Interferon beta-1 a   
   Serono GmbH
      2005   -   EUCTR2005-001026-89-DE   Germany;
Interferon beta-1a   
   BIOGEN IDEC LTD
      2010   -   EUCTR2009-015556-15-IT   Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
      2010   -   EUCTR2009-012500-11-IT   Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
   BIOGEN-DOMPE` SRL
      2010   -   EUCTR2009-017003-28-IT   Italy;
   Biogen
      2017   Phase 4   NCT03177083   Portugal;
      2014   Phase 3   NCT02283853   Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
      2013   -   NCT02076841   Czech Republic;Switzerland;
      2012   -   NCT01272128   Belgium;United States;
      2010   Phase 3   NCT01064401   Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2010   Phase 3   NCT01058005   Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States;
   Biogen Idec
      2007   Phase 4   NCT00574041   Australia;
      2005   Phase 3   NCT00915577   -
      2003   Phase 2   NCT00912860   -
      2002   -   NCT00599274   Australia;Austria;Canada;United States;
      1999   Phase 4   NCT00534261   Belgium;Luxembourg;United Kingdom;
   Biogen Idec GmbH
      2005   -   EUCTR2004-004130-14-AT   Austria;
   Biogen Idec Research Limited
      2013   Phase 2   EUCTR2011-006262-40-NL   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-IT   Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-HU   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-GB   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-006262-40-CZ   Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
   Celgene
      2014   Phase 3   NCT02294058   Argentina;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2013   Phase 3   NCT02047734   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
   Centre Hospitalier Universitaire Vaudois
      2005   Phase 1   NCT02515695   -
   Genzyme Corporation
      2008   -   EUCTR2007-001162-32-IT   Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
   Genzyme, a Sanofi Company
      2007   Phase 3   NCT00548405   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
      2007   Phase 3   NCT00530348   Argentina;Australia;Brazil;Canada;Croatia;Czech Republic;Former Serbia and Montenegro;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;United States;
      2002   Phase 2   NCT00050778   Croatia;Poland;Russian Federation;United Kingdom;United States;
   Hoffmann-La Roche
      2011   Phase 3   NCT01412333   Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;France;Germany;Ireland;Italy;Mexico;Morocco;Norway;Poland;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2011   Phase 3   NCT01247324   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
   ISTITUTO C. MONDINO
      2007   -   EUCTR2008-007162-32-IT   Italy;
   MERCK SERONO SA
      2010   -   EUCTR2009-016087-37-IT   France;Ireland;Italy;Spain;United Kingdom;
      2009   -   EUCTR2008-004954-34-IT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
      2009   -   EUCTR2008-003706-33-IT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2008-000499-25-IT   Germany;Italy;Spain;Sweden;
   MERCK SERONO SPA
      2009   -   EUCTR2009-013333-24-IT   Italy;
   MedImmune LLC
      2012   -   EUCTR2011-005475-16-GB   Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
   Merck KGaA
      2005   Phase 4   NCT01201343   -
      2005   -   NCT01142492   -
   Merck Serono International SA
      2007   -   EUCTR2006-005972-42-DE   France;Germany;
   NOVARTIS FARMA
      2011   -   EUCTR2010-024017-31-IT   Italy;
      2006   -   EUCTR2006-000704-17-IT   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
   Novartis Pharma AG
      2021   Phase 3   EUCTR2020-004505-32-FR   France;Germany;
      2021   Phase 3   EUCTR2020-004505-32-DE   France;Germany;Italy;Spain;
   Novartis Pharma Services AG
      2006   Phase 3   EUCTR2006-000704-17-GR   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   -   EUCTR2006-000704-17-PT   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
      2006   -   EUCTR2006-000704-17-GB   Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
   Novartis Pharmaceuticals
      2013   Phase 3   NCT01892722   Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
   OSPEDALE S. RAFFAELE
      200